Section 53

EurekaMag Full Text Articles Chapter 52,749


Rakitov, R.; Moysa, A.A.; Kopylov, A.T.; Moshkovskii, S.A.; Peters, R.S.; Meusemann, K.; Misof, B.; Dietrich, C.H.; Johnson, K.P.; Podsiadlowski, L.; Walden, K.K.O. 2018: Brochosomins and other novel proteins from brochosomes of leafhoppers (Insecta, Hemiptera, Cicadellidae). Insect Biochemistry and Molecular Biology 94: 10-17
Yang, S.-Y.; Yang, T.-Y.; Li, Y.-J.; Chen, K.-C.; Liao, K.-M.; Hsu, K.-H.; Tsai, C.-R.; Chen, C.-Y.; Hsu, C.-P.; Hsia, J.-Y.; Chuang, C.-Y.; Tsai, Y.-H.; Chen, K.-Y.; Huang, M.-S.; Su, W.-C.; Chen, Y.-M.; Hsiung, C.A.; Shen, C.-Y.; Chang, G.-C.; Yang, P.-C.; Chen, C.-J. 2013: EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients. International Journal of Cancer 132(2): 449-458
Park, J.; Kondo, C.; Shimizu, J.; Horio, Y.; Yoshida, K.; Hida, T. 2014: EGFR exon 19 insertions show good response to gefitinib, but short time to progression in Japanese patients. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9(2): E10-E11
He, M.; Capelletti, M.; Nafa, K.; Yun, C.-H.; Arcila, M.E.; Miller, V.A.; Ginsberg, M.S.; Zhao, B.; Kris, M.G.; Eck, M.J.; Jänne, P.A.; Ladanyi, M.; Oxnard, G.R. 2012: EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(6): 1790-1797
Voon, P.Jye.; Tsui, D.Wai.Yi.; Rosenfeld, N.; Chin, T.Min. 2013: EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib--Letter. Molecular Cancer Therapeutics 12(11): 2614-2615
Sasaki, H.; Endo, K.; Takada, M.; Kawahara, M.; Kitahara, N.; Tanaka, H.; Okumura, M.; Matsumura, A.; Iuchi, K.; Kawaguchi, T.; Kawano, O.; Yukiue, H.; Yokoyama, T.; Yano, M.; Fujii, Y. 2007: EGFR exon 20 insertion mutation in Japanese lung cancer. Lung Cancer 58(3): 324-328
Arcila, M.E.; Nafa, K.; Chaft, J.E.; Rekhtman, N.; Lau, C.; Reva, B.A.; Zakowski, M.F.; Kris, M.G.; Ladanyi, M. 2013: EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics. Molecular Cancer Therapeutics 12(2): 220-229
Yasuda, H.; Kobayashi, S.; Costa, D.B. 2012: EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications. LANCET. Oncology 13(1): E23-E31
Baty, F.; Rothschild, S.; Früh, M.; Betticher, D.; Dröge, C.; Cathomas, R.; Rauch, D.; Gautschi, O.; Bubendorf, L.; Crowe, S.; Zappa, F.; Pless, M.; Brutsche, M. 2013: EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer. Plos one 8(9): E72966
Koletsa, T.; Kotoula, V.; Karayannopoulou, G.; Nenopoulou, E.; Karkavelas, G.; Papadimitriou, C.S.; Kostopoulos, I. 2010: EGFR expression and activation are common in HER2 positive and triple-negative breast tumours. Histology and Histopathology 25(9): 1171-1179
Gumuskaya, B.; Alper, M.; Hucumenoglu, S.; Altundag, K.; Uner, A.; Guler, G. 2010: EGFR expression and gene copy number in triple-negative breast carcinoma. Cancer Genetics and Cytogenetics 203(2): 222-229
Raz, D.J.; Jablons, D.M. 2007: EGFR expression and mutational analysis as a predictive test. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 25(15): 2144; author reply 2144-5
Komaki, R.; Paulus, R.; Blumenschein, G.R.; Curran, W.J.; Robert, F.; Thariat, J.; Werner-Wasik, M.; Choy, H.; Hirsch, F.R.; Ang, K.K. 2014: EGFR expression and survival in patients given cetuximab and chemoradiation for stage IIi non-small cell lung cancer: a secondary analysis of RTOG 0324. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 112(1): 30-36
Hirsch, F.R.; Herbst, R.S. 2012: EGFR expression and the flexibility of FLEX. LANCET. Oncology 13(1): 3-5
Liu, D.; He, J.; Yuan, Z.; Wang, S.; Peng, R.; Shi, Y.; Teng, X.; Qin, T. 2012: EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray. Medical Oncology 29(2): 401-405
Kaufman, M.; Mehrotra, B.; Limaye, S.; White, S.; Fuchs, A.; Lebowicz, Y.; Nissel-Horowitz, S.; Thomas, A. 2008: EGFR expression in gallbladder carcinoma in North America. International Journal of Medical Sciences 5(5): 285-291
Handra-Luca, A.; Hammel, P.; Sauvanet, A.; Lesty, C.; Ruszniewski, P.; Couvelard, A. 2014: EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins. Journal of Clinical Pathology 67(4): 295-300
Long, J.L.; Strocker, A.M.; Wang, M.B.; Blackwell, K.E. 2009: EGFR expression in primary squamous cell carcinoma of the thyroid. Laryngoscope 119(1): 89-90
De Melo Maia, B.; Fontes, A.M.; Lavorato-Rocha, A.é M.ão.; Rodrigues, I.S.'A.; de Brot, L.; Baiocchi, G.; Stiepcich, M.M.; Soares, F.A.; Rocha, R.M. 2014: EGFR expression in vulvar cancer: clinical implications and tumor heterogeneity. Human Pathology 45(5): 917-925
Derer, S.; Lohse, S.; Valerius, T. 2013: EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodies. Oncoimmunology 2(5): E24052
Horbinski, C.; Hobbs, J.; Cieply, K.; Dacic, S.; Hamilton, R.L. 2011: EGFR expression stratifies oligodendroglioma behavior. American Journal of Pathology 179(4): 1638-1644
Yarom, N.; Marginean, C.; Moyana, T.; Gorn-Hondermann, I.; Birnboim, H.C.; Marginean, H.; Auer, R.C.; Vickers, M.; Asmis, T.R.; Maroun, J.; Jonker, D. 2010: EGFR expression variance in paired colorectal cancer primary and metastatic tumors. Cancer Biology and Therapy 10(5): 416-421
Varella-Garcia, M.; Diebold, J.; Eberhard, D.A.; Geenen, K.; Hirschmann, A.; Kockx, M.; Nagelmeier, I.; Rüschoff, J.; Schmitt, M.; Arbogast, S.; Cappuzzo, F. 2009: EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer. Journal of Clinical Pathology 62(11): 970-977
Li, Y.-H.; Wang, F.; Shen, L.; Deng, Y.-M.; Shao, Q.; Feng, F.; An, X.; Wang, F.-H.; Wang, Z.-Q.; Xu, R.-H.; Shao, J.-Y. 2011: EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(2): 382-390
Chiosea, S.; Shuai, Y.; Cieply, K.; Nikiforova, M.N.; Dacic, S. 2010: EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations. Human Pathology 41(8): 1053-1060
Kaneko, K.; Kumekawa, Y.; Makino, R.; Nozawa, H.; Hirayama, Y.; Kogo, M.; Konishi, K.; Katagiri, A.; Kubota, Y.; Muramoto, T.; Kushima, M.; Ohmori, T.; Oyama, T.; Kagawa, N.; Ohtsu, A.; Imawari, M. 2010: EGFR gene alterations as a prognostic biomarker in advanced esophageal squamous cell carcinoma. Frontiers in Bioscience 15(1): 65-72
Helland, Ås.; Skaug, H.M.; Kleinberg, L.; Iversen, M.L.; Rud, A.K.; Fleischer, T.; Sagerup, C.; Solberg, S.; Jørgensen, L.; Ariansen, S.; Brustugun, O.T. 2011: EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 6(5): 947-950
Park, K.; Han, S.; Shin, E.; Kim, H.J.; Kim, J.Y. 2007: EGFR gene and protein expression in breast cancers. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 33(8): 956-960
Russell, P.A.; Yu, Y.; Do, H.; Clay, T.D.; Moore, M.M.; Wright, G.M.; Conron, M.; Wainer, Z.; Dobrovic, A.; McLachlan, S.-A. 2014: EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma. Pathology 46(1): 32-36
Dahabreh, I.J.; Linardou, H.; Kosmidis, P.; Bafaloukos, D.; Murray, S. 2011: EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(3): 545-552
Shen, W.-D.; Chen, H.-L.; Liu, P.-F. 2014: EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis. Chinese Journal of Cancer Research 26(1): 59-71
Yang, Z.-Y.; Shen, W.-X.; Hu, X.-F.; Zheng, D.-Y.; Wu, X.-Y.; Huang, Y.-F.; Chen, J.-Z.; Mao, C.; Tang, J.-L. 2012: EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis. Journal of Hematology and Oncology 5: 52
Jiang, Z.; Li, C.; Li, F.; Wang, X. 2013: EGFR gene copy number as a prognostic marker in colorectal cancer patients treated with cetuximab or panitumumab: a systematic review and meta analysis. Plos one 8(2): E56205
Koh, Y.; Jang, B.; Jeon, Y.K.; Kim, T.M.; Lee, S.-H.; Kim, D.-W.; Chung, D.H.; Kim, Y.T.; Kim, Y.W.; Heo, D.S. 2011: EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma. Japanese Journal of Clinical Oncology 41(4): 548-554
Park, E.-A.; Lee, H.J.; Kim, Y.T.; Kang, C.H.; Kang, K.W.; Jeon, Y.K.; Goo, J.M.; Lee, C.H.; Park, C.M. 2009: EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: investigation of significantly related factors on CT, FDG-PET, and histopathology. Lung Cancer 64(2): 179-186
Deng, Q.-h.; Qiu, Y.; Mo, M.-c.; Zhang, X.; Xiong, X.-g.; Jiang, M.; He, P.; Wen, D.-p.; Zheng, G.-x.; He, J.-x. 2011: EGFR gene copy number, ERCC1 and BRCA1 protein expression and their relationship in non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 33(7): 508-512
Lin, Y.-e.; He, P.; Li, S.-y.; Gu, Y.-y.; Yu, M.-l. 2011: EGFR gene detection using transbronchial lung biopsy specimens. Zhonghua Bing Li Xue Za Zhi 40(2): 111-112
Razis, E.; Pentheroudakis, G.; Rigakos, G.; Bobos, M.; Kouvatseas, G.; Tzaida, O.; Makatsoris, T.; Papakostas, P.; Bai, M.; Goussia, A.; Samantas, E.; Papamichael, D.; Romanidou, O.; Efstratiou, I.; Tsolaki, E.; Psyrri, A.; De Roock, W.; Bafaloukos, D.; Klouvas, G.; Tejpar, S.; Kalogeras, K.T.; Pectasides, D.; Fountzilas, G. 2014: EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab. Journal of Cancer Research and Clinical Oncology 140(5): 737-748
Zhong, W.; Wang, M.; Li, L.; Xia, Y.; Chen, M.; Zhang, L.; Zhao, J. 2012: EGFR gene mutation statuses in advanced non-small cell lung cancer patients and their influence on effect of gefitinib. Zhongguo Fei Ai Za Zhi 15(9): 513-520
Ma, E.S.K.; Ng, W.-K.; Wong, C.L.P. 2012: EGFR gene mutation study in cytology specimens. Acta Cytologica 56(6): 661-668
Powrózek, T.; Krawczyk, P.ł; Ramlau, R.; Sura, S.; Wojas-Krawczyk, K.; Kucharczyk, T.; Walczyna, B.; Szumiło, J.; Szyszka-Barth, K.; Milecki, P.; Barinow-Wojewódzki, A.; Milanowski, J. 2014: EGFR gene mutations in patients with adenosquamous lung carcinoma. Asia-Pacific Journal of Clinical Oncology 10(4): 340-345
Mitsudomi, T.; Tada, H. 2012: EGFR gene mutations: is it prognostic or predictive in surgically resected lung cancer?. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 7(12): 1739-1741
Yi, D.; Hua, T.X.; Lin, H.Y. 2011: EGFR gene overexpression retained in an invasive xenograft model by solid orthotopic transplantation of human glioblastoma multiforme into nude mice. Cancer Investigation 29(3): 229-239
Da Cunha Santos, G.; Saieg, M.A.; Geddie, W.; Leighl, N. 2011: EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities. Cancer Cytopathology 119(2): 80-91
Wibom, C.; Ghasimi, S.; Van Loo, P.; Brännström, T.; Trygg, J.; Lau, C.; Henriksson, R.; Bergenheim, T.; Andersson, U.; Rydén, P.; Melin, B. 2012: EGFR gene variants are associated with specific somatic aberrations in glioma. Plos one 7(12): E47929
Jiang, S.-X.; Yamashita, K.; Yamamoto, M.; Piao, C.-J.; Umezawa, A.; Saegusa, M.; Yoshida, T.; Katagiri, M.; Masuda, N.; Hayakawa, K.; Okayasu, I. 2008: EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance. International Journal of Cancer 123(11): 2480-2486
Bronte, G.; Terrasi, M.; Rizzo, S.; Sivestris, N.; Ficorella, C.; Cajozzo, M.; Di Gaudio, F.; Gulotta, G.; Siragusa, S.; Gebbia, N.; Russo, A. 2011: EGFR genomic alterations in cancer: prognostic and predictive values. Frontiers in Bioscience 3(3): 879-887
Starska, K.; Głowacka, E.; Lewy-Trenda, I.; Stasikowska, O.; Łukomski, M. 2009: EGFR immunoexpression and peripheral blood cytokine secretion as potential biomarkers of tumor behavior in laryngeal squamous cell carcinoma. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 15(10): Cr518-Cr527
Gundogdu, A.G.; Onder, S.; Firat, P.; Dogan, R. 2014: EGFR immunoexpression, RAS immunoexpression and their effects on survival in lung adenocarcinoma cases. Journal of Thoracic Disease 6(6): 778-784
Burel-Vandenbos, F.; Benchetrit, M.; Miquel, C.; Fontaine, D.; Auvergne, R.; Lebrun-Frenay, C.; Cardot-Leccia, N.; Michiels, J-François.; Paquis-Flucklinger, V.; Virolle, T. 2011: EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis. Journal of Neuro-Oncology 102(2): 171-178
Eck, M.J.; Hahn, W.C. 2012: EGFR in limbo. Cell 149(4): 735-737
Boone, B.; Jacobs, K.; Ferdinande, L.; Taildeman, J.; Lambert, J.; Peeters, M.; Bracke, M.; Pauwels, P.; Brochez, L. 2011: EGFR in melanoma: clinical significance and potential therapeutic target. Journal of Cutaneous Pathology 38(6): 492-502
Sette, G.; Salvati, V.; Memeo, L.; Fecchi, K.; Colarossi, C.; Di Matteo, P.; Signore, M.; Biffoni, M.; D'Andrea, V.; De Antoni, E.; Canzonieri, V.; De Maria, R.; Eramo, A. 2012: EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential. Plos one 7(10): E46891
Enting, D.; Spicer, J. 2012: EGFR inhibition and more: a new generation growing up. Journal of Thoracic Disease 4(6): 553-555
Loeffler-Ragg, J.; Schwentner, I.; Sprinzl, G.M.; Zwierzina, H. 2008: EGFR inhibition as a therapy for head and neck squamous cell carcinoma. Expert Opinion on Investigational Drugs 17(10): 1517-1531
Sathya, S.; Sudhagar, S.; Sarathkumar, B.; Lakshmi, B.S. 2014: EGFR inhibition by pentacyclic triterpenes exhibit cell cycle and growth arrest in breast cancer cells. Life Sciences 95(1): 53-62
Herbst, R.S. 2004: EGFR inhibition in NSCLC: the emerging role of cetuximab. Journal of the National Comprehensive Cancer Network: Jnccn 2(Suppl 2): S41-S51
Kapoor, G.S.; Christie, A.; O'Rourke, D.M. 2007: EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53. Cancer Biology and Therapy 6(4): 571-579
Ramis, G.; Thomàs-Moyà, E.; Fernández de Mattos, S.; Rodríguez, J.é; Villalonga, P. 2012: EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth. Plos one 7(6): E38770
Chi, A.; Remick, S.; Tse, W. 2013: EGFR inhibition in non-small cell lung cancer: current evidence and future directions. Biomarker Research 1(1): 2
Fletcher, E.V.M.; Love-Homan, L.; Sobhakumari, A.; Feddersen, C.R.; Koch, A.T.; Goel, A.; Simons, A.L. 2013: EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC. Molecular Cancer Research: Mcr 11(12): 1574-1584
Basu, D.; Bewley, A.F.; Sperry, S.M.; Montone, K.T.; Gimotty, P.A.; Rasanen, K.; Facompre, N.D.; Weinstein, G.S.; Nakagawa, H.; Diehl, J.A.; Rustgi, A.K.; Herlyn, M. 2013: EGFR inhibition promotes an aggressive invasion pattern mediated by mesenchymal-like tumor cells within squamous cell carcinomas. Molecular Cancer Therapeutics 12(10): 2176-2186
Rössler, J.; Odenthal, E.; Geoerger, B.; Gerstenmeyer, A.; Lagodny, J.; Niemeyer, C.M.; Vassal, G. 2009: EGFR inhibition using gefitinib is not active in neuroblastoma cell lines. Anticancer Research 29(4): 1327-1333
Zhang, Y.; Wang, J.; Liu, F.; You, Z.; Yang, R.; Zhao, Y. 2010: EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells. Cancer Cell International 10: 39
Le Pichon, C.E.; Dominguez, S.L.; Solanoy, H.; Ngu, H.; Lewin-Koh, N.; Chen, M.; Eastham-Anderson, J.; Watts, R.; Scearce-Levie, K. 2013: EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS. Plos one 8(4): E62342
Duvic, M. 2008: EGFR inhibitor-associated acneiform folliculitis: assessment and management. American Journal of Clinical Dermatology 9(5): 285-294
Goel, S.; Hidalgo, M.; Perez-Soler, R. 2007: EGFR inhibitor-mediated apoptosis in solid tumors. Journal of Experimental Therapeutics and Oncology 6(4): 305-320
Cui, J.; Hu, Y.-F.; Feng, X.-M.; Tian, T.; Guo, Y.-H.; Ma, J.-W.; Nan, K.-J.; Zhang, H.-Y. 2014: EGFR inhibitors and autophagy in cancer treatment. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(12): 11701-11709
Fong, T.; Morgensztern, D.; Govindan, R. 2008: EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 3(3): 303-310
Kao, H.-F.; Lin, C.-C.; Yang, J.C.-H. 2013: EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer. Future Oncology 9(7): 991-1003
Kim, H.; Kim, S.-H.; Kim, M.-J.; Kim, S.-J.; Park, S.-J.; Chung, J.-S.; Bae, J.-H.; Kang, C.-D. 2011: EGFR inhibitors enhanced the susceptibility to NK cell-mediated lysis of lung cancer cells. Journal of ImmunoTherapy 34(4): 372-381
Sayar, B.S.; Rüegg, S.; Schmidt, E.; Sibilia, M.; Siffert, M.; Suter, M.M.; Galichet, A.; Müller, E.J. 2014: EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship. Experimental Dermatology 23(1): 33-38
Lainey, E.; Wolfromm, A.; Sukkurwala, A.Q.; Micol, J.-B.; Fenaux, P.; Galluzzi, L.; Kepp, O.; Kroemer, G. 2013: EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. Cell Cycle 12(18): 2978-2991
Mehra, R.; Cohen, R.B.; Harari, P.M. 2008: EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Current Oncology Reports 10(2): 176-184
Jassem, J.; Dziadziuszko, R.ł 2013: EGFR inhibitors for wild-type EGFR NSCLC: to use or not to use?. LANCET. Oncology 14(10): 916-917
Spicer, J.F.; Rudman, S.M. 2010: EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992. Targeted Oncology 5(4): 245-255
Cortot, A.B. 2010: EGFR inhibitors in non-small cell lung cancer: more than yesterday (but less than tomorrow). Revue de Pneumologie Clinique 66(6): 367-374
Hirsch, F.R. 2007: EGFR inhibitors in the treatment of lung cancer. Onkologie 30(10): 476
Anonymous 2014: EGFR inhibitors may induce tumor stemness. Cancer discovery 4(7): 753
Xu, F.; Tian, Y.; Huang, Y.; Zhang, L.-L.; Guo, Z.-Z.; Huang, J.-J.; Lin, T.-Y. 2011: EGFR inhibitors sensitize non-small cell lung cancer cells to TRAIL-induced apoptosis. Chinese Journal of Cancer 30(10): 701-711
Pollack, B.P. 2012: EGFR inhibitors, MHC expression and immune responses : can EGFR inhibitors be used as immune response modifiers?. Oncoimmunology 1(1): 71-74
Huang, C.-L.; Yang, C.-H.; Yeh, K.-H.; Hu, F.-C.; Chen, K.-Y.; Shih, J.-Y.; Lin, Z.-Z.; Yu, C.-J.; Cheng, A.-L.; Yang, P.-C. 2009: EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment. Lung Cancer 64(3): 346-351
Osaki, L.H.; Figueiredo, P.M.; Alvares, E.P.; Gama, P. 2011: EGFR is involved in control of gastric cell proliferation through activation of MAPK and Src signalling pathways in early-weaned rats. Cell Proliferation 44(2): 174-182
Albitar, L.; Pickett, G.; Morgan, M.; Wilken, J.A.; Maihle, N.J.; Leslie, K.K. 2010: EGFR isoforms and gene regulation in human endometrial cancer cells. Molecular Cancer 9: 166
Arscott, W.Tristram.; Camphausen, K.A. 2011: EGFR isoforms in exosomes as a novel method for biomarker discovery in pancreatic cancer. Biomarkers in Medicine 5(6): 821
Sengupta, P.; Bosis, E.; Nachliel, E.; Gutman, M.; Smith, S.O.; Mihályné, G.ön.; Zaitseva, I.; McLaughlin, S. 2009: EGFR juxtamembrane domain, membranes, and calmodulin: kinetics of their interaction. Biophysical Journal 96(12): 4887-4895
Abhold, E.L.; Kiang, A.; Rahimy, E.; Kuo, S.Z.; Wang-Rodriguez, J.; Lopez, J.P.; Blair, K.J.; Yu, M.A.; Haas, M.; Brumund, K.T.; Altuna, X.; Patel, A.; Weisman, R.A.; Ongkeko, W.M. 2012: EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells. Plos one 7(2): E32459
DeHaan, A.M.; Wolters, N.M.; Keller, E.T.; Ignatoski, K.M.Woods. 2009: EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling. Prostate 69(5): 528-537
Kataoka, H. 2009: EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments. Journal of Dermatological Science 56(3): 148-153
Kerpedjieva, S.S.; Kim, D.S.; Barbeau, D.J.; Tamama, K. 2012: EGFR ligands drive multipotential stromal cells to produce multiple growth factors and cytokines via early growth response-1. Stem Cells and Development 21(13): 2541-2551
Schneider, M.R.; Gratao, A.A.; Dahlhoff, M.; Boersma, A.; Hrabé de Angelis, M.; Hoang-Vu, C.; Wolf, E.; Klonisch, T. 2010: EGFR ligands exert diverging effects on male reproductive organs. Experimental and Molecular Pathology 88(1): 216-218
Wilson, K.J.; Mill, C.; Lambert, S.; Buchman, J.; Wilson, T.R.; Hernandez-Gordillo, V.; Gallo, R.M.; Ades, L.M.C.; Settleman, J.; Riese, D.J. 2012: EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling. Growth Factors 30(2): 107-116
Littlefield, P.; Jura, N. 2013: EGFR lung cancer mutants get specialized. Proceedings of the National Academy of Sciences of the United States of America 110(38): 15169-15170
Mill, C.P.; Chester, J.A.; Riese, D.J. 2009: EGFR may couple moderate alcohol consumption to increased breast cancer risk. Breast Cancer 1: 31-38
Hour, T.-C.; Chung, S.-D.; Kang, W.-Y.; Lin, Y.-C.; Chuang, S.-J.; Huang, A.-M.; Wu, W.-J.; Huang, S.-P.; Huang, C.-Y.; Pu, Y.-S. 2015: EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1). Archives of Toxicology 89(4): 591-605
Chou, R.-H.; Wang, Y.-N.; Hsieh, Y.-H.; Li, L.-Y.; Xia, W.; Chang, W.-C.; Chang, L.-C.; Cheng, C.-C.; Lai, C.-C.; Hsu, J.L.; Chang, W.-J.; Chiang, S.-Y.; Lee, H.-J.; Liao, H.-W.; Chuang, P.-H.; Chen, H.-Y.; Wang, H.-L.; Kuo, S.-C.; Chen, C.-H.; Yu, Y.-L.; Hung, M.-C. 2014: EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4. Developmental Cell 30(2): 224-237
Milella, M.; Nuzzo, C.; Bria, E.; Sperduti, I.; Visca, P.; Buttitta, F.; Antoniani, B.; Merola, R.; Gelibter, A.; Cuppone, F.; D'Alicandro, V.; Ceribelli, A.; Rinaldi, M.; Cianciulli, A.; Felicioni, L.; Malatesta, S.; Marchetti, A.; Mottolese, M.; Cognetti, F. 2012: EGFR molecular profiling in advanced NSCLC: a prospective phase Ii study in molecularly/clinically selected patients pretreated with chemotherapy. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 7(4): 672-680
Marks, J.L.; Golas, B.; Kirchoff, T.; Miller, V.A.; Riely, G.J.; Offit, K.; Pao, W. 2008: EGFR mutant lung adenocarcinomas in patients with germline BRCA mutations. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 3(7): 805
Gong, Y.; Pao, W. 2012: EGFR mutant lung cancer. Current Topics in Microbiology and Immunology 355: 59-81
Yang, B. 2004: EGFR mutants render Iressa more effective in treating lung cancer. Discovery Medicine 4(21): 72-73
Hendriks, L.E.L.; Smit, E.F.; Vosse, B.A.H.; Mellema, W.W.; Heideman, D.A.M.; Bootsma, G.P.; Westenend, M.; Pitz, C.; de Vries, G.J.; Houben, R.; Grünberg, K.; Bendek, M.; Speel, E.-J.M.; Dingemans, A.-M.C. 2014: EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?. Lung Cancer 84(1): 86-91
Tapia, C.; Savic, S.; Bihl, M.; Rufle, A.; Zlobec, I.; Terracciano, L.; Bubendorf, L. 2009: EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics. Der Pathologe 30(5): 384-392
Shin, D.-Y.; Na, I.I.; Kim, C.H.; Park, S.; Baek, H.; Yang, S.H. 2014: EGFR mutation and brain metastasis in pulmonary adenocarcinomas. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9(2): 195-199
Liam, C.-K.; Wong, C.-K.; Tan, J.-L. 2014: EGFR mutation detection by polymerase chain reaction-direct sequencing and allele-specific real-time PCR. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9(9): E71-E72
Penzel, R.; Sers, C.; Chen, Y.; Lehmann-Mühlenhoff, U.; Merkelbach-Bruse, S.; Jung, A.; Kirchner, T.; Büttner, R.; Kreipe, H.H.; Petersen, I.; Dietel, M.; Schirmacher, P. 2011: EGFR mutation detection in NSCLC--assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Archiv: An International Journal of Pathology 458(1): 95-98
Weber, B.; Hager, H.; Sorensen, B.S.; McCulloch, T.; Mellemgaard, A.; Khalil, A.A.; Nexo, E.; Meldgaard, P. 2014: EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancer. Lung Cancer 83(2): 224-230
Chen, Z.-Y.; Zhong, W.-Z.; Zhang, X.-C.; Su, J.; Yang, X.-N.; Chen, Z.-H.; Yang, J.-J.; Zhou, Q.; Yan, H.-H.; An, S.-J.; Chen, H.-J.; Jiang, B.-Y.; Mok, T.S.; Wu, Y.-L. 2012: EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas. Oncologist 17(7): 978-985
Iyevleva, A.G.; Novik, A.V.; Moiseyenko, V.M.; Imyanitov, E.N. 2009: EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: a case report. Urologic Oncology 27(5): 548-550
Sholl, L.M.; Xiao, Y.; Joshi, V.; Yeap, B.Y.; Cioffredi, L.-A.; Jackman, D.M.; Lee, C.; Jänne, P.A.; Lindeman, N.I. 2010: EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry. American Journal of Clinical Pathology 133(6): 922-934
Hasegawa, M.; Sakai, F.; Arimura, K.; Katsura, H.; Koh, E.; Sekine, Y.; Hiroshima, K. 2014: EGFR mutation of adenocarcinoma in congenital cystic adenomatoid malformation/congenital pulmonary airway malformation: a case report. Japanese Journal of Clinical Oncology 44(3): 278-281
Kimura, H.; Kasahara, K.; Shibata, K.; Sone, T.; Yoshimoto, A.; Kita, T.; Ichikawa, Y.; Waseda, Y.; Watanabe, K.; Shiarasaki, H.; Ishiura, Y.; Mizuguchi, M.; Nakatsumi, Y.; Kashii, T.; Kobayashi, M.; Kunitoh, H.; Tamura, T.; Nishio, K.; Fujimura, M.; Nakao, S. 2006: EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 1(3): 260-267
Houang, M.; Sioson, L.; Clarkson, A.; Watson, N.; Farzin, M.; Toon, C.W.; Raut, A.; O'Toole, S.A.; Cooper, W.A.; Pavlakis, N.; Mead, S.; Chou, A.; Gill, A.J. 2014: EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer. Pathology 46(6): 501-508
Luo, D.; Ye, X.; Hu, Z.; Peng, K.; Song, Y.; Yin, X.; Zhu, G.; Ji, Q.; Peng, Y. 2014: EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(3): 2437-2444
Eichler, A.F.; Kahle, K.T.; Wang, D.L.; Joshi, V.A.; Willers, H.; Engelman, J.A.; Lynch, T.J.; Sequist, L.V. 2010: EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer. Neuro-Oncology 12(11): 1193-1199
Shan, L.; Zhang, Y.; Zhao, F.; Zheng, L.; Zhang, G. 2013: EGFR mutation status in Uighur lung adenocarcinoma patients. Zhongguo Fei Ai Za Zhi 16(2): 78-81
Han, H.-S.; Eom, D.-W.; Kim, J.H.; Kim, K.-H.; Shin, H.-M.; An, J.Y.; Lee, K.M.; Choe, K.H.; Lee, K.H.; Kim, S.T.; Koo, J.H.; Lee, H.-c.; Lee, O.-J. 2011: EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases. Clinical Lung Cancer 12(6): 380-386
Liam, C.-K.; Leow, H.-R.; Pang, Y.-K. 2013: EGFR mutation testing for squamous cell lung carcinoma. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 8(12): E114
Ellison, G.; Zhu, G.; Moulis, A.; Dearden, S.; Speake, G.; McCormack, R. 2013: EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. Journal of Clinical Pathology 66(2): 79-89
Gil-Bazo, I.; Castañón, E.; Fusco, J.P. 2011: EGFR mutation testing in nonsmall cell lung cancer patients by using cytology specimens: when the tissue is no longer the issue. Cancer Cytopathology 119(5): 354
Choi, Y.-L.; Sun, J.-M.; Cho, J.; Rampal, S.; Han, J.; Parasuraman, B.; Guallar, E.; Lee, G.; Lee, J.; Shim, Y.M. 2013: EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital. Plos one 8(2): E56011
Szumera-Ciećkiewicz, A.; Olszewski, Włodzimierz.T.; Tysarowski, A.; Kowalski, D.M.; Głogowski, M.; Krzakowski, M.; Siedlecki, J.A.; Wągrodzki, Mł.; Prochorec-Sobieszek, M. 2013: EGFR mutation testing on cytological and histological samples in non-small cell lung cancer: a Polish, single institution study and systematic review of European incidence. International Journal of Clinical and Experimental Pathology 6(12): 2800-2812
Bar, J.; Cyjon, A.; Flex, D.; Sorotsky, H.; Biran, H.; Dudnik, J.; Peylan-Ramu, N.; Peled, N.; Nechushtan, H.; Gips, M.; Katsnelson, R.; Rosenberg, S.K.; Merimsky, O.; Onn, A.; Gottfried, M. 2014: EGFR mutation testing practice in advanced non-small cell lung cancer. Lung 192(5): 759-763
Yatabe, Y.; Kerr, K.M.; Utomo, A.; Rajadurai, P.; Tran, V.K.; Du, X.; Chou, T.-Y.; Enriquez, M.L.D.; Lee, G.K.; Iqbal, J.; Shuangshoti, S.; Chung, J.-H.; Hagiwara, K.; Liang, Z.; Normanno, N.; Park, K.; Toyooka, S.; Tsai, C.-M.; Waring, P.; Zhang, L.; McCormack, R.; Ratcliffe, M.; Itoh, Y.; Sugeno, M.; Mok, T. 2015: EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 10(3): 438-445
Maegawa, M.; Arao, T.; Yokote, H.; Matsumoto, K.; Kudo, K.; Tanaka, K.; Kaneda, H.; Fujita, Y.; Ito, F.; Nishio, K. 2009: EGFR mutation up-regulates EGR1 expression through the ERK pathway. Anticancer Research 29(4): 1111-1117
Babic, I.; Anderson, E.S.; Tanaka, K.; Guo, D.; Masui, K.; Li, B.; Zhu, S.; Gu, Y.; Villa, G.R.; Akhavan, D.; Nathanson, D.; Gini, B.; Mareninov, S.; Li, R.; Camacho, C.Espindola.; Kurdistani, S.K.; Eskin, A.; Nelson, S.F.; Yong, W.H.; Cavenee, W.K.; Cloughesy, T.F.; Christofk, H.R.; Black, D.L.; Mischel, P.S. 2013: EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. Cell Metabolism 17(6): 1000-1008
Ambrosini-Spaltro, A.; Campanini, N.; Bortesi, B.; Azzoni, C.; Naldi, N.; Ampollini, L.; Tiseo, M.; Ardizzoni, A.; Rusca, M.; Carbognani, P.; Silini, E.M. 2012: EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing. Applied Immunohistochemistry and Molecular Morphology: Aimm 20(4): 356-362
Kim, Y.H.; Masago, K.; Togashi, Y.; Sakamori, Y.; Okuda, C.; Mio, T.; Mishima, M. 2011: EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapy. Oncology Letters 2(2): 383-387
Reynolds, J.P.; Tubbs, R.R.; Minca, E.C.; MacNamara, S.; Almeida, F.A.; Ma, P.C.; Pennell, N.A.; Cicenia, J.C. 2014: EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC). Lung Cancer 86(2): 158-163
Di Lorenzo, G.; Buonerba, C.; Gaudioso, G.; Gigantino, V.; Quarto, G.; De Domenico, R.; Caraglia, M.; Di Trolio, R.; Ascierto, P.A.; De Placido, S.; Perdonà, S.; Franco, R. 2013: EGFR mutational status in penile cancer. Expert Opinion on Therapeutic Targets 17(5): 501-505
Miller, V.A. 2008: EGFR mutations and EGFR tyrosine kinase inhibition in non-small cell lung cancer. Seminars in Oncology Nursing 24(1): 27-33
Xu, J.M.; Han, Y.; Duan, H.Q.; Gao, E.M.; Zhang, Y.; Liu, X.Q.; Zhang, J.S.; Toschi, L.; Galetta, D.; Azzariti, A.; Paradiso, A. 2009: EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib. Journal of Cancer Research and Clinical Oncology 135(6): 771-782
Zhang, Q.; Dai, H.-H.; Dong, H.-Y.; Sun, C.-T.; Yang, Z.; Han, J.-Q. 2014: EGFR mutations and clinical outcomes of chemotherapy for advanced non-small cell lung cancer: a meta-analysis. Lung Cancer 85(3): 339-345
Da Cunha Santos, G.; Shepherd, F.A.; Tsao, M.S. 2011: EGFR mutations and lung cancer. Annual Review of Pathology 6: 49-69
O'Neill, I.D. 2012: EGFR mutations and mucoepidermoid carcinoma: putative significance in differing populations. Lung Cancer 78(1): 125-126
Yatabe, Y. 2010: EGFR mutations and the terminal respiratory unit. Cancer Metastasis Reviews 29(1): 23-36
Lee, H.-L.; Chung, T.-S.; Ting, L.-L.; Tsai, J.-T.; Chen, S.-W.; Chiou, J.-F.; Leung, H.W.-C.; Liu, H.E. 2012: EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases. Radiation Oncology 7: 181
Wu, M.; Zhao, J.; Song, S.W.; Zhuo, M.; Wang, X.; Bai, H.; Wang, S.; Yang, L.; An, T.; Zhang, Y.; Duan, J.; Wang, Y.; Guo, Q.; Liu, X.; Liu, N.; Wang, J. 2010: EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer. Lung Cancer 67(3): 343-347
Smouse, J.H.; Cibas, E.S.; Jänne, P.A.; Joshi, V.A.; Zou, K.H.; Lindeman, N.I. 2009: EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer. Cancer 117(1): 67-72
Liu, Y.; Xu, M.L.; Zhong, H.H.; Heng, W.J.; Wu, B.Q. 2008: EGFR mutations are more frequent in well-differentiated than in poor-differentiated lung adenocarcinomas. Pathology Oncology Research: Por 14(4): 373-379
Park, J.H.; Lee, S.-H.; Keam, B.; Kim, T.M.; Kim, D.-W.; Yang, S.-C.; Kim, Y.W.; Heo, D.S. 2012: EGFR mutations as a predictive marker of cytotoxic chemotherapy. Lung Cancer 77(2): 433-437
Fang, S.; Wang, Z. 2014: EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer. Drug Design Development and Therapy 8: 1595-1611
Mack, P.C.; Holland, W.S.; Burich, R.A.; Sangha, R.; Solis, L.J.; Li, Y.; Beckett, L.A.; Lara, P.N.; Davies, A.M.; Gandara, D.R. 2009: EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 4(12): 1466-1472
Malapelle, U.; Bellevicine, C.; De Luca, C.; Salatiello, M.; De Stefano, A.; Rocco, D.; de Rosa, N.; Vitiello, F.; Russo, S.; Pepe, F.; Iaccarino, A.; Micheli, P.; Illiano, A.; Carlomagno, C.; Piantedosi, F.V.; Troncone, G. 2013: EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. Cancer Cytopathology 121(10): 552-560
Liam, C.-K.; Pang, Y.-K.; Poh, M.-E. 2014: EGFR mutations in Asian patients with advanced lung adenocarcinoma. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9(9): E70-E71
Noronha, V.; Prabhash, K.; Thavamani, A.; Chougule, A.; Purandare, N.; Joshi, A.; Sharma, R.; Desai, S.; Jambekar, N.; Dutt, A.; Mulherkar, R. 2013: EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy. Plos one 8(4): E61561
Zhang, W.; McQuitty, E.B.; Olsen, R.; Fan, H.; Hendrickson, H.; Tio, F.O.; Newton, K.; Cagle, P.T.; Jagirdar, J. 2014: EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma. Archives of Pathology and Laboratory Medicine 138(4): 543-545
Rosell, R.; Molina, M.A.; Serrano, M.ía.J. 2012: EGFR mutations in circulating tumour DNA. LANCET. Oncology 13(10): 971-973
Li, A.R.; Chitale, D.; Riely, G.J.; Pao, W.; Miller, V.A.; Zakowski, M.F.; Rusch, V.; Kris, M.G.; Ladanyi, M. 2008: EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression. Journal of Molecular Diagnostics: Jmd 10(3): 242-248
Gazdar, A.F. 2014: EGFR mutations in lung cancer: different frequencies for different folks. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9(2): 139-140
Hung, J.-J.; Jeng, W.-J.; Hsu, W.-H.; Liu, J.-S.; Wu, Y.-C. 2010: EGFR mutations in non-small-cell lung cancer. LANCET. Oncology 11(5): 412
Ren, J.-H.; He, W.-S.; Yan, G.-L.; Jin, M.; Yang, K.-Y.; Wu, G. 2012: EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis. Environmental and Molecular Mutagenesis 53(1): 78-82
Fiala, O.; Pešek, M.; Fínek, J.; Brůha, F.; Bortlíček, Z.; Krejčí, J.; Benešová, L.; Minárik, M. 2012: EGFR mutations in patients with advanced NSCLC. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 25(4): 267-273
Wang, S.; Wang, Z. 2014: EGFR mutations in patients with non-small cell lung cancer from mainland China and their relationships with clinicopathological features: a meta-analysis. International Journal of Clinical and Experimental Medicine 7(8): 1967-1978
Baik, C.S.; Pritchard, C.C.; Eaton, K.D.; Chow, L.Q. 2013: EGFR mutations in squamous cell lung cancer in never-smokers. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 8(1): E6-E7
Lai, Y.; Zhang, Z.; Li, J.; Sun, D.; Zhou, Y.'a.; Jiang, T.; Han, Y.; Huang, L.; Zhu, Y.; Li, X.; Yan, X. 2013: EGFR mutations in surgically resected fresh specimens from 697 consecutive Chinese patients with non-small cell lung cancer and their relationships with clinical features. International Journal of Molecular Sciences 14(12): 24549-24559
Guo, H.; Wan, Y.; Tian, G.; Liu, Q.; Kang, Y.; Li, Y.; Yao, Z.; Lin, D. 2012: EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy. Oncology Reports 27(3): 880-890
Takano, T.; Fukui, T.; Ohe, Y.; Tsuta, K.; Yamamoto, S.; Nokihara, H.; Yamamoto, N.; Sekine, I.; Kunitoh, H.; Furuta, K.; Tamura, T. 2008: EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(34): 5589-5595
Han, C.; Ma, J.; Zhao, J.; Zhou, Y.; Jing, W.; Zou, H. 2011: EGFR mutations, gene amplification, and protein expression and KRAS mutations in primary and metastatic tumors of nonsmall cell lung cancers and their clinical implications: a meta-analysis. Cancer Investigation 29(9): 626-634
Li, C.-F.; Fang, F.-M.; Wang, J.-M.; Tzeng, C.-C.; Tai, H.-C.; Wei, Y.-C.; Li, S.-H.; Lee, Y.-T.; Wang, Y.-H.; Yu, S.-C.; Shiue, Y.-L.; Chu, P.Y.-W.; Wang, W.-L.; Chen, L.-T.; Huang, H.-Y. 2012: EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact. Annals of Surgical Oncology 19(2): 443-454
Liccardi, G.; Hartley, J.A.; Hochhauser, D. 2011: EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Research 71(3): 1103-1114
Dua, R.; Zhang, J.; Nhonthachit, P.; Penuel, E.; Petropoulos, C.; Parry, G. 2010: EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance. Breast Cancer Research and Treatment 122(3): 685-697
Heeg, S.; Hirt, N.; Queisser, A.; Schmieg, H.; Thaler, M.; Kunert, H.; Quante, M.; Goessel, G.; von Werder, A.; Harder, J.; Beijersbergen, R.; Blum, H.E.; Nakagawa, H.; Opitz, O.G. 2011: EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis. Cancer Science 102(2): 351-360
Kallel, I.; Khabir, A.; Boujelbene, N.; Abdennadher, R.; Daoud, J.; Frikha, M.; Aifa, S.; Sallemi-Boudawara, T.; Rebaï, A. 2012: EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia. Journal of Receptor and Signal Transduction Research 32(3): 142-149
Merlo, V.; Longo, M.; Novello, S.; Scagliotti, G.V. 2011: EGFR pathway in advanced non-small cell lung cancer. Frontiers in Bioscience 3(2): 501-517
Mason, R.A.; Morlock, E.V.; Karagas, M.R.; Kelsey, K.T.; Marsit, C.J.; Schned, A.R.; Andrew, A.S. 2009: EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Carcinogenesis 30(7): 1155-1160
Lin, X.; Zhong, S.; Ye, X.; Liao, Y.; Yao, F.; Yang, X.; Sun, B.; Zhang, J.; Li, Q.; Gao, Y.; Wang, Y.; Liu, J.; Han, B.; Chin, Y.E.; Zhou, B.P.; Deng, J. 2014: EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer. Molecular Cancer 13: 233
Fan, Q.-W.; Cheng, C.K.; Gustafson, W.C.; Charron, E.; Zipper, P.; Wong, R.A.; Chen, J.; Lau, J.; Knobbe-Thomsen, C.; Weller, M.; Jura, N.; Reifenberger, G.; Shokat, K.M.; Weiss, W.A. 2013: EGFR phosphorylates tumor-derived EGFRvIIi driving STAT3/5 and progression in glioblastoma. Cancer Cell 24(4): 438-449
Feng, H.; Lopez, G.Y.; Kim, C.K.; Alvarez, A.; Duncan, C.G.; Nishikawa, R.; Nagane, M.; Su, A.-J.A.; Auron, P.E.; Hedberg, M.L.; Wang, L.; Raizer, J.J.; Kessler, J.A.; Parsa, A.T.; Gao, W.-Q.; Kim, S.-H.; Minata, M.; Nakano, I.; Grandis, J.R.; McLendon, R.E.; Bigner, D.D.; Lin, H.-K.; Furnari, F.B.; Cavenee, W.K.; Hu, B.; Yan, H.; Cheng, S.-Y. 2014: EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. Journal of Clinical Investigation 124(9): 3741-3756
Jung, M.; Cho, B.C.; Lee, C.H.; Park, H.S.; Kang, Y.A.; Kim, S.K.; Chang, J.; Kim, D.J.; Rha, S.Y.; Kim, J.H.; Lee, J.H. 2012: EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKi. Yonsei Medical Journal 53(6): 1128-1135
Sasaki, H.; Endo, K.; Takada, M.; Kawahara, M.; Tanaka, H.; Kitahara, N.; Matsumura, A.; Iuchi, K.; Kawaguchi, T.; Okuda, K.; Kawano, O.; Yukiue, H.; Yokoyama, T.; Yano, M.; Fujii, Y. 2008: EGFR polymorphism of the kinase domain in Japanese lung cancer. Journal of Surgical Research 148(2): 260-263
Chen, K-Yu.; Hsiao, C-Fu.; Chang, G-Chen.; Tsai, Y-Huang.; Su, W-Chou.; Chen, Y-Min.; Huang, M-Shyan.; Hsiung, C.A.; Chen, C-Jen.; Yang, P-Chyr. 2013: EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women. Carcinogenesis 34(3): 612-619
Bonetti, L.Reggiani.; Lupi, M.; Trani, M.; Trani, N.; Sartori, G.; Schirosi, L.; Bettelli, S.; Zanelli, G.; Maccio, L.; Maiorana, A. 2010: EGFR polysomy in squamous cell carcinoma of the thyroid. Report of two cases and review of the literature. Tumori 96(3): 503-507
Zhang, W.; Gao, Y.; Jiang, Y.; Ping, L.; Cheng, H.; Zhang, J. 2013: EGFR promoter methylation detection in cervical cancer by a hybridization-fluorescence polarization assay. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 22(2): 102-106
Chou, Y.-T.; Lin, H.-H.; Lien, Y.-C.; Wang, Y.-H.; Hong, C.-F.; Kao, Y.-R.; Lin, S.-C.; Chang, Y.-C.; Lin, S.-Y.; Chen, S.-J.; Chen, H.-C.; Yeh, S.-D.; Wu, C.-W. 2010: EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Research 70(21): 8822-8831
Li, Q.; Tang, Y.; Cheng, X.; Ji, J.; Zhang, J.; Zhou, X. 2014: EGFR protein expression and gene amplification in squamous intraepithelial lesions and squamous cell carcinomas of the cervix. International Journal of Clinical and Experimental Pathology 7(2): 733-741
Mascaux, C.; Wynes, M.W.; Kato, Y.; Tran, C.; Asuncion, B.R.; Zhao, J.M.; Gustavson, M.; Ranger-Moore, J.; Gaire, F.; Matsubayashi, J.; Nagao, T.; Yoshida, K.; Ohira, T.; Ikeda, N.; Hirsch, F.R. 2011: EGFR protein expression in non-small cell lung cancer predicts response to an EGFR tyrosine kinase inhibitor--a novel antibody for immunohistochemistry or AQUA technology. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(24): 7796-7807
Ryott, M.; Wangsa, D.; Heselmeyer-Haddad, K.; Lindholm, J.; Elmberger, G.ör.; Auer, G.; Avall Lundqvist, E.; Ried, T.; Munck-Wikland, E. 2009: EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. European Journal of Cancer 45(9): 1700-1708
Huang, S.-F.; Chuang, W.-Y.; Chen, I.-H.; Liao, C.-T.; Wang, H.-M.; Hsieh, L.-L. 2009: EGFR protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan. Head and Neck 31(8): 1068-1077
Dorđević, G.; Matušan Ilijaš, K.; Hadžisejdić, I.; Maričić, A.; Grahovac, B.že.; Jonjić, N. 2012: EGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinoma. Journal of Biomedical Science 19: 40
Hayes, D.N.; McLeod, H.L. 2008: EGFR regulation by microRNA in lung cancer: a rose by any other name ... is an increasingly complicated rose. Annals of Oncology: Official Journal of the European Society for Medical Oncology 19(6): 1036-1037
Weiss, G.J.; Bemis, L.T.; Nakajima, E.; Sugita, M.; Birks, D.K.; Robinson, W.A.; Varella-Garcia, M.; Bunn, P.A.; Haney, J.; Helfrich, B.A.; Kato, H.; Hirsch, F.R.; Franklin, W.A. 2008: EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Annals of Oncology: Official Journal of the European Society for Medical Oncology 19(6): 1053-1059
Nautiyal, J.; Du, J.; Yu, Y.; Kanwar, S.S.; Levi, E.; Majumdar, A.P.N. 2012: EGFR regulation of colon cancer stem-like cells during aging and in response to the colonic carcinogen dimethylhydrazine. American Journal of Physiology. Gastrointestinal and Liver Physiology 302(7): G655-G663
Spindler, K-Lise.G.; Pallisgaard, N.; Lindebjerg, J.; Frifeldt, S.K.; Jakobsen, A. 2011: EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer. Bmc Cancer 11: 107
Resnier, P.; David, S.; Lautram, N.; Delcroix, G.ët.J.-R.; Clavreul, A.; Benoit, J.-P.; Passirani, C. 2013: EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro. International Journal of Pharmaceutics 454(2): 748-755
Jutten, B.; Rouschop, K.M.A. 2014: EGFR signaling and autophagy dependence for growth, survival, and therapy resistance. Cell Cycle 13(1): 42-51
Lurje, G.; Lenz, H-Josef. 2009: EGFR signaling and drug discovery. Oncology 77(6): 400-410
Zhang, Z.; Xiao, C.; Gibson, A.M.; Bass, S.A.; Khurana Hershey, G.K. 2014: EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis. Journal of Immunology 192(3): 859-866
Da Rosa, M.R.P.; Falcão, A.S.C.; Fuzii, H.T.; da Silva Kataoka, M.S.; Ribeiro, A.é L.R.; Boccardo, E.; de Siqueira, A.S.; Jaeger, R.G.; de Jesus Viana Pinheiro, J.ão.; de Melo Alves Júnior, S.ér. 2014: EGFR signaling downstream of EGF regulates migration, invasion, and MMP secretion of immortalized cells derived from human ameloblastoma. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(11): 11107-11120
Foley, J.; Nickerson, N.K.; Nam, S.; Allen, K.T.; Gilmore, J.L.; Nephew, K.P.; Riese, D.J. 2010: EGFR signaling in breast cancer: bad to the bone. Seminars in Cell and Developmental Biology 21(9): 951-960
Skoda, J.; Neradil, J.; Zitterbart, K.; Sterba, J.; Veselska, R. 2014: EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy. Oncology Reports 31(1): 480-487
Rahn, T.; Leippe, M.; Roeder, T.; Fedders, H. 2013: EGFR signaling in the brain is necessary for olfactory learning in Drosophila larvae. Learning and Memory 20(4): 194-200
Howard, B.M.; Gursel, D.B.; Bleau, A.-M.; Beyene, R.T.; Holland, E.C.; Boockvar, J.A. 2010: EGFR signaling is differentially activated in patient-derived glioblastoma stem cells. Journal of Experimental Therapeutics and Oncology 8(3): 247-260
Liu, M.; Yang, S-Chul.; Sharma, S.; Luo, J.; Cui, X.; Peebles, K.A.; Huang, M.; Sato, M.; Ramirez, R.D.; Shay, J.W.; Minna, J.D.; Dubinett, S.M. 2007: EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells. American Journal of Respiratory Cell and Molecular Biology 37(5): 578-588
Teixeira, A.L.; Gomes, M.ón.; Medeiros, R. 2012: EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222. Frontiers in Genetics 3: 286
Knudsen, S.L.J.; Mac, A.S.W.; Henriksen, L.; van Deurs, B.; Grøvdal, L.M.æt. 2014: EGFR signaling patterns are regulated by its different ligands. Growth Factors 32(5): 155-163
Chen, J.; Chen, J.-K.; Nagai, K.; Plieth, D.; Tan, M.; Lee, T.-C.; Threadgill, D.W.; Neilson, E.G.; Harris, R.C. 2012: EGFR signaling promotes TGFβ-dependent renal fibrosis. Journal of the American Society of Nephrology: Jasn 23(2): 215-224
Hakonen, E.; Ustinov, J.; Palgi, J.; Miettinen, P.äi.J.; Otonkoski, T. 2014: EGFR signaling promotes β-cell proliferation and survivin expression during pregnancy. Plos one 9(4): E93651
Fraguas, S.; Barberán, S.; Cebrià, F. 2011: EGFR signaling regulates cell proliferation, differentiation and morphogenesis during planarian regeneration and homeostasis. Developmental Biology 354(1): 87-101
Jiang, H.; Edgar, B.A. 2009: EGFR signaling regulates the proliferation of Drosophila adult midgut progenitors. Development 136(3): 483-493
Hölsken, A.; Gebhardt, M.; Buchfelder, M.; Fahlbusch, R.; Blümcke, I.; Buslei, R. 2011: EGFR signaling regulates tumor cell migration in craniopharyngiomas. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(13): 4367-4377
Zhu, J.; Shimizu, E.; Zhang, X.; Partridge, N.C.; Qin, L. 2011: EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. Journal of Cellular Biochemistry 112(7): 1749-1760
Guo, D.; Prins, R.M.; Dang, J.; Kuga, D.; Iwanami, A.; Soto, H.; Lin, K.Y.; Huang, T.T.; Akhavan, D.; Hock, M.B.; Zhu, S.; Kofman, A.A.; Bensinger, S.J.; Yong, W.H.; Vinters, H.V.; Horvath, S.; Watson, A.D.; Kuhn, J.G.; Robins, H.I.; Mehta, M.P.; Wen, P.Y.; DeAngelis, L.M.; Prados, M.D.; Mellinghoff, I.K.; Cloughesy, T.F.; Mischel, P.S. 2009: EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Science Signaling 2(101): Ra82
Li, S.; Gao, Y.; Ma, W.; Guo, W.; Zhou, G.; Cheng, T.; Liu, Y. 2014: EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(6): 5593-5598
Sahin, I.H.; Oktay, A.A. 2013: EGFR signalling and oncogenic pathway signature in colorectal cancer. Gut 62(11): 1670
Fan, Q.-W.; Cheng, C.; Knight, Z.A.; Haas-Kogan, D.; Stokoe, D.; James, C.D.; McCormick, F.; Shokat, K.M.; Weiss, W.A. 2009: EGFR signals to mTOR through PKC and independently of Akt in glioma. Science Signaling 2(55): Ra4
Guillaudeau, A.él.; Durand, K.; Bessette, B.; Chaunavel, A.; Pommepuy, I.; Projetti, F.; Robert, S.; Caire, F.ço.; Rabinovitch-Chable, H.él.èn.; Labrousse, F.ço. 2012: EGFR soluble isoforms and their transcripts are expressed in meningiomas. Plos one 7(5): E37204
Taga, M.; Mechanic, L.E.; Hagiwara, N.; Vähäkangas, K.H.; Bennett, W.P.; Alavanja, M.C.R.; Welsh, J.A.; Khan, M.A.; Lee, A.; Diasio, R.; Edell, E.; Bungum, A.; Jang, J.S.; Yang, P.; Jen, J.; Harris, C.C. 2012: EGFR somatic mutations in lung tumors: radon exposure and passive smoking in former- and never-smoking U.S. women. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 21(6): 988-992
Jedlinski, A.; Ansell, A.; Johansson, A.-C.; Roberg, K. 2013: EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 42(1): 26-36
Numico, G.; Russi, E.G.; Colantonio, I.; Lantermo, R.A.; Silvestris, N.; Vitiello, R.; Comino, A.; Abrate, M.; Zavattero, C.; Melano, A.; Merlano, M. 2010: EGFR status and prognosis of patients with locally advanced head and neck cancer treated with chemoradiotherapy. Anticancer Research 30(2): 671-676
Bernardes, V.F.át.; Gleber-Netto, F.O.; Sousa, S.íl.F.d.; Rocha, R.M.; Aguiar, M.C.ás.F.d. 2013: EGFR status in oral squamous cell carcinoma: comparing immunohistochemistry, FISH and CISH detection in a case series study. Bmj Open 3(1)
Kim, T.W. 2014: EGFR status is not a reliable biomarker to select patients suitable for cetuximab-based therapy. Clinical Colorectal Cancer 13(1): 3-4
Aggarwal, S.; Yadav, S.; Gupta, S. 2011: EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer. Journal of Biomedical Nanotechnology 7(1): 137-138
Poptani, H. 2010: EGFR targeted fluorescence imaging in gliomas. Academic Radiology 17(1): 1-2
Gursel, D.B.; Schlaff, C.D.; Boockvar, J.A. 2012: EGFR targeted inhibition resistance: compensatory activation of ERBB family members in glioblastoma cancer stem-like cells promotes proliferation. Neurosurgery 71(4): N17-N18
Reade, C.A.; Ganti, A.K. 2009: EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab. Biologics: Targets and Therapy 3: 215-224
Sundvall, M.; Karrila, A.; Nordberg, J.; Grénman, R.; Elenius, K. 2010: EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma. Expert Opinion on Emerging Drugs 15(2): 185-201
James, R.; Vishwakarma, S.; Chivukula, I.V.; Basavaraj, C.; Melarkode, R.; Montero, E.; Nair, P. 2012: EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs. Cancer Medicine 1(2): 114-127
Rocha-Lima, C.M.; Soares, H.P.; Raez, L.E.; Singal, R. 2007: EGFR targeting of solid tumors. Cancer Control: Journal of the Moffitt Cancer Center 14(3): 295-304
Hirsch, F.R.; Bunn, P.A. 2009: EGFR testing in lung cancer is ready for prime time. Lancet. Oncology 10(5): 432-433
Nowak, F. 2011: EGFR testing: state of organizations in France in 2010. Revue de Pneumologie Clinique 67(Suppl 1): S3-S4
Ripamonti, F.; Albano, L.; Rossini, A.; Borrelli, S.; Fabris, S.; Mantovani, R.; Neri, A.; Balsari, A.; Magnifico, A.; Tagliabue, E. 2013: EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas. Journal of Cellular Physiology 228(4): 871-878
Esposito, G.; Perrino, C.; Cannavo, A.; Schiattarella, G.G.; Borgia, F.; Sannino, A.; Pironti, G.; Gargiulo, G.; Di Serafino, L.; Franzone, A.; Scudiero, L.; Grieco, P.; Indolfi, C.; Chiariello, M. 2011: EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy. Basic Research in Cardiology 106(4): 577-589
Fan, J.-B.; Liu, W.; Yuan, K.; Zhu, X.-H.; Xu, D.-W.; Chen, J.-J.; Cui, Z.-M. 2014: EGFR trans-activation mediates pleiotrophin-induced activation of Akt and Erk in cultured osteoblasts. Biochemical and Biophysical Research Communications 447(3): 425-430
Fung, C.; Chen, X.; Grandis, J.R.; Duvvuri, U. 2012: EGFR tyrosine kinase inhibition induces autophagy in cancer cells. Cancer Biology and Therapy 13(14): 1417-1424
Harada, C.; Kawaguchi, T.; Ogata-Suetsugu, S.; Yamada, M.; Hamada, N.; Maeyama, T.; Souzaki, R.; Tajiri, T.; Taguchi, T.; Kuwano, K.; Nakanishi, Y. 2011: EGFR tyrosine kinase inhibition worsens acute lung injury in mice with repairing airway epithelium. American Journal of Respiratory and Critical Care Medicine 183(6): 743-751
Prada, P.O.; Ropelle, E.R.; Mourão, R.H.; de Souza, C.T.; Pauli, J.R.; Cintra, D.E.; Schenka, A.é; Rocco, S.A.; Rittner, R.; Franchini, K.G.; Vassallo, J.é; Velloso, L.íc.A.; Carvalheira, J.é B.; Saad, M.J.A. 2009: EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice. Diabetes 58(12): 2910-2919
Aravindan, N.; Aravindan, S.; Herman, T.S.; Natarajan, M. 2013: EGFR tyrosine kinase inhibitor pelitinib regulates radiation-induced p65-dependent telomerase activation in squamous cell carcinoma. Radiation Research 179(3): 304-312
Han, W.; Pan, H.; Chen, Y.; Sun, J.; Wang, Y.; Li, J.; Ge, W.; Feng, L.; Lin, X.; Wang, X.; Wang, X.; Jin, H. 2011: EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. Plos one 6(6): E18691
Colabufo, N.A.; Contino, M.; Niso, M.; Berardi, F.; Leopoldo, M.; Perrone, R. 2011: EGFR tyrosine kinase inhibitors and multidrug resistance: perspectives. Frontiers in Bioscience 16(5): 1811-1823
Svoboda, M.; Fabian, P.; Slabý, O.; Stanková, M.; Lakomý, R.; Nemecek, R.; Vyzula, R. 2010: EGFR tyrosine kinase inhibitors as a targeted therapy for bronchioloalveolar carcinoma of the lung: a case report of a clinically prompt and intensive response and literature review. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 23(4): 224-230
Yang, C.-H. 2008: EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future. Lung Cancer 60(Suppl 2): S23-S30
Moldvay, J.; Peták, I.án. 2012: EGFR tyrosine kinase inhibitors in lung cancer management: sensitivity and resistance. Magyar Onkologia 56(1): 38-49
Sequist, L.V.; Lynch, T.J. 2008: EGFR tyrosine kinase inhibitors in lung cancer: an evolving story. Annual Review of Medicine 59: 429-442
Finocchiaro, G.; Toschi, L.; Garassino, I.; De Vincenzo, F.; Campagnoli, E.; Zucali, P.; Cavina, R.; Ceresoli, G.L.; Santoro, A.; Cappuzzo, F. 2007: EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?. Expert Opinion on Medical Diagnostics 1(2): 183-191
Himaya, S.W.A.; Dewapriya, P.; Kim, S-Kwon. 2013: EGFR tyrosine kinase inhibitory peptide attenuates Helicobacter pylori-mediated hyper-proliferation in AGS enteric epithelial cells. Toxicology and Applied Pharmacology 269(3): 205-214
Kamel-Reid, S.; Chong, G.; Ionescu, D.N.; Magliocco, A.M.; Spatz, A.; Tsao, M.; Weng, X.; Young, S.; Zhang, T.; Soulieres, D. 2012: EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer. Current Oncology 19(2): E67-E74
Wu, W.; Sun, H.-Y.; Deng, X.-L.; Li, G.-R. 2013: EGFR tyrosine kinase regulates human small-conductance Ca2+-activated K+ (hSKCa1) channels expressed in HEK-293 cells. Biochemical Journal 452(1): 121-129
Quatrale, A.E.; Porcelli, L.; Silvestris, N.; Colucci, G.; Angelo, A.; Azzariti, A. 2011: EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence. Frontiers in Bioscience 16(5): 1962-1972
Kundu, S.; Sengupta, S.; Bhattacharyya, A. 2011: EGFR upregulates inflammatory and proliferative responses in human lung adenocarcinoma cell line (A549), induced by lower dose of cadmium chloride. Inhalation Toxicology 23(6): 339-348
Francis, J.M.; Zhang, C.-Z.; Maire, C.L.; Jung, J.; Manzo, V.E.; Adalsteinsson, V.A.; Homer, H.; Haidar, S.; Blumenstiel, B.; Pedamallu, C.S.; Ligon, A.H.; Love, J.C.; Meyerson, M.; Ligon, K.L. 2014: EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing. Cancer Discovery 4(8): 956-971
Rahimi, M.; George, J.; Tang, C. 2010: EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and post-translational mechanisms. International Journal of Cancer 126(8): 1850-1860
Schweiger, T.; Hegedüs, B.; Nikolowsky, C.; Hegedüs, Z.; Szirtes, I.; Mair, R.; Birner, P.; Döme, B.; Lang, G.ör.; Klepetko, W.; Ankersmit, H.J.; Hoetzenecker, K. 2014: EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study. Annals of Surgical Oncology 21(3): 946-954
Abdel-Aziz, A.; Amin, M.M. 2012: EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence. Diagnostic Pathology 7: 14
Hoffmann, A.-C.; Goekkurt, E.; Danenberg, P.V.; Lehmann, S.; Ehninger, G.; Aust, D.E.; Stoehlmacher-Williams, J. 2013: EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma. Plos one 8(5): E64186
Antonacopoulou, A.G.; Tsamandas, A.C.; Petsas, T.; Liava, A.; Scopa, C.D.; Papavassiliou, A.G.; Kalofonos, H.P. 2008: EGFR, HER-2 and COX-2 levels in colorectal cancer. Histopathology 53(6): 698-706
Terragni, R.; Casadei Gardini, A.; Sabattini, S.; Bettini, G.; Amadori, D.; Talamonti, C.; Vignoli, M.; Capelli, L.; Saunders, J.H.; Ricci, M.; Ricci, M.; Ulivi, P.; Ulivi, P. 2014: EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model?. Plos one 9(1): E85388
Fichter, C.D.; Timme, S.; Braun, J.A.; Gudernatsch, V.; Schöpflin, A.; Bogatyreva, L.; Geddert, H.; Faller, G.; Klimstra, D.; Tang, L.; Hauschke, D.; Werner, M.; Lassmann, S. 2014: EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer. International Journal of Cancer 135(7): 1517-1530
Wei, Q.; Shui, Y.; Zheng, S.; Wester, K.; Nordgren, H.; Nygren, P.; Glimelius, B.; Carlsson, J. 2011: EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy. Oncology Reports 25(1): 3-11
Press, M.F.; Lenz, H.-J. 2007: EGFR, HER2 and VEGF pathways: validated targets for cancer treatment. Drugs 67(14): 2045-2075
Wei, Q.; Sheng, L.; Shui, Y.; Hu, Q.; Nordgren, H.; Carlsson, J. 2008: EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases. Annals of Surgical Oncology 15(4): 1193-1201
Marinaş, M.C.; Mogoş, G.; Ciurea, R.; Mogoş, D.G. 2012: EGFR, HER2÷neu and Ki67 immunoexpression in serous ovarian tumors. Romanian Journal of Morphology and Embryology 53(3): 563-567
Warth, A.; Penzel, R.; Lindenmaier, H.; Brandt, R.; Stenzinger, A.; Herpel, E.; Goeppert, B.; Thomas, M.; Herth, F.J.F.; Dienemann, H.; Schnabel, P.A.; Schirmacher, P.; Hoffmann, H.; Muley, T.; Weichert, W. 2014: EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. European Respiratory Journal 43(3): 872-883
Villalva, C.; Duranton-Tanneur, V.ér.; Guilloteau, K.; Burel-Vandenbos, F.; Wager, M.; Doyen, J.ér.ôm.; Levillain, P.M.; Fontaine, D.; Blons, H.él.èn.; Pedeutour, F.; Karayan-Tapon, L. 2013: EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients. Cancer Medicine 2(3): 296-304
Martin, V.; Zanellato, E.; Franzetti-Pellanda, A.; Molinari, F.; Movilia, A.; Paganotti, A.; Deantonio, L.; De Dosso, S.; Assi, A.; Crippa, S.; Boldorini, R.; Mazzucchelli, L.; Saletti, P.; Frattini, M. 2014: EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer. Histology and Histopathology 29(4): 513-521
Lasam, G. 2018: Brockenbrough-Braunwald-Morrow Sign: An Evaluative Hemodynamic Maneuver for Left Ventricular Outflow Tract Obstruction. Cardiology Research 9(3): 180-182
Izycka-Swieszewska, E.; Brzeskwiniewicz, M.; Wozniak, A.; Drozynska, E.żb.; Grajkowska, W.ła.; Perek, D.; Balcerska, A.; Klepacka, T.; Limon, J. 2010: EGFR, PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours. Folia Neuropathologica 48(4): 238-245
Berghmans, T.; Mascaux, C.; Haller, A.; Meert, A.P.; Van Houtte, P.; Sculier, J.P. 2008: EGFR, TTF-1 and Mdm2 expression in stage III non-small cell lung cancer: a positive association. Lung Cancer 62(1): 35-44
Xu, N.; Wang, S.Q.; Tan, D.; Gao, Y.; Lin, G.; Xi, R. 2011: EGFR, Wingless and JAK/STAT signaling cooperatively maintain Drosophila intestinal stem cells. Developmental Biology 354(1): 31-43
Chung, K.; Mets, O.M.; Gerke, P.K.; Jacobs, C.; den Harder, A.M.; Scholten, E.T.; Prokop, M.; de Jong, P.A.; van Ginneken, B.; Schaefer-Prokop, C.M. 2018: Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population. Thorax 73(9): 857-863
El Hamdani, W.; Amrani, M.; Attaleb, M.; Laantri, N.; Ennaji, M.M.; Khyatti, M.; El Mzibri, M. 2010: EGFR, p16INK4a and E-cadherin immuno-histochemistry and EGFR point mutations analyses in invasive cervical cancer specimens from Moroccan women. Cellular and Molecular Biology 56 Suppl: Ol1373-Ol1384
Gori, S.; Sidoni, A.; Colozza, M.; Ferri, I.; Mameli, M.G.; Fenocchio, D.; Stocchi, L.; Foglietta, J.; Ludovini, V.; Minenza, E.; De Angelis, V.; Crinò, L. 2009: EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab. Annals of Oncology: Official Journal of the European Society for Medical Oncology 20(4): 648-654
Li, T.; Yang, Y.; Li, X.; Xu, C.; Meng, L. 2012: EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells. Molecular and Cellular Biochemistry 361(1-2): 19-29
Poindessous, V.; Ouaret, D.; El Ouadrani, K.; Battistella, A.; Mégalophonos, V.F.; Kamsu-Kom, N.; Petitprez, A.él.; Escargueil, A.E.; Boudou, P.; Dumont, S.; Cervera, P.; Fléjou, J.-F.ço.; André, T.; Tournigand, C.; Chibaudel, B.; de Gramont, A.; Larsen, A.K. 2011: EGFR- and VEGF(R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodies. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(20): 6522-6530
Fan, J.-B.; Liu, W.; Zhu, X.-H.; Yuan, K.; Xu, D.-W.; Chen, J.-J.; Cui, Z.-M. 2015: EGFR-AKT-mTOR activation mediates epiregulin-induced pleiotropic functions in cultured osteoblasts. Molecular and Cellular Biochemistry 398(1-2): 105-113
Graziano, P.; de Marinis, F.; Gori, B.; Gasbarra, R.; Migliorino, R.; De Santis, S.; Pelosi, G.; Leone, A. 2015: EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma with Squamous Histology. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33(31): E115-E118
Guo, Y.-h.; Gao, F.-h.; Shi, J.; Yuan, H.-h.; Jiang, B. 2013: EGFR-ERK signaling pathway down-regulates miRNA-145 in lung cancer cells. Zhonghua Zhong Liu Za Zhi 35(3): 187-192
Freudlsperger, C.; Burnett, J.R.; Friedman, J.A.; Kannabiran, V.R.; Chen, Z.; Van Waes, C. 2011: EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy. Expert Opinion on Therapeutic Targets 15(1): 63-74
Wu, D.; Peng, F.; Zhang, B.; Ingram, A.J.; Kelly, D.J.; Gilbert, R.E.; Gao, B.; Kumar, S.; Krepinsky, J.C. 2009: EGFR-PLCgamma1 signaling mediates high glucose-induced PKCbeta1-Akt activation and collagen i upregulation in mesangial cells. American Journal of Physiology. Renal Physiology 297(3): F822-F834
Ruppert, A.-M.; Beau-Faller, M.; Neuville, A.; Guerin, E.; Voegeli, A.-C.; Mennecier, B.; Legrain, M.; Molard, A.; Jeung, M.-Y.; Gaub, M.-P.; Oudet, P.; Quoix, E. 2009: EGFR-TKi and lung adenocarcinoma with CNS relapse: interest of molecular follow-up. European Respiratory Journal 33(2): 436-440
Koo, D.-H.; Kim, K.-p.; Choi, C.-M.; Lee, D.-H.; Lee, J.C.; Lee, J.-S.; Jang, S.J.; Kim, S.-W. 2015: EGFR-TKi is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutation. Cancer ChemoTherapy and Pharmacology 75(1): 197-206
Nakagawa, T.; Takeuchi, S.; Yamada, T.; Ebi, H.; Sano, T.; Nanjo, S.; Ishikawa, D.; Sato, M.; Hasegawa, Y.; Sekido, Y.; Yano, S. 2013: EGFR-TKi resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition. Cancer Research 73(8): 2428-2434
Lin, Y.; Wang, X.; Jin, H. 2014: EGFR-TKi resistance in NSCLC patients: mechanisms and strategies. American Journal of Cancer Research 4(5): 411-435
Fan, Y.; Xu, X.; Xie, C. 2014: EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data. Oncotargets and Therapy 7: 2075-2084
Klomp, H.M.; Kappers, I. 2009: EGFR-TKI treatment and surgical resection for oligometastatic NSCLC?. Onkologie 32(11): 627-628
Mak, I.T.; Kramer, J.H.; Chmielinska, J.J.; Spurney, C.F.; Weglicki, W.B. 2015: EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade. Journal of Cardiovascular Pharmacology 65(1): 54-61
Perez, R.; Moreno, E.; Garrido, G.; Crombet, T. 2011: EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects. Cancers 3(2): 2014-2031
Uramoto, H.; Shimokawa, H.; Nagata, Y.; Ono, K.; Hanagiri, T. 2010: EGFR-activating mutations are not present in breast tumors of Japanese patients. Anticancer Research 30(10): 4219-4222
Pfäffle, H.N.; Wang, M.; Gheorghiu, L.; Ferraiolo, N.; Greninger, P.; Borgmann, K.; Settleman, J.; Benes, C.H.; Sequist, L.V.; Zou, L.; Willers, H. 2013: EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity. Cancer Research 73(20): 6254-6263
Lv, P.-C.; Zhu, H.-L. 2014: EGFR-binding peptide: a patent evaluation of WO2014002836. Expert Opinion on Therapeutic Patents 24(12): 1409-1411
Zhang, J.; Ji, J.; Yuan, F.; Ma, T.; Ye, Z.-b.; Yu, Y.-y.; Liu, B.-y.; Zhu, Z.-g. 2009: EGFR-blockade by antibody Cetuximab inhibits the growth of human gastric cancer xenograft in nude mice and its possible mechanism. Zhonghua Zhong Liu Za Zhi 31(2): 85-89
Wertheimer, C.; Liegl, R.; Kernt, M.; Docheva, D.; Kampik, A.; Eibl-Lindner, K.H. 2014: EGFR-blockade with erlotinib reduces EGF and TGF-β2 expression and the actin-cytoskeleton which influences different aspects of cellular migration in lens epithelial cells. Current Eye Research 39(10): 1000-1012
Andreu, M.ía.J.é; Ajuria, L.; Samper, N.úr.; González-Pérez, E.; Campuzano, S.; González-Crespo, S.; Jiménez, G. 2012: EGFR-dependent downregulation of Capicua and the establishment of Drosophila dorsoventral polarity. Fly 6(4): 234-239
Xiao, X.; Meng, Q.; Xu, J.; Jiao, Y.; Rosen, E.M.; Fan, S. 2012: EGFR-dependent impact of indol-3-carbinol on radiosensitivity of lung cancer cells. Zhongguo Fei Ai Za Zhi 15(7): 391-398
Zahonero, C.; Sánchez-Gómez, P. 2014: EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy. Cellular and Molecular Life Sciences: Cmls 71(18): 3465-3488
Rappl, A.; Piontek, G.; Schlegel, J.ür. 2008: EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin. Journal of Cell Science 121(Part 24): 4089-4097
Simakov, D.S.A.; Cheung, L.S.; Pismen, L.M.; Shvartsman, S.Y. 2012: EGFR-dependent network interactions that pattern Drosophila eggshell appendages. Development 139(15): 2814-2820
Ishikawa, K.; Nara, A.; Matsumoto, K.; Hanafusa, H. 2012: EGFR-dependent phosphorylation of leucine-rich repeat kinase LRRK1 is important for proper endosomal trafficking of EGFR. Molecular Biology of the Cell 23(7): 1294-1306
Ho, C.; Laskin, J. 2009: EGFR-directed therapies to treat non-small-cell lung cancer. Expert Opinion on Investigational Drugs 18(8): 1133-1145
Vokes, E.E.; Seiwert, T.Y. 2013: EGFR-directed treatments in SCCHN. LANCET. Oncology 14(8): 672-673
Wu, N-Lin.; Huang, D-Yi.; Hsieh, S-Liang.; Hsiao, C-Hsiang.; Lee, T-An.; Lin, W-Wan. 2013: EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis. Biochimica et Biophysica Acta 1832(10): 1538-1548
Shir, A.; Ogris, M.; Roedl, W.; Wagner, E.; Levitzki, A. 2011: EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in mice. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(5): 1033-1043
Buffet, W.; Geboes, K.P.; Dehertogh, G.; Geboes, K. 2008: EGFR-immunohistochemistry in colorectal cancer and non-small cell lung cancer: comparison of 3 commercially available EGFR-antibodies. Acta Gastro-Enterologica Belgica 71(2): 213-218
Stegeman, H.; Span, P.N.; Cockx, S.C.; Peters, J.P.W.; Rijken, P.F.J.W.; van der Kogel, A.J.; Kaanders, J.H.A.M.; Bussink, J. 2013: EGFR-inhibition enhances apoptosis in irradiated human head and neck xenograft tumors independent of effects on DNA repair. Radiation Research 180(4): 414-421
Alam, S.; Pal, A.; Kumar, R.; Dwivedi, P.D.; Das, M.; Ansari, K.M. 2014: EGFR-mediated Akt and MAPKs signal pathways play a crucial role in patulin-induced cell proliferation in primary murine keratinocytes via modulation of Cyclin D1 and COX-2 expression. Molecular Carcinogenesis 53(12): 988-998
Wei, Y.; Zou, Z.; Becker, N.; Anderson, M.; Sumpter, R.; Xiao, G.; Kinch, L.; Koduru, P.; Christudass, C.S.; Veltri, R.W.; Grishin, N.V.; Peyton, M.; Minna, J.; Bhagat, G.; Levine, B. 2013: EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 154(6): 1269-1284
Chen, S-Jun.; Luan, J.; Zhang, H-Shi.; Ruan, C-Ping.; Xu, X-Yun.; Li, Q-Quan.; Wang, N-Hong. 2012: EGFR-mediated G1/S transition contributes to the multidrug resistance in breast cancer cells. Molecular Biology Reports 39(5): 5465-5471
Lau, S.K.M.; Shields, D.J.; Murphy, E.A.; Desgrosellier, J.S.; Anand, S.; Huang, M.; Kato, S.; Lim, S.-T.; Weis, S.M.; Stupack, D.G.; Schlaepfer, D.D.; Cheresh, D.A. 2012: EGFR-mediated carcinoma cell metastasis mediated by integrin αvβ5 depends on activation of c-Src and cleavage of MUC1. Plos one 7(5): E36753
Wang, M.; Kern, A.M.; Hülskötter, M.; Greninger, P.; Singh, A.; Pan, Y.; Chowdhury, D.; Krause, M.; Baumann, M.; Benes, C.H.; Efstathiou, J.A.; Settleman, J.; Willers, H. 2014: EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation. Cancer Research 74(10): 2825-2834
Master, A.M.; Qi, Y.; Oleinick, N.L.; Gupta, A.S. 2012: EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies. Nanomedicine: Nanotechnology Biology and Medicine 8(5): 655-664
Corcoran, R.B.; Ebi, H.; Turke, A.B.; Coffee, E.M.; Nishino, M.; Cogdill, A.P.; Brown, R.D.; Della Pelle, P.; Dias-Santagata, D.; Hung, K.E.; Flaherty, K.T.; Piris, A.; Wargo, J.A.; Settleman, J.; Mino-Kenudson, M.; Engelman, J.A. 2012: EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discovery 2(3): 227-235
Concha-Benavente, F.; Srivastava, R.M.; Ferrone, S.; Ferris, R.L. 2013: EGFR-mediated tumor immunoescape: the imbalance between phosphorylated STAT1 and phosphorylated STAT3. Oncoimmunology 2(12): E27215
Bemis, L.T.; Robinson, W.A.; McFarlane, R.; Buyers, E.; Kelly, K.; Varella-Garcia, M.; Mitchell, J.D.; Franklin, W.A. 2007: EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome. Lancet. Oncology 8(6): 559-560
Chmielecki, J.; Pietanza, M.C.; Aftab, D.; Shen, R.; Zhao, Z.; Chen, X.; Hutchinson, K.; Viale, A.; Kris, M.G.; Stout, T.; Miller, V.; Rizvi, N.; Pao, W. 2012: EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 7(2): 434-442
Michalarea, V.; Calcasola, M.; Cane, P.; Tobal, K.; Izatt, L.; Spicer, J. 2014: EGFR-mutated lung cancer in Li-Fraumeni syndrome. Lung Cancer 85(3): 485-487
Scher, K.S.; Saldivar, J-Sebastian.; Fishbein, M.; Marchevsky, A.; Reckamp, K.L. 2013: EGFR-mutated lung cancer with T790M-acquired resistance in the brain and histologic transformation in the lung. Journal of the National Comprehensive Cancer Network: Jnccn 11(9): 1040-1044
Zhang, Z.; Stiegler, A.L.; Boggon, T.J.; Kobayashi, S.; Halmos, B. 2010: EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget 1(7): 497-514
Thunnissen, E.; Smit, E.F.; Nederlof, P.M.; Dingemans, A.-M.C. 2011: EGFR-mutation in non-small cell lung carcinoma. Treatment with tyrosine kinase inhibitors possible. Nederlands Tijdschrift Voor Geneeskunde 155: A2554
Doma, E.; Rupp, C.; Baccarini, M. 2013: EGFR-ras-raf signaling in epidermal stem cells: roles in hair follicle development, regeneration, tissue remodeling and epidermal cancers. International Journal of Molecular Sciences 14(10): 19361-19384
Gao, J.; Yu, Y.; Zhang, Y.; Song, J.; Chen, H.; Li, W.; Qian, W.; Deng, L.; Kou, G.; Chen, J.; Guo, Y. 2012: EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials 33(1): 270-282
Schuler, P.J.; Boeckers, P.; Engers, R.; Boelke, E.; Bas, M.; Greve, J.; Dumitru, C.A.; Lehnerdt, G.F.; Ferris, R.L.; Andrade Filho, P.A.; Brandau, S.; Lang, S.; Whiteside, T.L.; Hoffmann, T.K. 2011: EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma. Journal of Translational Medicine 9: 168
Möller, Y.; Siegemund, M.; Beyes, S.; Herr, R.; Lecis, D.; Delia, D.; Kontermann, R.; Brummer, T.; Pfizenmaier, K.; Olayioye, M.A. 2014: EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells. Plos one 9(9): E107165
Horita, H.; Thorburn, J.; Frankel, A.E.; Thorburn, A. 2009: EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins. Journal of Neuro-Oncology 95(2): 175-184
Oberoi, P.; Jabulowsky, R.A.; Bähr-Mahmud, H.; Wels, W.S. 2013: EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells. Plos one 8(4): E61267
Yokoyama, T.; Tam, J.; Kuroda, S.; Scott, A.W.; Aaron, J.; Larson, T.; Shanker, M.; Correa, A.M.; Kondo, S.; Roth, J.A.; Sokolov, K.; Ramesh, R. 2011: EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. Plos one 6(11): E25507
Creixell, M.; Bohórquez, A.C.; Torres-Lugo, M.; Rinaldi, C. 2011: EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. Acs Nano 5(9): 7124-7129
Kuroda, S.; Tam, J.; Roth, J.A.; Sokolov, K.; Ramesh, R. 2014: EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage. International Journal of Nanomedicine 9: 3825-3839
Ren, H.; Gao, C.; Zhou, L.; Liu, M.; Xie, C.; Lu, W. 2015: EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation. Drug Delivery 22(6): 785-794
Sattler, M.; Abidoye, O.; Salgia, R. 2008: EGFR-targeted therapeutics: focus on SCCHN and NSCLC. Thescientificworldjournal 8: 909-919
Chen, P.; Wang, L.; Liu, B.; Zhang, H.-Z.; Liu, H.-C.; Zou, Z. 2011: EGFR-targeted therapies combined with chemotherapy for treating advanced non-small-cell lung cancer: a meta-analysis. European Journal of Clinical Pharmacology 67(3): 235-243
Overman, M.J.; Hoff, P.M. 2007: EGFR-targeted therapies in colorectal cancer. Diseases of the Colon and Rectum 50(8): 1259-1270
Heist, R.S.; Christiani, D. 2009: EGFR-targeted therapies in lung cancer: predictors of response and toxicity. Pharmacogenomics 10(1): 59-68
Antonicelli, A.; Cafarotti, S.; Indini, A.; Galli, A.; Russo, A.; Cesario, A.; Lococo, F.M.; Russo, P.; Mainini, A.F.; Bonifati, L.G.; Nosotti, M.; Santambrogio, L.; Margaritora, S.; Granone, P.M.; Dutly, A.é E. 2013: EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation. International Journal of Medical Sciences 10(3): 320-330
Valentini, A.M.; Pirrelli, M.; Caruso, M.L. 2008: EGFR-targeted therapy in colorectal cancer: does immunohistochemistry deserve a role in predicting the response to cetuximab?. Current Opinion in Molecular Therapeutics 10(2): 124-131
Wilken, J.A.; Badri, T.; Cross, S.; Raji, R.; Santin, A.D.; Schwartz, P.; Branscum, A.J.; Baron, A.T.; Sakhitab, A.I.; Maihle, N.J. 2012: EGFR/HER-targeted therapeutics in ovarian cancer. Future Medicinal Chemistry 4(4): 447-469
Viel, E.; Curtit, E.; Mansi, L.; Vignot, S.ép. 2012: EGFR/HER1: a target life. Bulletin du Cancer 99(2): 181-189
Milanezi, F.; Carvalho, S.; Schmitt, F.C. 2008: EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy. Expert Review of Molecular Diagnostics 8(4): 417-434
Eke, I.; Schneider, L.; Förster, C.; Zips, D.; Kunz-Schughart, L.A.; Cordes, N. 2013: EGFR/JIP-4/JNK2 signaling attenuates cetuximab-mediated radiosensitization of squamous cell carcinoma cells. Cancer Research 73(1): 297-306
Schmid, K.; Oehl, N.; Wrba, F.; Pirker, R.; Pirker, C.; Filipits, M. 2009: EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(14): 4554-4560
Mueller, K.L.; Yang, Z-Quan.; Haddad, R.; Ethier, S.P.; Boerner, J.L. 2010: EGFR/Met association regulates EGFR TKI resistance in breast cancer. Journal of Molecular Signaling 5: 8
Jiang, H.; Grenley, M.O.; Bravo, M.-J.; Blumhagen, R.Z.; Edgar, B.A. 2011: EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeostasis and regeneration in Drosophila. Cell Stem Cell 8(1): 84-95
Kidd, M.; Schimmack, S.; Lawrence, B.; Alaimo, D.; Modlin, I.M. 2013: EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical Therapeutic Targets. Neuroendocrinology 97(1): 35-44
Sousa, V.ít.; Espírito Santo, J.; Silva, M.; Cabral, T.; Alarcão, A.M.; Gomes, A.; Couceiro, P.íc.; Carvalho, L. 2011: EGFR/erB-1, HER2/erB-2, CK7, LP34, Ki67 and P53 expression in preneoplastic lesions of bronchial epithelium: an immunohistochemical and genetic study. Virchows Archiv: An International Journal of Pathology 458(5): 571-581
Collin de L'hortet, A.; Gilgenkrantz, H.él.èn.; Guidotti, J.-E. 2012: EGFR: a Master Piece in G1/S Phase Transition of Liver Regeneration. International Journal of Hepatology 2012: 476910
Hirsch, F.R. 2006: EGFR: a prognostic and/or a predictive marker?. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 1(5): 395-397
Gajiwala, K.S. 2013: EGFR: tale of the C-terminal tail. Protein Science: a Publication of the Protein Society 22(7): 995-999
Yadav, I.S.; Singh, H.; Khan, M.I.; Chaudhury, A.; Raghava, G.P.S.; Agarwal, S.M. 2014: EGFRIndb: epidermal growth factor receptor inhibitor database. Anti-Cancer Agents in Medicinal Chemistry 14(7): 928-935
Mukherjee, B.; McEllin, B.; Camacho, C.V.; Tomimatsu, N.; Sirasanagandala, S.; Nannepaga, S.; Hatanpaa, K.J.; Mickey, B.; Madden, C.; Maher, E.; Boothman, D.A.; Furnari, F.; Cavenee, W.K.; Bachoo, R.M.; Burma, S. 2009: EGFRvIIi and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Research 69(10): 4252-4259
Lal, B.; Goodwin, C.R.; Sang, Y.; Foss, C.A.; Cornet, K.; Muzamil, S.; Pomper, M.G.; Kim, J.; Laterra, J. 2009: EGFRvIIi and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. Molecular Cancer Therapeutics 8(7): 1751-1760
Hadjipanayis, C.G.; Machaidze, R.; Kaluzova, M.; Wang, L.; Schuette, A.J.; Chen, H.; Wu, X.; Mao, H. 2010: EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Research 70(15): 6303-6312
Bax, D.A.; Gaspar, N.; Little, S.E.; Marshall, L.; Perryman, L.; Regairaz, M.; Viana-Pereira, M.; Vuononvirta, R.; Sharp, S.Y.; Reis-Filho, J.S.; Stávale, J.ão.N.; Al-Sarraj, S.; Reis, R.M.; Vassal, G.; Pearson, A.D.J.; Hargrave, D.; Ellison, D.W.; Workman, P.; Jones, C. 2009: EGFRvIIi deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(18): 5753-5761
Li, L.; Dutra, A.; Pak, E.; Labrie, J.E.; Gerstein, R.M.; Pandolfi, P.P.; Recht, L.D.; Ross, A.H. 2009: EGFRvIIi expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro-Oncology 11(1): 9-21
Dziunycz, P.J.; Lazarova, Z.; Duncan, N.; Wong, S.; Neuburg, M.; Hofbauer, G.ün.F.L.; Olasz, E.B. 2013: EGFRvIIi expression in squamous cell carcinoma of the skin. JAMA Dermatology 149(10): 1240-1242
Sampson, J.H.; Choi, B.D.; Sanchez-Perez, L.; Suryadevara, C.M.; Snyder, D.J.; Flores, C.T.; Schmittling, R.J.; Nair, S.K.; Reap, E.A.; Norberg, P.K.; Herndon, J.E.; Kuan, C.-T.; Morgan, R.A.; Rosenberg, S.A.; Johnson, L.A. 2014: EGFRvIIi mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(4): 972-984
Zhou, M.; Gong, B.; Gu, J.; Li, Z. 2010: EGFRvIIi mRNA detection in the serum of patients with hepatocellular carcinoma. Liver International: Official Journal of the International Association for the Study of the Liver 30(6): 925-927
Luo, X.; Xie, H.; Long, X.; Zhou, M.; Xu, Z.; Shi, B.; Jiang, H.; Li, Z. 2013: EGFRvIIi mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression. Plos one 8(12): E83332
Banaszczyk, M.; Stoczynska-Fidelus, E.; Winiecka-Klimek, M.; Bienkowski, M.; Och, W.; Rieske, P.; Piaskowski, S. 2013: EGFRvIII--a stable target for anti-EGFRvIIi therapy. Anticancer Research 33(12): 5343-5348
Zhang, Y.; Su, H.; Rahimi, M.; Tochihara, R.; Tang, C. 2009: EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer. International Journal of Cancer 125(9): 2021-2028
Miao, H.; Choi, B.D.; Suryadevara, C.M.; Sanchez-Perez, L.; Yang, S.; De Leon, G.; Sayour, E.J.; McLendon, R.; Herndon, J.E.; Healy, P.; Archer, G.E.; Bigner, D.D.; Johnson, L.A.; Sampson, J.H. 2014: EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma. Plos one 9(4): E94281
Choi, B.D.; Archer, G.E.; Mitchell, D.A.; Heimberger, A.B.; McLendon, R.E.; Bigner, D.D.; Sampson, J.H. 2009: EGFRvIII-targeted vaccination therapy of malignant glioma. Brain Pathology 19(4): 713-723
Stern, D.F. 2010: EGFs and ERBBs--brief history and prospects. Seminars in Cell and Developmental Biology 21(9): 917-921
Kankare, E.; Liu, D.; Laukkanen, A.-M.; Geneid, A. 2013: EGG and acoustic analyses of different voice samples: comparison between perceptual evaluation and voice activity and participation profile. Folia Phoniatrica et Logopaedica: Official Organ of the International Association of Logopedics and Phoniatrics 65(2): 98-104
Parry, J.M.; Singson, A. 2011: EGG molecules couple the oocyte-to-embryo transition with cell cycle progression. Results and Problems in Cell Differentiation 53: 135-151
Parry, J.M.; Velarde, N.V.; Lefkovith, A.J.; Zegarek, M.H.; Hang, J.S.; Ohm, J.; Klancer, R.; Maruyama, R.; Druzhinina, M.K.; Grant, B.D.; Piano, F.; Singson, A. 2009: EGG-4 and EGG-5 Link Events of the Oocyte-to-Embryo Transition with Meiotic Progression in C. elegans. Current Biology: Cb 19(20): 1752-1757
Che, D.; Hasan, M.S.; Wang, H.; Fazekas, J.; Huang, J.; Liu, Q. 2011: EGID: an ensemble algorithm for improved genomic island detection in genomic sequences. Bioinformation 7(6): 311-314
Ruskoné-Fourmestraux, A.; Fischbach, W.; Aleman, B.M.P.; Boot, H.; Du, M.Q.; Megraud, F.; Montalban, C.; Raderer, M.; Savio, A.; Wotherspoon, A.; Streubel, B.; Cervera, P.; Fabiani, B.; Hennequin, C.; Thieblemont, C.; Copie-Bergman, C.; Delchier, J.C.; Levy, M.; de Mascarel, A.; Lehours, P.; Matysiak, T.; Neubauer, A.; Wundish, T.; Thiede, C.; Willich, N.; D'Elios, M.; Ferreri, A.; Ponzoni, M.; Boer, J.P.De.; De Jong, D.; Zucca, E.; Isaacson, P. 2011: EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60(6): 747-758
Meyers, B.F.; Samson, P.P. 2014: EGJ and esophageal cancers: choosing induction therapy so as to err on the side of overtreatment rather than undertreatment when staging is imperfect. Oncology 28(6): 512; 519-520
Gramstrup Petersen, J.; Rojo Romanos, T.; Juozaityte, V.; Redo Riveiro, A.; Hums, I.; Traunmüller, L.; Zimmer, M.; Pocock, R. 2013: EGL-13/SoxD specifies distinct O2 and CO2 sensory neuron fates in Caenorhabditis elegans. Plos Genetics 9(5): E1003511
Kalis, A.K.; Murphy, M.W.; Zarkower, D. 2010: EGL-5/ABD-B plays an instructive role in male cell fate determination in the C. elegans somatic gonad. Developmental Biology 344(2): 827-835
Luhachack, L.G.; Visvikis, O.; Wollenberg, A.C.; Lacy-Hulbert, A.; Stuart, L.M.; Irazoqui, J.E. 2012: EGL-9 controls C. elegans host defense specificity through prolyl hydroxylation-dependent and -independent HIF-1 pathways. Plos Pathogens 8(7): E1002798
Aggarwal, S.; Negi, S.; Jha, P.; Singh, P.K.; Stobdan, T.; Pasha, M.A.Q.; Ghosh, S.; Agrawal, A.; Prasher, B.; Mukerji, M.; Brahmachari, S.K.; Majumder, P.P.; Mukerji, M.; Habib, S.; Dash, D.; Ray, K.; Bahl, S.; Singh, L.; Sharma, A.; Roychoudhury, S.; Chandak, G.R.; Thangaraj, K.; Parmar, D.; Sengupta, S.; Bharadwaj, D.; Rath, S.K.; Singh, J.; Jha, G.N.; Virdi, K.; Rao, V.R.; Sinha, S.; Singh, A.; Mitra, A.K.; Mishra, S.K.; Pasha, Q.; Sivasubbu, S.; Pandey, R.; Baral, A.; Singh, P.K.; Sharma, A.; Kumar, J.; Stobdan, T.; Bhasin, Y.; Chauhan, C.; Hussain, A.; Sundaramoorthy, E.; Singh, S.P.; Bandyopadhyay, A.; Dasgupta, K.; Reddy, A.K.; Spurgeon, C.J.; Idris, M.M.; Khanna, V.; Dhawan, A.; Anand, M.; Shankar, R.; Bharti, R.S.; Singh, M.; Sing 2010: EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proceedings of the National Academy of Sciences of the United States of America 107(44): 18961-18966
Mishra, A.; Mohammad, G.; Thinlas, T.; Pasha, M.A.Q. 2013: EGLN1 variants influence expression and SaO2 levels to associate with high-altitude pulmonary oedema and adaptation. Clinical Science 124(7): 479-489
Fu, J.; Taubman, M.B. 2013: EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination. Molecular and Cellular Biology 33(15): 3050-3061
Browne, M.; Langham, E.; Rockloff, M.J.; Li, E.; Donaldson, P.; Goodwin, B. 2015: EGM Jackpots and Player Behaviour: An In-venue Shadowing Study. Journal of Gambling Studies 31(4): 1695-1714
Mahmood, K.; Konagurthu, A.S.; Song, J.; Buckle, A.M.; Webb, G.I.; Whisstock, J.C. 2010: EGM: encapsulated gene-by-gene matching to identify gene orthologs and homologous segments in genomes. Bioinformatics 26(17): 2076-2084
Carena, A.; Bosco, G.; Curri, V.; Jiang, Y.; Poggiolini, P.; Forghieri, F. 2014: EGN model of non-linear fiber propagation. Optics Express 22(13): 16335-16362
Kick, A.; Bönsch, M.; Mertig, M. 2012: EGNAS: an exhaustive DNA sequence design algorithm. Bmc Bioinformatics 13: 138
Maniar, J.M.; Fire, A.Z. 2011: EGO-1, a C. elegans RdRP, modulates gene expression via production of mRNA-templated short antisense RNAs. Current Biology: Cb 21(6): 449-459
Zech, N.H.; Vanderzwalmen, P.; Stecher, A.; Spitzer, D.; Wirleitner, B. 2013: EGP: expected gametes performance evaluated by blastocyst culture, a new standard to define "response" from a holistic viewpoint. Journal of Assisted Reproduction and Genetics 30(8): 1059-1061
Gudaitye, A.; Kasiulevicius, V. 2007: EGPRN Vilnius meeting 2007: mental health in primary care. European Journal of General Practice 13(4): 255-256
Huas, C.; Lukas, W.; Petrazzuoli, F. 2011: EGPRN: European General Practice Research Network. European Journal of General Practice 17(3): 195-196
Petrazzuoli, F. 2011: EGPRN: European General Practice Research Network. European Journal of General Practice 17(4): 246-247
Neves, A.L.ís. 2013: EGPRN: European General Practice Research Network. European Journal of General Practice 19(1): 62-64
Ungan, M.; Petek, D. 2013: EGPRN: European General Practice Research Network EGPRN is networking in many ways. European Journal of General Practice 19(3): 201-202
Bouchard, F.éd.ér.; Bélanger, S.D.; Biron-Pain, K.; St-Pierre, Y. 2010: EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth. Blood 116(5): 759-766
Han, W.; Liu, G.-N. 2010: EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat. Life Sciences 86(7-8): 234-243
Chen, H.; Wang, L.; Gong, T.; Yu, Y.; Zhu, C.; Li, F.; Wang, L.; Li, C. 2010: EGR-1 regulates Ho-1 expression induced by cigarette smoke. Biochemical and Biophysical Research Communications 396(2): 388-393
Ramón, H.E.; Cejas, P.J.; LaRosa, D.; Rahman, A.; Harris, J.E.; Zhang, J.; Hunter, C.; Choi, Y.; Turka, L.A. 2010: EGR-2 is not required for in vivo CD4 T cell mediated immune responses. Plos one 5(9): E12904
De Lartigue, G.; Lur, G.; Dimaline, R.; Varro, A.; Raybould, H.; Dockray, G.J. 2010: EGR1 Is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons. Endocrinology 151(8): 3589-3599
Lejard, V.ér.; Blais, F.éd.ér.; Guerquin, M.-J.; Bonnet, A.; Bonnin, M.-A.; Havis, E.; Malbouyres, M.; Bidaud, C.B.; Maro, G.ér.; Gilardi-Hebenstreit, P.; Rossert, J.ér.; Ruggiero, F.; Duprez, D. 2011: EGR1 and EGR2 involvement in vertebrate tendon differentiation. Journal of Biological Chemistry 286(7): 5855-5867
Tarcic, G.; Avraham, R.; Pines, G.; Amit, I.; Shay, T.; Lu, Y.; Zwang, Y.; Katz, M.; Ben-Chetrit, N.; Jacob-Hirsch, J.; Virgilio, L.; Rechavi, G.; Mavrothalassitis, G.; Mills, G.B.; Domany, E.; Yarden, Y. 2012: EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 26(4): 1582-1592
Chbicheb, S.; Yao, X.; Rodeau, J-Luc.; Salamone, Séphane.; Boisbrun, M.; Thiel, G.; Spohn, D.; Grillier-Vuissoz, I.; Chapleur, Y.; Flament, Séphane.; Mazerbourg, S. 2011: EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. Biochemical pharmacology 81(9): 1087-1097
Press, T.; Viale-Bouroncle, S.; Felthaus, O.; Gosau, M.; Morsczeck, C. 2015: EGR1 supports the osteogenic differentiation of dental stem cells. International Endodontic Journal 48(2): 185-192
Kumbrink, J.; Kirsch, K.H.; Johnson, J.P. 2010: EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin. Journal of Cellular Biochemistry 111(1): 207-217
Kim, J.; Kang, H.S.; Lee, Y.-J.; Lee, H.-J.; Yun, J.; Shin, J.H.; Lee, C.W.; Kwon, B.-M.; Hong, S.-H. 2014: EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer. Cancer Letters 349(1): 35-44
Du, N.; Kwon, H.; Li, P.; West, E.E.; Oh, J.; Liao, W.; Yu, Z.; Ren, M.; Leonard, W.J. 2014: EGR2 is critical for peripheral naïve T-cell differentiation and the T-cell response to influenza. Proceedings of the National Academy of Sciences of the United States of America 111(46): 16484-16489
Kim, S.H.; Song, J.Y.; Joo, E.-J.; Lee, K.Y.; Ahn, Y.M.; Kim, Y.S. 2010: EGR3 as a potential susceptibility gene for schizophrenia in Korea. American Journal of Medical Genetics. Part B Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 153b (7): 1355-1360
Hogarth, C.A.; Mitchell, D.; Small, C.; Griswold, M. 2010: EGR4 displays both a cell- and intracellular-specific localization pattern in the developing murine testis. Developmental Dynamics: An Official Publication of the American Association of Anatomists 239(11): 3106-3114
Hadziselimovic, F.; Hadziselimovic, N.O.; Demougin, P.; Krey, G.; Hoecht, B.; Oakeley, E.J. 2009: EGR4 is a master gene responsible for fertility in cryptorchidism. Sexual Development: Genetics Molecular Biology Evolution Endocrinology Embryology and Pathology of Sex Determination and Differentiation 3(5): 253-263
Yang, H.-W.; Lu, Y.-J.; Lin, K.-J.; Hsu, S.-C.; Huang, C.-Y.; She, S.-H.; Liu, H.-L.; Lin, C.-W.; Xiao, M.-C.; Wey, S.-P.; Chen, P.-Y.; Yen, T.-C.; Wei, K.-C.; Ma, C.-C.M. 2013: EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy. Biomaterials 34(29): 7204-7214
Namito, Y.; Hirayama, H. 2013: EGS5 code, outline and how to start using the code. Igaku Butsuri: Nihon Igaku Butsuri Gakkai Kikanshi 33(2): 82-87
Malik, A.H.; Shimazoe, K.; Takahashi, H. 2013: EGS5 simulations to design a Ce:GAGG scintillator based Compton camera. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2013: 5147-5150
Taylor, R.E.P.; Rogers, D.W.O. 2008: EGSnrc Monte Carlo calculated dosimetry parameters for 192Ir and 169Yb brachytherapy sources. Medical Physics 35(11): 4933-4944
Anwarul, I.M.; Akramuzzaman, M.M.; Zakaria, G.A. 2013: EGSnrc Monte Carlo-aided dosimetric studies of the new BEBIG (60)Co HDR brachytherapy source. Journal of Contemporary BrachyTherapy 5(3): 148-156
Selvam, T.P.; Sahoo, S.; Vishwakarma, R.S. 2009: EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models. Medical Physics 36(9): 3870-3879
Zhang, W.; Welihinda, A.; Mechanic, J.; Ding, H.; Zhu, L.; Lu, Y.; Deng, Z.; Sheng, Z.; Lv, B.; Chen, Y.; Roberge, J.Y.; Seed, B.; Wang, Y.-X. 2011: EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA(1c) levels in db/db mice and prolongs the survival of stroke-prone rats. Pharmacological Research 63(4): 284-293
Yang, T.H.; Young, Y.H.; Liu, S.H. 2011: EGb 761 (Ginkgo biloba) protects cochlear hair cells against ototoxicity induced by gentamicin via reducing reactive oxygen species and nitric oxide-related apoptosis. Journal of Nutritional Biochemistry 22(9): 886-894
Gautam, J.; Kushwaha, P.; Swarnkar, G.; Khedgikar, V.; Nagar, G.K.; Singh, D.; Singh, V.; Jain, M.; Barthwal, M.; Trivedi, R. 2012: EGb 761 promotes osteoblastogenesis, lowers bone marrow adipogenesis and atherosclerotic plaque formation. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 19(12): 1134-1142
Chen, C-Chiang.; Chiang, A-Na.; Liu, H-Nan.; Chang, Y-Ting. 2014: EGb-761 prevents ultraviolet B-induced photoaging via inactivation of mitogen-activated protein kinases and proinflammatory cytokine expression. Journal of Dermatological Science 75(1): 55-62
Tsai, J.-Y.; Su, K.-H.; Shyue, S.-K.; Kou, Y.R.; Yu, Y.-B.; Hsiao, S.-H.; Chiang, A.-N.; Wu, Y.-L.; Ching, L.-C.; Lee, T.-S. 2010: EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovascular Research 88(3): 415-423
Chen, Y.J.; Tsai, K.S.; Chiu, C.Y.; Yang, T.H.; Lin, T.H.; Fu, W.M.; Chen, C.F.; Yang, R.S.; Liu, S.H. 2013: EGb761 inhibits inflammatory responses in human chondrocytes and shows chondroprotection in osteoarthritic rat knee. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 31(7): 1032-1038
Rojas, P.; Serrano-García, N.; Mares-Sámano, J.é J.; Medina-Campos, O.N.; Pedraza-Chaverri, J.é; Ogren, S.O. 2008: EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. European Journal of Neuroscience 28(1): 41-50
Jiang, X.; Nie, B.; Fu, S.; Hu, J.; Yin, L.; Lin, L.; Wang, X.; Lu, P.; Xu, X.-M. 2009: EGb761 protects hydrogen peroxide-induced death of spinal cord neurons through inhibition of intracellular ROS production and modulation of apoptotic regulating genes. Journal of Molecular Neuroscience: Mn 38(2): 103-113
Cheng, X.; Liu, F.-L.; Zhang, J.; Wang, L.-L.; Li, F.-L.; Liu, S.; Zhou, L.-H. 2010: EGb761 protects motoneurons against avulsion-induced oxidative stress in rats. Journal of Brachial Plexus and Peripheral Nerve Injury 5: 12
Lim, S.; Yoon, J.W.; Kang, S.M.; Choi, S.H.; Cho, B.J.; Kim, M.; Park, H.S.; Cho, H.J.; Shin, H.; Kim, Y.-B.; Kim, H.S.; Jang, H.C.; Park, K.S. 2011: EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. Plos one 6(6): E20301
Falco, E.E.; Roth, J.S.; Fisher, J.P. 2008: EH Networks as a scaffold for skeletal muscle regeneration in abdominal wall hernia repair. Journal of Surgical Research 149(1): 76-83
Gudmundsson, H.; Hund, T.J.; Wright, P.J.; Kline, C.F.; Snyder, J.S.; Qian, L.; Koval, O.M.; Cunha, S.R.; George, M.; Rainey, M.A.; Kashef, F.E.; Dun, W.; Boyden, P.A.; Anderson, M.E.; Band, H.; Mohler, P.J. 2010: EH domain proteins regulate cardiac membrane protein targeting. Circulation Research 107(1): 84-95
Schoenauer, R.; Emmert, M.Y.; Felley, A.; Ehler, E.; Brokopp, C.; Weber, B.; Nemir, M.; Faggian, G.G.; Pedrazzini, T.; Falk, V.; Hoerstrup, S.P.; Agarkova, I. 2011: EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Research in Cardiology 106(2): 233-247
Alberto, M.E.; Russo, N.; Sicilia, E. 2013: EH3 (E = N, P, As) and H2 activation with N-heterocyclic silylene and germylene homologues. Chemistry 19(24): 7835-7846
Shi, A.; Chen, C.C.-H.; Banerjee, R.; Glodowski, D.; Audhya, A.; Rongo, C.; Grant, B.D. 2010: EHBP-1 functions with RAB-10 during endocytic recycling in Caenorhabditis elegans. Molecular Biology of the Cell 21(16): 2930-2943
Naslavsky, N.; Caplan, S. 2011: EHD proteins: key conductors of endocytic transport. Trends in Cell Biology 21(2): 122-131
Bar, M.; Leibman, M.; Schuster, S.; Pitzhadza, H.; Avni, A. 2013: EHD1 functions in endosomal recycling and confers salt tolerance. Plos one 8(1): E54533
Wei, S.; Xu, Y.; Shi, H.; Wong, S.-H.; Han, W.; Talbot, K.; Hong, W.; Ong, W.-Y. 2010: EHD1 is a synaptic protein that modulates exocytosis through binding to snapin. Molecular and Cellular Neurosciences 45(4): 418-429
Posey, A.D.; Swanson, K.E.; Alvarez, M.G.; Krishnan, S.; Earley, J.U.; Band, H.; Pytel, P.; McNally, E.M.; Demonbreun, A.R. 2014: EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development. Developmental Biology 387(2): 179-190
Bar, M.; Avni, A. 2009: EHD2 inhibits ligand-induced endocytosis and signaling of the leucine-rich repeat receptor-like protein LeEix2. Plant Journal: for Cell and Molecular Biology 59(4): 600-611
Bar, M.; Avni, A. 2009: EHD2 inhibits signaling of leucine rich repeat receptor-like proteins. Plant Signaling and Behavior 4(7): 682-684
Benjamin, S.; Weidberg, H.; Rapaport, D.; Pekar, O.; Nudelman, M.; Segal, D.; Hirschberg, K.; Katzav, S.; Ehrlich, M.; Horowitz, M. 2011: EHD2 mediates trafficking from the plasma membrane by modulating Rac1 activity. Biochemical Journal 439(3): 433-442
Morén, B.ör.; Shah, C.; Howes, M.T.; Schieber, N.L.; McMahon, H.T.; Parton, R.G.; Daumke, O.; Lundmark, R. 2012: EHD2 regulates caveolar dynamics via ATP-driven targeting and oligomerization. Molecular Biology of the Cell 23(7): 1316-1329
Pekar, O.; Benjamin, S.; Weidberg, H.; Smaldone, S.; Ramirez, F.; Horowitz, M. 2012: EHD2 shuttles to the nucleus and represses transcription. Biochemical Journal 444(3): 383-394
Naslavsky, N.; McKenzie, J.; Altan-Bonnet, N.; Sheff, D.; Caplan, S. 2009: EHD3 regulates early-endosome-to-Golgi transport and preserves Golgi morphology. Journal of Cell Science 122(Part 3): 389-400
Curran, J.; Makara, M.A.; Little, S.C.; Musa, H.; Liu, B.; Wu, X.; Polina, I.; Alecusan, J.S.; Wright, P.; Li, J.; Billman, G.E.; Boyden, P.A.; Gyorke, S.; Band, H.; Hund, T.J.; Mohler, P.J. 2014: EHD3-dependent endosome pathway regulates cardiac membrane excitability and physiology. Circulation Research 115(1): 68-78
Sengupta, S.; George, M.; Miller, K.K.; Naik, K.; Chou, J.; Cheatham, M.A.; Dallos, P.; Naramura, M.; Band, H.; Zheng, J. 2009: EHD4 and CDH23 are interacting partners in cochlear hair cells. Journal of Biological Chemistry 284(30): 20121-20129
Swanepoel, D.; Störbeck, C. 2008: EHDI Africa: advocating for infants with hearing loss in Africa. International Journal of Audiology 47 Suppl. 1: S1-S2
Zhang, J.; Naslavsky, N.; Caplan, S. 2012: EHDs meet the retromer: Complex regulation of retrograde transport. Cellular Logistics 2(3): 161-165
Svenungsson, B.; Insulander, M.; Berge, A. 2011: EHEC can cause serious intestinal infection also in adults. a seriously ill 56-year old woman--developed life-threatening complications. Lakartidningen 108(29-31): 1437-1440
Forano, E.; Chaucheyras-Durand, F.éd.ér.; Bertin, Y.; Martin, C. 2013: EHEC carriage in ruminants and probiotic effects. Biologie Aujourd'hui 207(4): 261-267
Kaijser, B. 2011: EHEC is a still current and potent bacteria. more outbreaks coming--complete preparedness is required. Lakartidningen 108(29-31): 1424-1425
Ruchalla, E. 2012: EHEC-HUS: which therapeutic strategy was effective?. Deutsche Medizinische Wochenschrift 137(38): 1841
Aurass, P.; Prager, R.; Flieger, A. 2011: EHEC/EAEC O104:H4 strain linked with the 2011 German outbreak of haemolytic uremic syndrome enters into the viable but non-culturable state in response to various stresses and resuscitates upon stress relief. Environmental Microbiology 13(12): 3139-3148
Efimenko, N.V.; Osipov, I.S.; Kaĭsinova, A.S.; Fedorova, T.E.; Kim, N.K. 2011: EHF therapy in the combined resort-based treatment of patients after surgery for the early cancer of the gastrointestinal tract. Medical technology. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 46-50
Al'tman, N.S.; Cherednichenko, A.M. 2011: EHF-therapy in children the treatment with erosive and ulcerative lesions of the upper gastrointestinal tract. Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 31-37
Liu, Y.; Xie, D.; Han, L.; Bai, H.; Li, F.; Wang, S.; Bo, X. 2015: EHFPI: a database and analysis resource of essential host factors for pathogenic infection. Nucleic Acids Research 43(Database Issue): D946-D955
Cho, S.-J.; Park, S.C. 2009: EHGbox in the clitellate Perionyx excavatus. Biochemical Genetics 47(11-12): 843-849
Ea, C.-K.; Hao, S.; Yeo, K.S.; Baltimore, D. 2012: EHMT1 protein binds to nuclear factor-κB p50 and represses gene expression. Journal of Biological Chemistry 287(37): 31207-31217
Tilson, H.A. 2011: EHP Classic Paper of the Year, 2011. Environmental Health Perspectives 119(6): A238
Tilson, H.A. 2012: EHP Classic Paper of the Year, 2012. Environmental Health Perspectives 120(7): A263
Tilson, H.A. 2013: EHP Classic Paper of the Year, 2013. Environmental Health Perspectives 121(9): A266
Tilson, H.A. 2013: EHP Paper of the Year, 2013. EnvironmentalHealthPerspectives 121(11-12):A322
Tilson, H.A. 2009: EHP Update. Environmental Health Perspectives 117(1): A12
Tilson, H.A. 2009: EHP paper of the year, 2009. Environmental Health Perspectives 117(6): A232
Tilson, H.A. 2010: EHP paper of the year, 2010. Environmental Health Perspectives 118(6): A238
Tilson, H.A.; Schroeder, J.C. 2009: EHP's policy on integrity of published research. Environmental Health Perspectives 117(9): A380
Ford, T.E.; Bass, A.L.; Cheng, S.; Cherr, G.N.; Cole, B.; Fairbairn, E.; Gu, J.-D.; Halbrook, R.S.; Löffler, F.E.; Madsen, E.L.; McGinn, N.A. 2011: EHPC 2010: sharing knowledge on environmental health for risk mitigation. Ecotoxicology 20(5): 937-939
Kuźnik, N.; Jewuła, P.ł; Oczek, L.; Kozłowicz, S.; Grucela, A.; Domagała, W. 2014: EHPG iron(III) complexes as potential contrast contrast agents for MRi. Acta Chimica Slovenica 61(1): 87-93
Yuasa, Y. 2006: EHPM for a new era. Environmental Health and Preventive Medicine 11(5): 219
Heubusch, K. 2012: EHR 2014: highlights of the proposed stage 2 certification rule. Journal of AHIMA 83(5): 38-39
Frey, L.J.; Lenert, L.; Lopez-Campos, G. 2014: EHR Big Data Deep Phenotyping. Contribution of the IMIA Genomic Medicine Working Group. Yearbook of Medical Informatics 9: 206-211
Macdonald, A.; Riahi, S. 2012: EHR Implementation: one Organization's Road to Success. Ni 2012: 11th International Congress on Nursing Informatics June: 23-27 2012 Montreal Canada. International Congress in Nursing Informatics 2012: 258
Schuerenberg, B.K. 2008: EHR a saint at volunteer practice. Health Data Management 16(8): 56; 58
Morton, M.E.; Wiedenbeck, S. 2010: EHR acceptance factors in ambulatory care: a survey of physician perceptions. Perspectives in Health Information Management 7: 1c
Shu, T.; Liu, H.; Goss, F.R.; Yang, W.; Zhou, L.; Bates, D.W.; Liang, M. 2014: EHR adoption across China's tertiary hospitals: a cross-sectional observational study. International Journal of Medical Informatics 83(2): 113-121
Yeager, V.A.; Menachemi, N.; Brooks, R.G. 2010: EHR adoption among doctors who treat the elderly. Journal of Evaluation in Clinical Practice 16(6): 1103-1107
Guida, K.; LaVenture, M. 2011: EHR adoption and use. Results from the 2010 Minnesota ambulatory clinic survey. Minnesota Medicine 94(4): 33-36
Weaver, S.; Dick, M.; Dougherty, M.; Anderson, D.; Everhard, L.; Mansell, J.; McGlaughlin, C.; Moen, M.; Niederkorn, S.; Updegrove, J.; Watson, M. 2011: EHR adoption in LTC and the HIM value. Journal of Ahima 82(1): 46-51
McAnally, J. 2011: EHR adoption supported by tnREC. Tennessee Medicine: Journal of the Tennessee Medical Association 104(2): 31-32
Lang, R.D. 2010: EHR adoption--Are financial incentives enough?. Journal of Healthcare Information Management: Jhim 24(2): 2-3
Madden, A. 2011: EHR adoption: help is here for your decision-making process. Tennessee Medicine: Journal of the Tennessee Medical Association 104(9): 35; 37
Virone, M.G. 2012: EHR and data protection issues in Italy. Studies in Health Technology and Informatics 180: 741-745
Hess, C.T. 2011: EHR and meaningful use checklist. Advances in Skin and Wound Care 24(1): 48
Sappington, R.W. 2010: EHR and the real meaning of technology adoption. Radiology Management 32(4): 16-25; Quiz: 26-27
Brighi, R.; Virone, M.G. 2014: EHR and usability of health data to benefit patient and public health. Studies in Health Technology and Informatics 205: 965-969
Blobel, B. 2008: EHR architectures - comparison and trends. Studies in Health Technology and Informatics 134: 59-73
Forrey, A.W. 2007: EHR at AACC. MLO: medical laboratory observer 39(8): 6; author reply 6-7
Dente, M. 2011: EHR benefits in action. how leveraging actionable knowledge will strengthen public health efforts. Health Management Technology 32(3): 32
Selenke, J. 2007: EHR bliss. a small family practice reaps the benefits of a Web-based EHR. Health Management Technology 28(12): 38-39
Juhl, J.H. 2012: EHR boat not ready to sail in United States. Journal of the American Osteopathic Association 112(5): 261-262
Faskhutdinova, A.A.; Akatov, V.S.; Solov'eva, M.E.; Solov'ev, V.S.; Chailakhyan, L.M. 2008: The mechanism of cytotoxic action of acetylcysteine in combination with vitamin B12b. Doklady Biological Sciences: Proceedings of the Academy of Sciences of the Ussr Biological Sciences Sections 422(11): 366-368
Drummond, R. 2011: EHR certification: getting comfortable with the concept. Health Management Technology 32(7): 26-27
Terry, K. 2007: EHR certification: its true value. Medical Economics 84(18): 28-34
Verdon, D.R. 2012: Customizing EHR templates can speed up your workflow. Medical Economics 89(18): 68
Conn, J. 2013: EHR developers under pressure. Fewer systems ready for stage 2, analysis shows. Modern Healthcare 43(39): 14-15
Adler, K.G. 2014: EHR dissatisfaction: is it time to switch your EHR?. Family Practice Management 21(4): 6
Verdon, D.R. 2013: EHR divorce: what's driving dissatisfaction?. Medical Economics 90(12): 23-27
Dowling, R. 2014: EHR documentation: avoid note cloning and up-coding. Medical Economics 91(12): 33
West, C.E.; West, C.E. 2008: EHR enabled quality improvement: a two year follow-up study of 6 community health centers. AMIA . Annual Symposium Proceedings. AMIA Symposium 2008: 1175
Tripathi, M. 2012: EHR evolution: policy and legislation forces changing the EHR. Journal of Ahima 83(10): 24-9; Quiz 30
Goedert, J. 2008: EHR face-off: what's easy, hard. Health Data Management 16(10): 62
Gaudreau, E.; Palermo, D. 2009: EHR fast track. Fundamentals of rapid implementation planning. Journal of Ahima 80(8): 40-43
Gillespie, G. 2012: EHR game changer focuses on taking invisible path to change. Health Data Management 20(6): 48-49
Baldwin, G. 2012: EHR game changer goal: rural hospital connectivity. Health Data Management 20(3): 50
Gillespie, G. 2012: EHR game changer makes I.T. fit the clinician. Health Data Management 20(2): 99
Mazzolini, C. 2013: EHR holdouts: why some physicians refuse to plug in. Medical Economics 90(22): 42
Huntington, M.K.; Shafer, C.W. 2010: EHR implementation adversely affects performance on process quality measures in a community health center. American Journal of Medical Quality: the Official Journal of the American College of Medical Quality 25(5): 404-405
Yogeswaran, P.; Wright, G. 2010: EHR implementation in South Africa: how do we get it right?. Studies in Health Technology and Informatics 160(Part 1): 396-400
Crosson, J.C.; Bazemore, A.W.; Phillips, R.L. 2011: EHR implementation without meaningful use can lead to worse outcomes. American Family Physician 84(11): 1220
Peck, A.D. 2013: EHR implementation: training pays dividends. Medical Economics 90(14): 53-56
Ben-Assuli, O.; Shabtai, I.; Leshno, M.; Hill, S. 2014: EHR in emergency rooms: exploring the effect of key information components on main complaints. Journal of Medical Systems 38(4): 36
Bailey, J.E. 2008: EHR initiatives in the Mid-South. Tennessee Medicine: Journal of the Tennessee Medical Association 101(7): 27-28
Conn, J. 2014: EHR leaders vying for \$11 B military contract. Modern Healthcare 44(26): 15
De Boer, C.G.; Regev, A. 2018: BROCKMAN: deciphering variance in epigenomic regulators by k-mer factorization. Bmc Bioinformatics 19(1): 253
Hazewinkel, J. 2012: EHR meaningful use incentives begin to flow. Michigan Medicine 111(2): 18
Schackow, T.E.; Palmer, T.; Epperly, T. 2008: EHR meltdown: how to protect your patient data. Family Practice Management 15(6): A3-A8
Walsh, C.; Stetson, P. 2012: EHR on the move: resident physician perceptions of iPads and the clinical workflow. AMIA .. Annual Symposium Proceedings. AMIA Symposium 2012: 1422-1430
Conn, J. 2009: EHR pilot program nixed. Subsidies were to help pay docs for implementation. Modern Healthcare 39(16): 10
Anderson, H.J. 2007: EHR pioneers try to stay out front. Health Data Management 15(5): 26-28; 30 32 Passim
Martin, Z. 2007: EHR project is something special. Health Data Management 15(9): 54
Ma, C.; Frankel, H.; Beale, T.; Heard, S. 2007: EHR query language (EQL)--a query language for archetype-based health records. Studies in Health Technology and Informatics 129(Part 1): 397-401
Gardner, E. 2012: EHR research: a study in contradictions. Health Data Management 20(6): 42; 44, 46
Walker, J.M.; Carayon, P.; Leveson, N.; Paulus, R.A.; Tooker, J.; Chin, H.; Bothe, A.; Stewart, W.F. 2008: EHR safety: the way forward to safe and effective systems. Journal of the American Medical Informatics Association: Jamia 15(3): 272-277
Drummond, H. 2010: EHR satisfaction in large medical groups. Family Practice Management 17(5): 9; Author Reply 9
Adler, K.G.; Shields, J.; Edsall, R.L. 2010: EHR satisfaction: user characteristics matter. Family Practice Management 17(4): 22-25
Rashbaum, K.N. 2011: EHR security: confluence of law, patient protection, benefit to physicians. Medical Economics 88(19): 77-78
Prestigiacomo, J. 2011: EHR solution for pediatric dose range checking. Healthcare Informatics: the Business Magazine for Information and Communication Systems 28(8): 43
Bowden, T.C. 2011: EHR strategy: top down, bottom up or middle out?. Studies in Health Technology and Informatics 164: 138-142
Gardner, E. 2012: EHR success all in the details. Health Data Management 20(5): 30
Turso, C. 2009: EHR success starts with a "reality check". Behavioral Healthcare 29(10): 19-20
Dimick, C. 2008: EHR support group. HIM professional cofounds Connecticut's first EHR roundtable. Journal of Ahima 79(5): 84
Rashbaum, K.N. 2012: EHR templates: time-saver or patient safety risk?. Medical Economics 89(1): 58; 65
Safian, S.C. 2009: EHR triggers: a force for improved care--and revenue. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 63(9): 108
Leftwich, R.B. 2011: EHR update: progress on meaningful use requirements. Tennessee Medicine: Journal of the Tennessee Medical Association 104(9): 36-37
Gomez, R. 2010: EHR upgrade considerations. Nursing Management 41(12): 35-37
Aleksandrova, E.N.; Novikov, A.A.; Nasonov, E.L. 2013: The role of biomarkers in diagnostics and forecasting of effectiveness of modern therapy of rheumatoid arthritis. Klinicheskaia Laboratornaia Diagnostika 43(8): 3-13
Amatayakul, M. 2009: EHR versus EMR: what's in a name?. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 63(3): 24
Sexton, C.J. 2013: EHR "meaningful use"--getting ready for Stage 2. Journal of the Medical Association of Georgia 102(2): 8-10
Giannangelo, K.; Fenton, S. 2008: EHR's effect on the revenue cycle management Coding function. Journal of Healthcare Information Management: Jhim 22(1): 26-30
Khan, Y.; Roth, C.; Payne, P.; Patterson, E.; Leonard, A.; Elder, N.; Eckman, M.; Embi, P.J. 2013: EHR-based Clinical Trial Alert Effects on Recruitment to a Neurology Trial across Institutions: Interim Analysis of a Randomized Controlled Study. AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science 2013: 117
Liaw, S.-T.; Taggart, J.; Yu, H. 2014: EHR-based disease registries to support integrated care in a health neighbourhood: an ontology-based methodology. Studies in Health Technology and Informatics 205: 171-175
Persell, S.D.; Eder, M.; Friesema, E.; Connor, C.; Rademaker, A.; French, D.D.; King, J.; Wolf, M.S. 2013: EHR-based medication support and nurse-led medication therapy management: rationale and design for a three-arm clinic randomized trial. Journal of the American Heart Association 2(5): E000311
Kern, S.I. 2010: EHR-related risk lowered if records safe, accessible. Medical Economics 87(23): 89
Slater, K. 2011: EHR: a match made in heaven. Mgma Connexion 11(2): 11
Williams, B. 2008: EHR: taking the plunge. Tennessee Medicine: Journal of the Tennessee Medical Association 101(7): 29-30
Padeletti, L.; Arnar, D.O.; Boncinelli, L.; Brachman, J.; Camm, J.A.; Daubert, J.Claude.; Hassam, S.K.; Kassam, S.; Deliens, L.; Glikson, M.; Hayes, D.; Israel, C.; Lampert, R.; Lobban, T.; Raatikainen, P.; Siegal, G.; Vardas, P.; Kirchhof, P.; Becker, Rüdiger.; Cosio, F.; Loh, P.; Cobbe, S.; Grace, A.; Morgan, J. 2010: EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 12(10): 1480-1489
Morgan, J. 2009: EHRA Scientific Initiatives Committee: initiative for surveys. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 11(8): 1001
Mont, L. 2013: EHRA is all of us. Herzschrittmachertherapie and Elektrophysiologie 24(1): 60-62
Meier, B.; Blaauw, Y.; Khattab, A.A.; Lewalter, T.; Sievert, H.; Tondo, C.; Glikson, M.; Lip, G.Y.H.; Lopez-Minguez, J.; Roffi, M.; Israel, C.; Dudek, D.; Savelieva, I. 2014: EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 16(10): 1397-1416
Elqatni, M.; Qacif, H.; Zyani, M.; Ghafir, D.; Amezyane, T. 2018: Brocq-Pautrier's angiolupoid. Presse Medicale 47(6): 600-601
Pedersen, C.Torp.; Kay, G.Neal.; Kalman, J.; Borggrefe, M.; Della-Bella, P.; Dickfeld, T.; Dorian, P.; Huikuri, H.; Kim, Y-Hoon.; Knight, B.; Marchlinski, F.; Ross, D.; Sacher, Fédéric.; Sapp, J.; Shivkumar, K.; Soejima, K.; Tada, H.; Alexander, M.E.; Triedman, J.K.; Yamada, T.; Kirchhof, P.; Lip, G.Y.H.; Kuck, K.Heinz.; Mont, Lís.; Haines, D.; Indik, J.; Dimarco, J.; Exner, D.; Iesaka, Y.; Savelieva, I. 2014: EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm 11(10): E166-E196
Rousche, L.E. 2013: EHRs and audits mean new roles for doctors, staff. Medical Economics 90(17): 39-41
Daniel, J.G.; Reider, J.M.; Posnack, S.L. 2013: EHRs and clinical documentation to optimize patient care. Journal of the American Medical Informatics Association: Jamia 20(E1): E195-E196
Mohan, V.; Hersh, W.R. 2011: EHRs and health care quality: correlation with out-of-date, differently purposed data does not equate with causality. Archives of Internal Medicine 171(10): 952-953
Sugarman, J.R.; Secord, M.; Rempel, M. 2011: EHRs and performance improvement. American Journal of Medical Quality: the Official Journal of the American College of Medical Quality 26(2): 163
Amatayakul, M. 2008: EHRs are not IT projects. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 62(11): 128; 130
Bernstein, K.E. 2007: EHRs can boost compliance. Health Management Technology 28(5): 22; 24
Newbell, B.J. 2007: EHRs don't fix everything. Family Practice Management 14(4): 16
Trachtenbarg, D.E. 2007: EHRs fix everything--and nine other myths. Family Practice Management 14(3): 26-30
Susman, J. 2010: EHRs for all: Regional extension centers to the rescue?. Journal of Family Practice 59(7): 372
Mehta, N.; Vakharia, N.; Wright, A. 2014: EHRs in a web 2.0 world: time to embrace a problem-list Wiki. Journal of General Internal Medicine 29(3): 434-436
Goetz Goldberg, D.; Kuzel, A.J.; Feng, L.B.; DeShazo, J.P.; Love, L.E. 2012: EHRs in primary care practices: benefits, challenges, and successful strategies. American Journal of Managed Care 18(2): E48-E54
Lamar, M. 2011: EHRs in the cloud: contract protection for a rainy day. Journal of Ahima 82(7): 48-49
Versel, N. 2009: EHRs must be certified, but who will do that? 'A lot of people's hands are tied' as federal IT leaders ponder which group or groups to tap. Hospitals and Health Networks 83(10): 12
Robeznieks, A. 2008: EHRs not for short-timers: doc. HIMSS, AAFP reject notion, urge docs to get tech. Modern Healthcare 38(32): 34
Batres, J. 2012: EHRs offer coders opportunities, challenges. Journal of Ahima 83(10): 76-7; Quiz 78
Chen, X. 2007: Choices at crossroads in my academic career. Sheng Li Ke Xue Jin Zhan 38(4): 289-294
Dearworth, J.R. 2011: EHRs privacy and practice. Delaware Medical Journal 83(1): 23
Carroll, J. 2013: EHRs turning out to be not as wonderful as expected. Managed Care 22(2): 5-6
Beaulieu-Volk, D. 2014: EHRs' interoperability challenge. HIE expansion aimed at helping providers exchange health information safely, but not all services created equally. Medical Economics 91(6): 50-53
Silverman, R.D. 2013: EHRs, EMRs, and health information technology: to meaningful use and beyond: a symposium introduction and overview. Journal of Legal Medicine 34(1): 1-6
Wax, C.M. 2010: EHRs, insurance, and government: when did we lose sight of the patient?. Medical Economics 87(23): 82-84
Anonymous 2013: EHRs, quality measures: study points to problems. Hospital peer review 38(9): 100-101
Terry, K. 2007: EHRs. The Feds get something right. Doctors have nothing but praise for a government program that helps them adopt electronic health records. Medical Economics 84(6): 48-50
Terry, K. 2014: EHRs: 5 ways to put data into action. Physicians share strategies to improve quality metrics, chronic care. Medical Economics 91(11): 22-26
Nayyar, G. 2011: EHRs: Why one size doesn't fit all. HITECH Act regulations should not be adopted in isolation, but rather customized to organizations and their practitioners. Health Management Technology 32(1): 16-17
Gibula, R. 2011: EHRs: attitude isn't everything. Family Practice Management 18(2): 8
Connors, W.R. 2007: EHRs: back to the basic benefits. Behavioral Healthcare 27(9): 47-49
Walker, A. 2013: EHRs: boon or bane?. Tennessee Medicine: Journal of the Tennessee Medical Association 106(10): 25-26
Gans, D.N. 2012: EHRs: increase revenue, replace paper charts. Mgma Connexion 12(1): 39
Murer, C.G. 2007: EHRs: issues preventing widespread adoption. Rehab Management 20(5): 38-39
Szyf, M. 2012: DNA methylation biomarkers for colorectal carcinoma and adenomatous polyps. Epigenomics 4(1): 14-15
Ritchie, A. 2013: EHRs: solution or problem for your front-office staff?. Medical Economics 90(21): 35
Hickner, J. 2014: EHRs: something's gotta give. Journal of Family Practice 63(10): 558
Painter, D. 2013: EHRs: the need for speed. Medical Economics 90(23): 42-44
Verdon, D.R. 2014: EHRs: the real story. Why a national outcry from physicians will shake the health information technology sector. Medical Economics 91(3): 18-20 27
McClelland, B. 2011: EHRs: watching and waiting. Family Practice Management 18(6): 8
Ketchersid, T. 2010: EHRs: what's all the fuss about?. Nephrology News and Issues 24(12): 58-60 64
Minch, F.M. 2012: EHRs: worth the time and the investment. Tennessee Medicine: Journal of the Tennessee Medical Association 105(3): 5
Kulkarni, G.K. 2012: EHS challenges: Project sites. Indian Journal of Occupational and Environmental Medicine 16(3): 93-94
Kwon, M.K.; Kim, S.K.; Koo, J.M.; Choi, J.Y.; Kim, D.W. 2012: EHS subjects do not perceive RF EMF emitted from smart phones better than non-EHS subjects. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2012: 2190-2193
Brown, L.G. 2013: EHS-net restaurant food safety studies: what have we learned?. Journal of Environmental Health 75(7): 44-45
Heimann, P.; Issakov, A.; Judd, T.M. 2006: EHTP: improving health quality through health technology. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference Suppl: 6610-6613
Crombie, H.David. 2007: EHealth. Connecticut Medicine 71(7): 431-432
Nicolas, L. 2012: EHealth, health networks and electronic health record: towards a culture of sharing and trust. Revue Medicale de Bruxelles 33(4): 416-419
Przybylski, P.; Pospieszny, T.; Huczyński, A.; Brzezinski, B.ł 2008: Ei MS and ESi MS studies of the bisesquiterpene from cotton seeds: Gossypol and its Aza-derivatives. Journal of Mass Spectrometry: Jms 43(5): 680-686
Kerr, R.A. 1993: Ei Nino Metamorphosis Throws Forecasters. Science 262(5134): 656-657
Choi, J.-M.; Devkota, S.; Sung, Y.H.; Lee, H.-W. 2013: EI24 regulates epithelial-to-mesenchymal transition and tumor progression by suppressing TRAF2-mediated NF-κB activity. Oncotarget 4(12): 2383-2396
Carraro, S.; Cogo, P.E.; Isak, I.; Simonato, M.; Corradi, M.; Carnielli, V.P.; Baraldi, E. 2010: EIA and GC/MS analysis of 8-isoprostane in EBC of children with problematic asthma. European Respiratory Journal 35(6): 1364-1369
Zhou, K.-Y.; Sheate, W.R. 2011: EIA application in China's expressway infrastructure: clarifying the decision-making hierarchy. Journal of Environmental Management 92(6): 1471-1483
Christensen, P.; Kørnøv, L. 2011: EIA screening and nature protection in Denmark. Journal of Environmental Management 92(4): 1097-1103
Takayama, N.; Saika, S.; Ichinohe, S. 2009: EIA-IgG antibody measles prevention level estimated from measles neutralizing, particle agglutination and hemagglutination-inhibition antibody titer. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 83(5): 519-524
Zallocchi, M.; Binley, K.; Lad, Y.; Ellis, S.; Widdowson, P.; Iqball, S.; Scripps, V.; Kelleher, M.; Loader, J.; Miskin, J.; Peng, Y.-W.; Wang, W.-M.; Cheung, L.; Delimont, D.; Mitrophanous, K.A.; Cosgrove, D. 2014: EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat. Plos one 9(4): E94272
Bonini, S. 2008: EIB or not EIB? That is the question. Medicine and Science in Sports and Exercise 40(9): 1565-1566
Blair, H.A. 2018: Brodalumab: a Review in Moderate to Severe Plaque Psoriasis. Drugs 78(4): 495-504
Rusta-Sallehy, S.; Gooderham, M.; Papp, K. 2018: Brodalumab: a Review of Safety. Skin Therapy Letter 23(2): 1-3
Wade, R.; Grosso, A.; South, E.; Rothery, C.; Saramago, P.; Schmitt, L.; Wright, K.; Palmer, S. 2019: Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal. Pharmacoeconomics 37(2): 131-139
Holanda Peña, M.S.; Domínguez Artiga, M.J.; Ots Ruiz, E.; Lorda de los Ríos, M.I.; Castellanos Ortega, A.; Ortiz Melón, F. 2011: EICS (Extended Intensive Care Service): looking outside the ICU. Medicina Intensiva 35(6): 349-353
Park, Y.-Y.; Park, K.C.; Shong, M.; Lee, S.-J.; Lee, Y.-H.; Choi, H.-S. 2007: EID-1 interacts with orphan nuclear receptor SF-1 and represses its transactivation. Molecules and Cells 24(3): 372-377
Lizcano, F.; Vargas, D. 2010: EID1-induces brown-like adipocyte traits in white 3T3-L1 pre-adipocytes. Biochemical and Biophysical Research Communications 398(2): 160-165
Ferner, R.E.; Aronson, J.K. 2010: EIDOS: a mechanistic classification of adverse drug effects. Drug Safety 33(1): 15-23
Jahnavi, S.; Poovazhagi, V.; Kanthimathi, S.; Gayathri, V.; Mohan, V.; Radha, V. 2014: EIF2AK3 mutations in South Indian children with permanent neonatal diabetes mellitus associated with Wolcott-Rallison syndrome. Pediatric Diabetes 15(4): 313-318
Aminkeng, F. 2014: EIF2AK4 genetic mutations cause a recessive form of rare and deadly lung disease, pulmonary veno-occlusive disease. Clinical Genetics 86(3): 218-219
Best, D.H.; Sumner, K.L.; Austin, E.D.; Chung, W.K.; Brown, L.M.; Borczuk, A.C.; Rosenzweig, E.B.; Bayrak-Toydemir, P.; Mao, R.; Cahill, B.C.; Tazelaar, H.D.; Leslie, K.O.; Hemnes, A.R.; Robbins, I.M.; Elliott, C.G. 2014: EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest 145(2): 231-236
Chang, S.S.; Smith, I.; Glazer, C.; Hennessey, P.; Califano, J.A. 2010: EIF2C is overexpressed and amplified in head and neck squamous cell carcinoma. Orl; Journal for Oto-Rhino-Laryngology and its Related Specialties 72(6): 337-343
Zhang, A.; Zhang, J.; Sun, P.; Yao, C.; Su, C.; Sui, T.; Huang, H.; Cao, X.; Ge, Y. 2010: EIF2alpha and caspase-12 activation are involved in oxygen-glucose-serum deprivation/restoration-induced apoptosis of spinal cord astrocytes. Neuroscience Letters 478(1): 32-36
Wu, M.; Liu, Y.; Di, X.; Kang, H.; Zeng, H.; Zhao, Y.; Cai, K.; Pang, T.; Wang, S.; Yao, Y.; Hu, X. 2013: EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma. Medical Oncology 30(1): 400
Blanckenberg, J.; Ntsapi, C.; Carr, J.A.; Bardien, S. 2014: EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa. Neurobiology of Aging 35(2): 445.E1
Nishioka, K.; Funayama, M.; Vilariño-Güell, C.; Ogaki, K.; Li, Y.; Sasaki, R.; Kokubo, Y.; Kuzuhara, S.; Kachergus, J.M.; Cobb, S.A.; Takahashi, H.; Mizuno, Y.; Farrer, M.J.; Ross, O.A.; Hattori, N. 2014: EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population. Parkinsonism and Related Disorders 20(6): 659-661
Huttenlocher, J.; Krüger, R.; Capetian, P.; Lohmann, K.; Brockmann, K.; Csoti, I.; Klein, C.; Berg, D.; Gasser, T.; Bonin, M.; Riess, O.; Bauer, P. 2015: EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts. Journal of Medical Genetics 52(1): 37-41
Liu, Y.; Du, F.; Chen, W.; Yao, M.; Lv, K.; Fu, P. 2015: EIF5A2 is a novel chemoresistance gene in breast cancer. Breast Cancer 22(6): 602-607
Adlersberg, D. 1947: Vitamin problems in oral pathology. New York State Dental Journal 13(4): 181-190
Lei, G.; Shen, M.; Li, Z.-G.; Zhang, B.; Duan, K.-X.; Wang, N.; Cao, Y.-R.; Zhang, W.-K.; Ma, B.; Ling, H.-Q.; Chen, S.-Y.; Zhang, J.-S. 2011: EIN2 regulates salt stress response and interacts with a MA3 domain-containing protein ECIP1 in Arabidopsis. Plant Cell and Environment 34(10): 1678-1692
Bisson, M.M.A.; Bleckmann, A.; Allekotte, S.; Groth, G. 2009: EIN2, the central regulator of ethylene signalling, is localized at the ER membrane where it interacts with the ethylene receptor ETR1. Biochemical Journal 424(1): 1-6
Zhong, S.; Zhao, M.; Shi, T.; Shi, H.; An, F.; Zhao, Q.; Guo, H. 2009: EIN3/EIL1 cooperate with PIF1 to prevent photo-oxidation and to promote greening of Arabidopsis seedlings. Proceedings of the National Academy of Sciences of the United States of America 106(50): 21431-21436
Aalbers, J. 2012: EINSTEIN-PE study results, with South African expert comment. Cardiovascular Journal of Africa 23(5): 299
Kołtowski, Łu. 2012: EINSTEIN-PE: rivaroxaban for treatment of symptomatic pulmonary embolism. Kardiologia Polska 70(9): 971-975
Helme, M. 2009: EIPEN--The European Interprofessional Education Network. Journal of Interprofessional Care 23(5): 430-431
Bian, J.; Topaloglu, U.; Lane, C. 2009: EIR: enterprise imaging repository, an alternative imaging archiving and communication system. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2009: 2168-2171
Chiriacò, M.S.; Primiceri, E.; D'Amone, E.; Ionescu, R.E.; Rinaldi, R.; Maruccio, G. 2011: EIS microfluidic chips for flow immunoassay and ultrasensitive cholera toxin detection. Lab on a Chip 11(4): 658-663
Cortina-Puig, M.; Muñoz-Berbel, X.; Alonso-Lomillo, M.A.ón.; Muñoz-Pascual, F.J.; Del Valle, M. 2007: EIS multianalyte sensing with an automated SIA system-An electronic tongue employing the impedimetric signal. Talanta 72(2): 774-779
Kongsuphol, P.; Ng, H.H.; Pursey, J.P.; Arya, S.K.; Wong, C.C.; Stulz, E.; Park, M.K. 2014: EIS-based biosensor for ultra-sensitive detection of TNF-α from non-diluted human serum. Biosensors and Bioelectronics 61: 274-279
Li, X.-L.; Meng, X.-D.; Yang, Z.-C.; Sun, J. 2013: EIT and MOLLOW spectrum in N-type four-level system. Guang Pu Xue Yu Guang Pu Fen Xi 33(3): 590-594
De Marco, T.; Ries, F.; Guermandi, M.; Guerrieri, R. 2012: EIT forward problem parallel simulation environment with anisotropic tissue and realistic electrode models. IEEE Transactions on Bio-Medical Engineering 59(5): 1229-1239
Dai, T.; Soleimani, M.; Adler, A. 2008: EIT image reconstruction with four dimensional regularization. Medical and Biological Engineering and Computing 46(9): 889-899
Dong, G.; Bayford, R.; Liu, H.; Zhou, Y.; Yan, W. 2006: EIT images with improved spatial resolution using a realistic head model. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006: 1134-1137
Lee, M.-J.; Chen, Y.-H.; Wang, I.-C.; Yu, I.A. 2012: EIT-based all-optical switching and cross-phase modulation under the influence of four-wave mixing. Optics Express 20(10): 11057-11063
Yao, A.; Yang, C.L.; Seo, J.K.; Soleimani, M. 2013: EIT-based fabric pressure sensing. Computational and Mathematical Methods in Medicine 2013: 405325
Narváez Pérez, K.; Fernández Crespo, L.; Teresa Miranda, M.ía.; Boulón Diaz, F. 2013: EIWA-IIi measures of cognitive function in young Puerto Rico patients with epilepsy. Boletin de la Asociacion Medica de Puerto Rico 105(1): 24-31
Tramèr, M.R. 2010: EJA 2010: new style, new team, new energy - what we want and what we do not want. European Journal of Anaesthesiology 27(1): 1-2
Tramèr, M.R. 2011: EJA 2011: Finding the balance between science and politics. European Journal of Anaesthesiology 28(1): 1-2
Haux, R.; Zvárová, J. 2008: EJBi and methods agree on close cooperation. Methods of Information in Medicine 47(2): 97
Chazal, P-Etienne.; Daguenet, E.; Wendling, C.; Ulryck, N.; Tomasetto, C.; Sargueil, B.; Le Hir, Hé. 2013: EJC core component MLN51 interacts with eIF3 and activates translation. Proceedings of the National Academy of Sciences of the United States of America 110(15): 5903-5908
Farooqi, I.Sadaf. 2014: EJE Prize 2012: Obesity: from genes to behaviour. European Journal of Endocrinology 171(5): R191-R195
Ronchi, C.L.; Kroiss, M.; Sbiera, S.; Deutschbein, T.; Fassnacht, M. 2014: EJE prize 2014: current and evolving treatment options in adrenocortical carcinoma: where do we stand and where do we want to go?. European Journal of Endocrinology 171(1): R1-R11
Brenna, F.; Devigus, A. 2010: EJED and the Accademia Italiana di Conservativa. European Journal of Esthetic Dentistry: Official Journal of the European Academy of Esthetic Dentistry 5(1): 9
Takahashi, H.; Sato, K.; Takagi, A.; Iizuka, H. 2018: Brodalumab-induced palmar pustular eruption and joint swelling accompanied by muscle pains in two cases of psoriasis. Journal of Dermatology 45(11): E325-E326
Eickner, T.; Mikkat, S.; Lorenz, P.; Sklorz, M.; Zimmermann, R.; Thiesen, H.-J.ür.; Glocker, M.O. 2011: EJMS protocol: systematic studies on TiO2-based phosphopeptide enrichment procedures upon in-solution and in-gel digestions of proteins. Are there readily applicable protocols suitable for matrix-assisted laser desorption/ionization mass spectrometry-based phosphopeptide stability estimations?. European Journal of Mass Spectrometry 17(5): 507-523
Beyer, T.; Flux, G.; Sattler, B.; Bischof Delaloye, A.; Carrio, I. 2014: EJNMMi Physics--access is open for open access. European Journal of Nuclear Medicine and Molecular Imaging 41(2): 197-198
Bischof Delaloye, A. 2011: EJNMMI Research: a new journal in nuclear medicine. European Journal of Nuclear Medicine and Molecular Imaging 38(1): 1-2
Carrió, I. 2013: EJNMMI: the European way of communicating science. European Journal of Nuclear Medicine and Molecular Imaging 40(1): 1-3
Esposito, M. 2013: EJOI New Year's wishes. European Journal of Oral Implantology 6(4): 315
Zaina, F.; Negrini, S. 2011: EJPRM systematic continuous Update on Cochrane reviews in rehabilitation: news from April 2011 to July 2011. European Journal of Physical and Rehabilitation Medicine 47(3): 507-511
Zaina, F.; Negrini, S. 2012: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from December 2011 to February 2012. European Journal of Physical and Rehabilitation Medicine 48(1): 57-70
Zaina, F.; Negrini, S. 2011: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from February 2011 to April 2011. European Journal of Physical and Rehabilitation Medicine 47(2): 327-340
Zaina, F.; Negrini, S. 2011: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from July to December 2011. European journal of physical and rehabilitation medicine 47(4): 601-605
Zaina, F.; Negrini, S. 2011: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from September 2010 to January 2011. European Journal of Physical and Rehabilitation Medicine 47(1): 57-68
Zaina, F.; Negrini, S. 2010: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from the 1st and 2nd Issues of 2010. European Journal of Physical and Rehabilitation Medicine 46(2): 269-282
Zaina, F.; Negrini, S. 2010: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from the 3rd 4th and 5th Issues of 2010. European journal of physical and rehabilitation medicine 46(3): 439-452
Zaina, F.; Negrini, S. 2009: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from the 3rd Issue 2009. European journal of physical and rehabilitation medicine 45(4): 605-619
Zaina, F. 2008: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from the 3rd issue 2008. European Journal of Physical and Rehabilitation Medicine 44(4): 441-448
Zaina, F. 2009: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from the 4th Issue 2008. European Journal of Physical and Rehabilitation Medicine 45(1): 93-101
Zaina, F.; Negrini, S. 2010: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from the 4th Issue 2009. European Journal of Physical and Rehabilitation Medicine 46(1): 95-111
Zaina, F.; Negrini, S. 2010: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from the 8th, 9th and 10th issues of 2010. European journal of physical and rehabilitation medicine 46(4): 525-535
Zaina, F.; Negrini, S. 2009: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from the first issue 2009. European journal of physical and rehabilitation medicine 45(2): 193-195
Zaina, F.; Negrini, S. 2009: EJPRM systematic continuous update on Cochrane reviews in rehabilitation: news from the second issue 2009. European journal of physical and rehabilitation medicine 45(3): 427-430
Brownfield, J.; Herbert, M. 2008: EKG Criteria for Fibrinolysis: What's Up with the J Point?. Western Journal of Emergency Medicine 9(1): 40-42
Bennett, C.R. 1986: EKG Monitoring for Conscious-Sedation. Anesthesia Progress 33(5): 281
Spalding, M.D.; Giron, L.T. 2012: EKG filter artifact mimicking epileptiform discharges. Neurodiagnostic Journal 52(1): 82-89
Sova, J.; Kolda, M. 1949: EKG in normal pregnancy. Ceskoslovenska Gynekologie 14(5): 282-291
Franco, E.; Dias, A.; Teresa, D.; Hebert, K. 2014: EKG pattern of Brugada syndrome and sudden infant death syndrome--is it time to review the diagnostic criteria? Case report and review of literature. Annals of Noninvasive Electrocardiology: the Official Journal of the International Society for Holter and Noninvasive Electrocardiology Inc 19(2): 198-202
Foster, C.E.; Taylor, M.; Schallert, E.K.; Rosenfeld, S.; King, K.Y. 2019: Brodie Abscess in Children: A 10-Year Single Institution Retrospective Review. Pediatric Infectious Disease Journal 38(2): E32-E34
Crossley, B. 2012: EKG signals, blanket warmers, and fluid warmers. Biomedical Instrumentation and Technology 46(1): 72
Anonymous 1947: EKIRI Commission. Circular letter. United States. Far East Command. Medical Section 1947(10): 13
Siatecka, M.; Lohmann, F.; Bao, S.; Bieker, J.J. 2010: EKLF directly activates the p21WAF1/CIP1 gene by proximal promoter and novel intronic regulatory regions during erythroid differentiation. Molecular and Cellular Biology 30(11): 2811-2822
Tallack, M.R.; Keys, J.R.; Humbert, P.O.; Perkins, A.C. 2009: EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2. Journal of Biological Chemistry 284(31): 20966-20974
Yien, Y.Y.; Bieker, J.J. 2013: EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination. Molecular and Cellular Biology 33(1): 4-13
Marmagkiolis, K.; Lendel, V.; Cilingiroglu, M. 2014: EKOS™ ultrasound - accelerated catheter - directed thrombolysis for acutely occluded femoro-popliteal graft. Cardiovascular Revascularization Medicine: Including Molecular Interventions 15(1): 43-45
Wang, Y.; Liu, Z.; Cheng, H.; Gao, T.; Pan, Z.; Yang, Q.; Guo, A.; Xue, Y. 2014: EKPD: a hierarchical database of eukaryotic protein kinases and protein phosphatases. Nucleic Acids Research 42(Database Issue): D496-D502
Tattersall, D.; Scott, C.A.; Gray, C.; Zicha, D.; Kelsell, D.P. 2009: EKV mutant connexin 31 associated cell death is mediated by ER stress. Human Molecular Genetics 18(24): 4734-4745
Rueda, A.J.; Feito, F.R. 2011: EL-REP: a new 2D Geometric Decomposition Scheme and its Applications. IEEE Transactions on Visualization and Computer Graphics 17(9): 1325-1336
Lindsey, C.Y.; Brown, J.E.; Torabazar, N.R.; Smith, L.A. 2013: EL4 cell-based colorimetric toxin neutralization activity assays for determination of neutralizing anti-ricin antibodies. Journal - Association of Official Analytical Chemists 96(1): 147-154
Nishizawa, Y.; Katoh, S.; Koiwai, H.; Katoh, E. 2008: EL5 is involved in root development as an anti-cell death ubiquitin ligase. Plant Signaling and Behavior 3(2): 148-150
Kalemkerian, P.B.; Metz, G.E.; Peral-Garcia, P.; Echeverria, M.G.; Giovambattista, G.; Díaz, S. 2012: ELA-DRA polymorphisms are not associated with Equine Arteritis Virus infection in horses from Argentina. Research in Veterinary Science 93(3): 1271-1273
Chng, S.C.; Ho, L.; Tian, J.; Reversade, B. 2013: ELABELA: a hormone essential for heart development signals via the apelin receptor. Developmental Cell 27(6): 672-680
Xie, F.; Lv, D.; Chen, L. 2014: ELABELA: a novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor. Acta Biochimica et Biophysica Sinica 46(7): 620-622
Giugliani, R.; Matte, U. 2014: ELAG - 10 Successful Years. Genetics and Molecular Biology 37(1 Suppl): 147-148
Aguera, P.-E.; Jerbi, K.; Caclin, A.; Bertrand, O. 2011: ELAN: a software package for analysis and visualization of MEG, EEG, and LFP signals. Computational Intelligence and Neuroscience 2011: 158970
Horwitz, M.S.; Corey, S.J.; Grimes, H.L.; Tidwell, T. 2013: ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology. Hematology/Oncology Clinics of North America 27(1): 19-41 Vii
Dayman, H. 1945: Silicosis; a clinical study. American Review of Tuberculosis 52: 449-462
Pascale, A.; Amadio, M.; Caffino, L.; Racagni, G.; Govoni, S.; Fumagalli, F. 2011: ELAV-GAP43 pathway activation following combined exposure to cocaine and stress. Psychopharmacology 218(1): 249-256
Chang, S.-H.; Elemento, O.; Zhang, J.; Zhuang, Z.W.; Simons, M.; Hla, T. 2014: ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 111(51): 18309-18314
Schwank, M.; Wiesmann, A.; Werner, C.; Mätzler, C.; Weber, D.; Murk, A.; Völksch, I.; Wegmüller, U. 2010: ELBARA II, an L-band radiometer system for soil moisture research. Sensors 10(1): 584-612
Lista, G.; Fontana, P.; Castoldi, F.; Cavigioli, F.; Bianchi, S.; Bastrenta, P. 2012: ELBW infants: to intubate or not to intubate in the delivery room?. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 25(Suppl 4): 63-65
Eltsov, M.; Sosnovski, S.; Olins, A.L.; Olins, D.E. 2014: ELCS in ice: cryo-electron microscopy of nuclear envelope-limited chromatin sheets. Chromosoma 123(3): 303-312
Hu, Y.; Smyth, G.K. 2009: ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. Journal of Immunological Methods 347(1-2): 70-78
Häder, D-Peter.; Lebert, M.; Schuster, M.; del Ciampo, L.; Helbling, E.Walter.; McKenzie, R. 2007: ELDONET--a decade of monitoring solar radiation on five continents. Photochemistry and Photobiology 83(6): 1348-1357
Rigby, S.E.J.; Lou, X.; Toogood, H.S.; Wolthers, K.R.; Scrutton, N.S. 2011: ELDOR spectroscopy reveals that energy landscapes in human methionine synthase reductase are extensively remodelled following ligand and partner protein binding. Chembiochem: a European Journal of Chemical Biology 12(6): 863-867
Hong, L.; Qian, Q.; Zhu, K.; Tang, D.; Huang, Z.; Gao, L.; Li, M.; Gu, M.; Cheng, Z. 2010: ELE restrains empty glumes from developing into lemmas. Journal of Genetics and Genomics 37(2): 101-115
Chaudhary, S.U.; Shin, S.-Y.; Lee, D.; Song, J.-H.; Cho, K.-H. 2013: ELECANS--an integrated model development environment for multiscale cancer systems biology. Bioinformatics 29(7): 957-959
Malakoff, D. 2000: ELECTION 2000: Uncertainty Wins by a Landslide. Science 290(5495): 1277-1279
Schwatka, L.F. 1881: Observations on Ice and Icebergs in the Polar Regions. Science 2(31): 31-32
Offiah, A.; Hume, J.; Bamsey, I.; Jenkinson, H.; Lings, B. 2011: ELECTRICA: ELEctronic knowledge base for Clinical care, Teaching and Research in Child Abuse. Pediatric Radiology 41(11): 1433-1439
Scripture, E.W. 1900: ELECTRICAL ANAeSTHESIA. Science 11(265): 153
Adam, A.L.; Klein, M. 1945: ELECTRICAL CATARACT Notes on a Case and a Review of the Literature. British Journal of Ophthalmology 29(4): 169-175
Sanford, F. 1915: Electrical Density and Absorption of Beta-Rays. Science 42(1073): 130-131
Jin, C-Jin.; Ye, H-Yun.; Luo, G-Wei.; Chen, W-Rong.; Lai, K-Bei.; Xu, L. 2011: Electrical Injury induced Bilateral Peripapillary Meridional Retina-Choroidal Atrophy: A Case Report. Retinal Cases and Brief Reports 5(3): 237-240
Anonymous 1946: ELECTRODIAGNOSIS of peripheral nerve lesions in man. Research program. United States. Army. Medical Department 1946: 33
Anonymous 1954: ELECTROLYTE balance quickly; flame photometry; becoming essential tool. What's new 185: 5-9
Koehler, J.K.; Mühlethaler, K.; Freywyssling, A. 1963: Electron Microscopic Autoradiography : An Improved Technique for Producing Thin Films and its Application to H-Thymidine-Labeled Maize Nuclei. Journal of Cell Biology 16(1): 73-80
Sedar, A.W. 1962: Electron Microscopy of the Oxyntic cell in the Gastric Glands of the Bullfrog, Rana Catesbiana: Iii. Permanganate Fixation of the Endoplasmic Reticulum. Journal of Cell Biology 14(1): 152-156
Anonymous 1948: ELECTRON microscopy of wool fibers by a shadowed replica method. Journal of the Franklin Institute 246(1): 66-70
Dunn, L.C. 1945: Organization and support of science in the United States. Science 102(2657): 548-554
Service, R.F. 2000: ELECTRONIC OPTICS: Organic Lasers Promise new Lease on Light. Science 289(5479): 519-521
Anonymous 1947: ELECTRONIC timer for viscosity measurements. Review of Scientific Instruments 18(11): 857
Anonymous 1946: ELECTROPHOTOMETER applications greatly extended. Laboratory 16(1): 22
Li, S.-D.; Wang, Y.-F.; Qi, J.-Y.; Qiu, L.-G. 2010: Clinical Features of Bone Complications and Prognostic Value of Bone Lesions Detected by X-ray Skeletal Survey in Previously Untreated Patients with Multiple Myeloma. Indian Journal of Hematology and Blood Transfusion: An Official Journal of Indian Society of Hematology and Blood Transfusion 26(3): 83-88
Bongiorni, M.G.; Romano, S.L.; Kennergren, C.; Butter, C.; Deharo, J.C.; Kutarsky, A.; Rinaldi, C.A.; Maggioni, A.P.; Blomström-Lundqvist, C.; Auricchio, A. 2013: ELECTRa (European Lead Extraction ConTRolled) Registry--shedding light on transvenous lead extraction real-world practice in Europe. Herzschrittmachertherapie and Elektrophysiologie 24(3): 171-175
Anonymous 1881: Elements and Ephemeris of Comet (C), 1881.--Schaeberle. Science 2(58): 357
Anonymous 1881: ELEMENTS OF COMET (b), 1881: Communicated by Rear Admiral John Rodgers, Superintendent U.S. Naval Observatory. Science 2(61): 400
Marshall, E. 1981: ELF Resurrected After Drowning by Navy. Science 212(4495): 644-645
Panagopoulos, D.J.; Karabarbounis, A.; Lioliousis, C. 2013: ELF alternating magnetic field decreases reproduction by DNA damage induction. Cell Biochemistry and Biophysics 67(2): 703-716
Capstick, M.; Schär, P.; Schuermann, D.; Romann, A.; Kuster, N. 2013: ELF exposure system for live cell imaging. Bioelectromagnetics 34(3): 231-239
Mizuno, K.; Narita, E.; Yamada, M.; Shinohara, N.; Miyakoshi, J. 2014: ELF magnetic fields do not affect cell survival and DNA damage induced by ultraviolet B. Bioelectromagnetics 35(2): 108-115
Gavoçi, E.ë; Zironi, I.; Remondini, D.; Virelli, A.; Castellani, G.; Del Re, B.; Giorgi, G.; Aicardi, G.; Bersani, F. 2013: ELF magnetic fields tuned to ion parametric resonance conditions do not affect TEA-sensitive voltage-dependent outward K(+) currents in a human neural cell line. Bioelectromagnetics 34(8): 579-588
Mild, K.H.; Mattsson, M.-O. 2010: ELF noise fields: a review. Electromagnetic Biology and Medicine 29(3): 72-97
Brisdelli, F.; Bennato, F.; Bozzi, A.; Cinque, B.; Mancini, F.; Iorio, R. 2014: ELF-MF attenuates quercetin-induced apoptosis in K562 cells through modulating the expression of Bcl-2 family proteins. Molecular and Cellular Biochemistry 397(1-2): 33-43
Bravo, G.; Scaringi, M.; Vandelli, A.M.; Romanelli, A.; Rossi, P.; Gobba, F. 2007: ELF-MF occupational exposure: repeated measures on workers. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 29(3 Suppl): 424-425
Iorio, R.; Bennato, F.; Mancini, F.; Colonna, R.C. 2013: ELF-MF transiently increases skeletal myoblast migration: possible role of calpain system. International Journal of Radiation Biology 89(7): 548-561
Yang, J.; Yang, W.; Hirankarn, N.; Ye, D.Q.; Zhang, Y.; Pan, H.-F.; Mok, C.C.; Chan, T.M.; Wong, R.W.S.; Mok, M.Y.; Lee, K.W.; Wong, S.N.; Leung, A.M.H.; Li, X.-P.; Avihingsanon, Y.; Rianthavorn, P.; Deekajorndej, T.; Suphapeetiporn, K.; Shotelersuk, V.; Baum, L.; Kwan, P.; Lee, T.L.; Ho, M.H.K.; Lee, P.P.W.; Wong, W.H.S.; Zeng, S.; Zhang, J.; Wong, C.-M.; Ng, I.O.L.; Garcia-Barceló, M.-M.è; Cherny, S.S.; Tam, P.K.-H.; Sham, P.C.; Lau, C.S.; Lau, Y.L. 2011: ELF1 is associated with systemic lupus erythematosus in Asian populations. Human Molecular Genetics 20(3): 601-607
Chow, B.Y.; Helfer, A.; Nusinow, D.A.; Kay, S.A. 2012: ELF3 recruitment to the PRR9 promoter requires other Evening Complex members in the Arabidopsis circadian clock. Plant Signaling and Behavior 7(2): 170-173
Kolmos, E.; Davis, S.J. 2007: ELF4 as a Central Gene in the Circadian Clock. Plant Signaling and Behavior 2(5): 370-372
Sashida, G.; Liu, Y.; Elf, S.; Miyata, Y.; Ohyashiki, K.; Izumi, M.; Menendez, S.; Nimer, S.D. 2009: ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation. Molecular and Cellular Biology 29(13): 3687-3699
Kalyuga, M.; Gallego-Ortega, D.; Lee, H.J.; Roden, D.L.; Cowley, M.J.; Caldon, C.E.; Stone, A.; Allerdice, S.L.; Valdes-Mora, F.; Launchbury, R.; Statham, A.L.; Armstrong, N.; Alles, M.C.; Young, A.; Egger, A.; Au, W.; Piggin, C.L.; Evans, C.J.; Ledger, A.; Brummer, T.; Oakes, S.R.; Kaplan, W.; Gee, J.M.W.; Nicholson, R.I.; Sutherland, R.L.; Swarbrick, A.; Naylor, M.J.; Clark, S.J.; Carroll, J.S.; Ormandy, C.J. 2012: ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer. Plos Biology 10(12): E1001461
Hemberger, M.; Udayashankar, R.; Tesar, P.; Moore, H.; Burton, G.J. 2010: ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta. Human Molecular Genetics 19(12): 2456-2467
Polev, D.E.; Karnaukhova, I.K.; Krukovskaya, L.L.; Kozlov, A.P. 2014: ELFN1-AS1: a novel primate gene with possible microRNA function expressed predominantly in human tumors. Biomed Research International 2014: 398097
Ströher, A.; Honekamp, W. 2011: ELGA--the electronic health record in the light of data protection and data security. Wiener Medizinische Wochenschrift 161(13-14): 341-346
Tillman, T.S.; Seyoum, E.; Mowrey, D.D.; Xu, Y.; Tang, P. 2014: ELIC-α7 Nicotinic acetylcholine receptor (α7nAChR) chimeras reveal a prominent role of the extracellular-transmembrane domain interface in allosteric modulation. Journal of Biological Chemistry 289(20): 13851-13857
Yin, S.; Ohmori, H.; Liu, Q.; Morita, S.; Chen, F.; Asami, M.; Fan, Y. 2009: ELID grinding characteristics of large stamping die for Wolter mirror. Journal of X-Ray Science and Technology 17(3): 265-277
Shayman, J.A. 2010: ELIGLUSTAT TARTRATE: Glucosylceramide Synthase Inhibitor Treatment of Type 1 Gaucher Disease. Drugs of the Future 35(8): 613-620
Romanazzo, D.; Ricci, F.; Vesco, S.; Piermarini, S.; Volpe, G.; Moscone, D.; Palleschi, G. 2009: ELIME (enzyme linked immuno magnetic electrochemical) method for mycotoxin detection. Journal of Visualized Experiments: Jove 2009(32)
Raths, D. 2007: ELINCS gets adopted. HL 7 is taking over ELINCS to ensure lab data and EHRs continue towards interoperability. Healthcare Informatics: the Business Magazine for Information and Communication Systems 24(3): 20; 24
Anonymous 2007: ELIPPSE 65-80 study. Medecine sciences: M/S 23 Spec No 3: 52-54
Sanaei Dashti, A.; Karimi, A.; Javad, V.; Shiva, F.; Fallah, F.; Alaei, M.R.; Angoti, G.; Pournasiri, Z. 2012: ELISA Cut-off Point for the Diagnosis of Human Brucellosis; a Comparison with Serum Agglutination Test. Iranian Journal of Medical Sciences 37(1): 9-14
Zhu, B.; Li, X.-f.; Zhu, X.-l.; Lin, Y.; Zhong, S.; Zhu, C.-f.; Tang, X.-l.; Hu, Y.-q.; Cheng, X.-x.; Wang, Y.-j. 2014: ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome. Journal of Nephrology 27(4): 411-417
Leng, S.X.; McElhaney, J.E.; Walston, J.D.; Xie, D.; Fedarko, N.S.; Kuchel, G.A. 2008: ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. Journals of Gerontology. Series A Biological Sciences and Medical Sciences 63(8): 879-884
Rodríguez-Ulloa, C.; Rivera-Jacinto, M. 2011: ELISA and spontaneous sedimentation technique for the diagnosis of Giardia lamblia infection in stool samples of Peruvian children. Salud Publica de Mexico 53(6): 516-519
Von Maltzan, K.; Pruett, S.B. 2011: ELISA assays and alcohol: increasing carbon chain length can interfere with detection of cytokines. Alcohol 45(1): 1-9
Anders, G.; Vakil, H.B. 2007: ELISA assays for rabies antibodies?. Human Vaccines 3(5): 156
Kikuchi, Y.; Ohnishi, T.; Furusawa, H.; Kawai, T.; Fukuda, Y.; Yokoyama, H.; Sugita-Konishi, Y. 2013: ELISA detection of Kudoa septempunctata in raw Paralichthys olivaceus (olive flounder) using a chicken anti-Kudoa antiserum. Biocontrol Science 18(4): 193-197
Cucu, T.; Platteau, C.; Taverniers, I.; Devreese, B.; de Loose, M.; de Meulenaer, B. 2011: ELISA detection of hazelnut proteins: effect of protein glycation in the presence or absence of wheat proteins. Food Additives and Contaminants. Part A Chemistry Analysis Control Exposure and Risk Assessment 28(1): 1-10
Fang, Z.; Jiang, B.; Wu, W.; Xiang, Z.; Ouyang, C.; Huang, T.; Chen, J.; Zeng, L. 2013: ELISA detection of semicarbazide based on a fast sample pretreatment method. Chemical Communications 49(55): 6164-6166
Zhang, X.-y.; Ding, X.-q.; Lv, W.-L.; Teng, J.; Zhong, Y.-H. 2013: ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients. Molecular Biology Reports 40(10): 5817-5824
Mogi, M.; Kondo, A. 2010: ELISA for RANKL-OPG complex in mouse sera. Journal of Immunoassay and Immunochemistry 31(2): 103-110
Jiang, H.; Chen, W.; Qu, L.; Chen, Y.; He, Q.; Wang, H.; Wu, J.; Shou, Z.; Ju, Z.; Chen, J. 2010: ELISA for aging biomarkers induced by telomere dysfunction in human plasma. Journal of Biomedicine and Biotechnology 2010: 121947
Sanmarco, M. 2010: ELISA for antiphosphatidylethanolamine antibody detection: high impact of assay buffer on results. Journal of Immunological Methods 358(1-2): 9-16
Thepsuriyanont, P.; Intarapuk, A.; Chanket, P.; Tunyong, W.; Kalambaheti, T. 2014: ELISA for brucellosis detection based on three Brucella recombinant proteins. Southeast Asian Journal of Tropical Medicine and Public Health 45(1): 130-141
Habirov, Z.; Manilova, E.; Kadamov, D.; Komilova, S.; Harbach, R.E. 2013: ELISA incrimination of Anopheles superpictus and Anopheles hyrcanus (Diptera: Culicidae) as vectors of Plasmodium vivax (Haemosporida: Plasmodiidae) in Tajikistan. Journal of Medical Entomology 50(6): 1298-1302
Panigrahi, B.; Jones, B.C.; Rowe, S.P. 2018: Brodifacoum-contaminated synthetic marijuana: clinical and radiologic manifestations of a public health outbreak causing life-threatening coagulopathy. Emergency Radiology 25(6): 715-718
Stumr, F.; Gabrovská, D.; Rysová, J.; Hanák, P.; Plicka, J.; Tomková, K.ĕt.; Dvorská, P.; Cuhra, P.; Kubík, M.; Barsová, S.; Karsulínová, L.; Bulawová, H.; Brychta, J.; Yman, I.M. 2010: ELISA kit for casein determination: interlaboratory study. Journal - Association of Official Analytical Chemists 93(2): 676-682
Tomková, K.ìt.; Cuhra, P.; Rysová, J.; Hanák, P.; Gabrovská, D. 2010: ELISA kit for determination of egg white proteins: interlaboratory study. Journal - Association of Official Analytical Chemists 93(6): 1923-1929
Cuhra, P.; Gabrovská, D.; Rysová, J.; Hanák, P.; Stumr, F. 2011: ELISA kit for mustard protein determination: interlaboratory study. Journal - Association of Official Analytical Chemists 94(2): 605-610
Lexmaulová, H.; Gabrovská, D.; Rysová, J.; Stumr, F.; Netusilová, K.; Blazková, M.; Bulawová, H.; Brychta, J.; Subrtová, Z.; Pavelka, J.; Iametti, S.; Del Barco, J.A.G.; Quesada, J.M.; Pardo, E.S.; Resa, I.P.; Takkinen, K.; Laukkanen, M.-L.; Piknová, L.; Langerholc, T.; Cencic, A.; Barsová, S.; Cuhra, P.; Plicka, J. 2013: ELISA kit for peanut protein determination: collaborative study. Journal - Association of Official Analytical Chemists 96(5): 1041-1047
Shimizu, S.; Iwata, K.; Morishita, C.; Takano, H.; Aoki, M.; Watanabe, Y.; Odauti, S.; Suzuki, K. 2007: ELISA kit in outbreaks of infectious gastroenteritis among elderly nursing home. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 81(6): 751-753
Saito, J.; Imamura, Y.; Itoh, J.; Matsuyama, S.; Maruta, A.; Hayashi, T.; Sato, A.; Wada, N.; Kashiwazaki, K.; Inagaki, Y.; Watanabe, T.; Kitagawa, Y.; Okazaki, I. 2010: ELISA measurement for urinary 3-hydroxyproline-containing peptides and its preliminary application to healthy persons and cancer patients. Anticancer Research 30(3): 1007-1014
Klaver, A.C.; Coffey, M.P.; Smith, L.M.; Bennett, D.A.; Finke, J.M.; Dang, L.; Loeffler, D.A. 2011: ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects. Journal of Neuroinflammation 8: 93
Qin, H.; Benveniste, E.N. 2012: ELISA methodology to quantify astrocyte production of cytokines/chemokines in vitro. Methods in Molecular Biology 814: 235-249
Benabid, M.; Galai, Y.; Nouira, R.; Alaya, N.B.; Bouratbine, A.; Aoun, K. 2010: ELISA on Saliva Samples for the Detection of Anti-Hydatid Cyst Antibodies. Clinical Laboratory 56(11-12): 543-546
Cho, H.J.; Deregt, D.; Loewen, K.G. 1993: ELISA reliable for detection of antibodies to BHV1. Canadian Veterinary Journal 34(1): 7-8
Yibar, A.; Cetinkaya, F.; Soyutemiz, G.E. 2011: ELISA screening and liquid chromatography-tandem mass spectrometry confirmation of chloramphenicol residues in chicken muscle, and the validation of a confirmatory method by liquid chromatography-tandem mass spectrometry. Poultry Science 90(11): 2619-2626
Rodriguez, M.-V.; Hernandez, W.Y.; Garcia, A.N.; Colato, C.M.; Cardoza, P.G.; Cardozo, L.M. 2013: ELISA seroprevalence of Trypanosoma cruzi in a cohort of heart disease patients. Journal of Infection in Developing Countries 7(4): 348-354
Subasic, D.; Karamehic, J.; Gavrankapetanovic, F.; Hodzic, H.; Kasumovic, M.; Delic-Sarac, M.; Prljaca-Zecevic, L. 2009: ELISA subtypization of anti-ENA autoantibodies in clinical management of autoimmune diseases in Bosnia and Herzegovina. Medicinski Arhiv 63(6): 312-316
Sahud, M.A.; Pratt, K.P.; Zhukov, O.; Qu, K.; Thompson, A.R. 2007: ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia: the Official Journal of the World Federation of Hemophilia 13(3): 317-322
Solomon, L.W.; Stark, P.C.; Winter, L.; Kumar, V.; Sinha, S. 2010: ELISA test for p63 antibodies in chronic ulcerative stomatitis. Oral Diseases 16(2): 151-155
García-Agudo, L.; Rodríguez-Iglesias, M. 2007: ELISA test for the detection of Entamoeba histolytica in stool specimens. Enfermedades Infecciosas y Microbiologia Clinica 25(10): 657
Ding, L.; Zou, X.-J.; Ao, J.-E.; Yao, A.-X.; Cai, L. 2008: ELISA test to detect CDKN2A (p16(INK4a)) expression in exfoliative cells: a new screening tool for cervical cancer. Molecular Diagnosis and Therapy 12(6): 395-400
Kovtoniuk, H.V.; Korshun, L.M.; Shevchuk, V.O.; Kysel'ova, O.K.; Vudmaska, M.I.; Hanova, L.O.; Tereshchenko, M.I.; Moĭsa, L.M.; Spivak, M.I. 2012: ELISA test-kit for herpes 2 serodiagnosis. Mikrobiolohichnyi Zhurnal 74(2): 67-72
Raditic, D.M.; Remillard, R.L.; Tater, K.C. 2011: ELISA testing for common food antigens in four dry dog foods used in dietary elimination trials. Journal of Animal Physiology and Animal Nutrition 95(1): 90-97
Willis-Mahn, C.; Remillard, R.; Tater, K. 2014: ELISA testing for soy antigens in dry dog foods used in dietary elimination trials. Journal of the American Animal Hospital Association 50(6): 383-389
Abasq, C.; Mouquet, H.; Gilbert, D.èl.; Tron, F.ço.; Grassi, V.; Musette, P.; Joly, P. 2009: ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. Archives of Dermatology 145(5): 529-535
Mancuso, J.D.; Krauss, M.R.; Audet, S.; Beeler, J.A. 2008: ELISA underestimates measles antibody seroprevalence in US military recruits. Vaccine 26(38): 4877-4878
Brasil, P.E.A.A.; De Castro, L.; Hasslocher-Moreno, A.M.; Sangenis, L.H.C.; Braga, J.é U. 2010: ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis. Bmc Infectious Diseases 10: 337
Mantur, B.; Parande, A.; Amarnath, S.; Patil, G.; Walvekar, R.; Desai, A.; Parande, M.; Shinde, R.; Chandrashekar, M.; Patil, S. 2010: ELISA versus conventional methods of diagnosing endemic brucellosis. American Journal of Tropical Medicine and Hygiene 83(2): 314-318
Islam, M.Z.; Itoh, M.; Ul Islam, M.A.; Saifuddin Ekram, A.R.M.; Rahman, M.A.; Takagi, H.; Takesue, A.; Hashiguchi, Y.; Kimura, E. 2012: ELISA with recombinant rKRP42 antigen using urine samples: a tool for predicting clinical visceral leishmaniasis cases and its outbreak. American Journal of Tropical Medicine and Hygiene 87(4): 658-662
White, A.M.; Collett, J.R.; Seurynck-Servoss, S.L.; Daly, D.S.; Zangar, R.C. 2009: ELISA-BASE: an integrated bioinformatics tool for analyzing and tracking ELISA microarray data. Bioinformatics 25(12): 1566-1567
Meden, H.; Fattahi-Meibodi, A.; Marx, D. 2001: ELISA-Based Quantification of p105 (c-erbB-2, HER2/neu) in Serum of Ovarian Carcinoma. Methods in Molecular Medicine 39: 125-133
Sun, S.; Yang, M.; Kostov, Y.; Rasooly, A. 2010: ELISA-LOC: lab-on-a-chip for enzyme-linked immunodetection. Lab on a Chip 10(16): 2093-2100
Drabe, C.Heldbjerg.; Blauenfeldt, T.; Ruhwald, M. 2014: ELISA-based assay for IP-10 detection from filter paper samples. Methods in Molecular Biology 1172: 27-37
El-Badry, A.A. 2009: ELISA-based coproantigen in human strongyloidiaisis: a diagnostic method correlating with worm burden. Journal of the Egyptian Society of Parasitology 39(3): 757-768
Schmeding, M.; Kienlein, S.; Röcken, C.; Neuhaus, R.; Neuhaus, P.; Heidenhain, C.; Neumann, U.P. 2010: ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?. Transplant Immunology 23(4): 156-160
Lazarus, J.J.; McCarter, A.L.; Neifer-Sadhwani, K.; Wooten, R.M. 2012: ELISA-based measurement of antibody responses and PCR-based detection profiles can distinguish between active infection and early clearance of Borrelia burgdorferi. Clinical and Developmental Immunology 2012: 138069
Yonamine, Y.; Hoshino, Y.; Shea, K.J. 2012: ELISA-mimic screen for synthetic polymer nanoparticles with high affinity to target proteins. Biomacromolecules 13(9): 2952-2957
Haridy, F.M.; Shoukry, N.M.; Hassan, A.A.; Morsy, T.A. 2009: ELISA-seroprevalence of Toxoplasma gondii in draught horses in Greater Cairo, Egypt. Journal of the Egyptian Society of Parasitology 39(3): 821-826
Grop, S.; Bourgeois, P.Y.; Bazin, N.; Kersalé, Y.; Rubiola, E.; Langham, C.; Oxborrow, M.; Clapton, D.; Walker, S.; De Vicente, J.; Giordano, V. 2010: ELISA: a cryocooled 10 GHz oscillator with 10(-15) frequency stability. Review of Scientific Instruments 81(2): 025102
Hiasa, J.; Kohara, J.; Nishimura, M.; Xuan, X.; Tokimitsu, H.; Nishikawa, Y. 2012: ELISAs based on rNcGRA7 and rNcSAG1 antigens as an indicator of Neospora caninum activation. Veterinary Parasitology 187(3-4): 379-385
Malyguine, A.M.; Strobl, S.; Dunham, K.; Shurin, M.R.; Sayers, T.J. 2012: ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials. Cells 1(2): 111-126
Sibley, L.S.; White, A.D.; Marriott, A.; Dennis, M.J.; Williams, A.; Marsh, P.D.; Sharpe, S.A. 2012: ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis. Cells 1(1): 5-14
Ji, N.; Forsthuber, T.G. 2016: ELISPOT Techniques. Methods in Molecular Biology 1304: 63-71
Mahdavi, M.; Ebtekar, M.; Khorram Khorshid, H.R.; Azadmanesh, K.; Hartoonian, C.; Hassan, Z.M. 2011: ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses. Immunology Letters 140(1-2): 14-20
Horlock, C.; Stott, B.; Dyson, J.; Ogg, G.; McPherson, T.; Jones, L.; Sewell, A.K.; Wooldridge, L.; Cole, D.K.; Stebbing, J.; Savage, P. 2009: ELISPOT and functional T cell analyses using HLA mono-specific target cells. Journal of Immunological Methods 350(1-2): 150-160
Hagen, J.; Houchins, J.P.; Kalyuzhny, A.E. 2012: ELISPOT assay as a tool to study oxidative stress in lymphocytes. Methods in Molecular Biology 792: 87-96
Shin, J.-S.; Park, C.-G. 2012: ELISPOT assay as a tool to study the effects of stem cells on cytokine secretion. Methods in Molecular Biology 792: 105-114
Hagen, J.; Houchins, J.P.; Kalyuzhny, A.E. 2012: ELISPOT assay for neuroscience research: studying TNFα secretion from microglial cells. Methods in Molecular Biology 792: 97-104
Kalyuzhny, A.E. 2009: ELISPOT assay on membrane microplates. Methods in Molecular Biology 536: 355-365
Klinman, D. 2008: ELISPOT assay to detect cytokine-secreting murine and human cells. Current Protocols in Immunology Chapter 6: 6.19.1-6.19.9
Zhang, W.; Caspell, R.; Karulin, A.Y.; Ahmad, M.; Haicheur, N.; Abdelsalam, A.; Johannesen, K.; Vignard, V.; Dudzik, P.; Georgakopoulou, K.; Mihaylova, A.; Silina, K.; Aptsiauri, N.; Adams, V.; Lehmann, P.V.; McArdle, S. 2009: ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring--even in hands of ELISPOT-inexperienced investigators. Journal of Immunotoxicology 6(4): 227-234
Vordermeier, M.; Whelan, A.O. 2012: ELISPOT assays to enumerate bovine IFN-γ-secreting cells for the development of novel vaccines against bovine tuberculosis. Methods in Molecular Biology 792: 219-227
Murakami, S.; Takeno, M.; Kobayashi, M.; Kudo, M.; Watanuki, Y.; Kaneko, T.; Ishigatsubo, Y. 2009: ELISPOT response to Mycobacterium tuberculosis antigens for diagnosing and monitoring tuberculosis patient therapy. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 83(3): 229-235
Girlanda, S.; Mantegani, P.; Baldissera, E.; Aiello, P.; Ratti, M.; Sabbadini, M.G.; Fortis, C. 2010: ELISPOT-IFN-gamma assay instead of tuberculin skin test for detecting latent Mycobacterium tuberculosis infection in rheumatic patients candidate to anti-TNF-alpha treatment. Clinical Rheumatology 29(10): 1135-1141
Smedman, C.; Gårdlund, B.; Nihlmark, K.; Gille-Johnson, P.; Andersson, J.; Paulie, S. 2009: ELISpot analysis of LPS-stimulated leukocytes: human granulocytes selectively secrete IL-8, MIP-1beta and TNF-alpha. Journal of Immunological Methods 346(1-2): 1-8
Hagen, J.; Houchins, J.P.; Kalyuzhny, A.E. 2011: ELISpot assay as a tool to study oxidative stress in peripheral blood mononuclear cells. Methods in Molecular Biology 682: 207-215
Slota, M.; Lim, J.-B.; Dang, Y.; Disis, M.L. 2011: ELISpot for measuring human immune responses to vaccines. Expert Review of Vaccines 10(3): 299-306
Fiolka, A.; Gillen, S.; Meining, A.; Feussner, H. 2010: ELITE--the ex vivo training unit for NOTES: development and validation. Minimally Invasive Therapy and Allied Technologies: Mitat: Official Journal of the Society for Minimally Invasive Therapy 19(5): 281-286
Wang, B.; Chiang, H.-D. 2011: ELITE: ensemble of optimal input-pruned neural networks using TRUST-TECH. IEEE Transactions on Neural Networks 22(1): 96-109
Anonymous 1938: ELIXIR SULFANILAMIDE-MASSENGILL: Report of the United States Secretary of Agriculture. California and Western Medicine 48(1): 68-70
Crosswell, L.C.; Thornton, J.M. 2012: ELIXIR: a distributed infrastructure for European biological data. Trends in Biotechnology 30(5): 241-242
Odrowaz, Z.; Sharrocks, A.D. 2012: ELK1 uses different DNA binding modes to regulate functionally distinct classes of target genes. Plos Genetics 8(5): E1002694
Heo, S.-H.; Cho, J.-Y. 2014: ELK3 suppresses angiogenesis by inhibiting the transcriptional activity of ETS-1 on MT1-MMP. International Journal of Biological Sciences 10(4): 438-447
Day, B.W.; Stringer, B.W.; Spanevello, M.D.; Charmsaz, S.; Jamieson, P.R.; Ensbey, K.S.; Carter, J.C.; Cox, J.M.; Ellis, V.J.; Brown, C.L.; Walker, D.G.; Inglis, P.L.; Allan, S.; Reynolds, B.A.; Lickliter, J.D.; Boyd, A.W. 2011: ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1. Neuro-Oncology 13(11): 1202-1212
Billings, S.E.; Clarke, G.ël.L.; Nishimune, H. 2012: ELKS1 and Ca(2+) channel subunit β4 interact and colocalize at cerebellar synapses. Neuroreport 23(1): 49-54
Kaeser, P.S.; Deng, L.; Chávez, A.és.E.; Liu, X.; Castillo, P.E.; Südhof, T.C. 2009: ELKS2alpha/CAST deletion selectively increases neurotransmitter release at inhibitory synapses. Neuron 64(2): 227-239
Zhang, W.; Ji, W.; Liu, X.; Ouyang, G.; Xiao, W. 2014: ELL inhibits E2F1 transcriptional activity by enhancing E2F1 deacetylation via recruitment of histone deacetylase 1. Molecular and Cellular Biology 34(4): 765-775
Liu, L.; Ai, J.; Xiao, W.; Liu, J.; Wang, Y.; Xin, D.; He, Z.; Guo, Y.; Wang, Z. 2010: ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells. Prostate 70(7): 797-805
Mourgues, S.; Gautier, V.; Lagarou, A.; Bordier, C.; Mourcet, A.; Slingerland, J.; Kaddoum, L.; Coin, F.éd.ér.; Vermeulen, W.; Gonzales de Peredo, A.; Monsarrat, B.; Mari, P.-O.; Giglia-Mari, G. 2013: ELL, a novel TFIIH partner, is involved in transcription restart after DNA repair. Proceedings of the National Academy of Sciences of the United States of America 110(44): 17927-17932
Dupuis-Girod, S.; Ambrun, A.; Decullier, E.; Samson, G.ér.; Roux, A.; Fargeton, A.-E.; Rioufol, C.; Schwiertz, V.; Disant, F.ço.; Chapuis, F.ço.; Donazzolo, Y.; Paintaud, G.; Edery, P.; Faure, F. 2014: ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia. Mabs 6(3): 794-799
Anonymous 1946: ELLIS flotation stretcher. Air Sea Rescue Bulletin 3(9): 22-24
Ueno, K.; Ishii, A.; Ito, K. 2014: ELM: enhanced lowest common ancestor based method for detecting a pathogenic virus from a large sequence dataset. Bmc Bioinformatics 15: 254
Gould, C.M.; Diella, F.; Via, A.; Puntervoll, P.ål.; Gemünd, C.; Chabanis-Davidson, S.; Michael, S.; Sayadi, A.; Bryne, J.C.; Chica, C.; Seiler, M.; Davey, N.E.; Haslam, N.; Weatheritt, R.J.; Budd, A.; Hughes, T.; Pas, J.; Rychlewski, L.; Travé, G.; Aasland, R.; Helmer-Citterich, M.; Linding, R.; Gibson, T.J. 2010: ELM: the status of the 2010 eukaryotic linear motif resource. Nucleic Acids Research 38(Database Issue): D167-D180
East, M.P.; Bowzard, J.B.; Dacks, J.B.; Kahn, R.A. 2012: ELMO domains, evolutionary and functional characterization of a novel GTPase-activating protein (GAP) domain for Arf protein family GTPases. Journal of Biological Chemistry 287(47): 39538-39553
Margaron, Y.; Fradet, N.; Côté, J.-F.ço. 2013: ELMO recruits actin cross-linking family 7 (ACF7) at the cell membrane for microtubule capture and stabilization of cellular protrusions. Journal of Biological Chemistry 288(2): 1184-1199
Capala, M.E.; Vellenga, E.; Schuringa, J.J. 2014: ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML. Plos one 9(10): E111568
Elliott, M.R.; Ravichandran, K.S. 2010: ELMO1 signaling in apoptotic germ cell clearance and spermatogenesis. Annals of the new York Academy of Sciences 1209: 30-36
Hanson, R.L.; Millis, M.P.; Young, N.J.; Kobes, S.; Nelson, R.G.; Knowler, W.C.; DiStefano, J.K. 2010: ELMO1 variants and susceptibility to diabetic nephropathy in American Indians. Molecular genetics and metabolism 101(4): 383-390
Pulkkinen, V.; Bruce, S.; Rintahaka, J.; Hodgson, U.; Laitinen, T.; Alenius, H.; Kinnula, V.L.; Myllärniemi, M.; Matikainen, S.; Kere, J. 2010: ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 24(4): 1167-1177
Etienne, G.; Dulucq, S.ép.; Lascaux, A.; Schmitt, A.; Bidet, A.; Fort, M.-P.; Lippert, E.; Bureau, C.; Adiko, D.; Hayette, S.; Reiffers, J.; Nicolini, F.-E.; Mahon, F.ço.-X. 2015: ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?. American Journal of Hematology 90(1): 37-41
Guemann, A.-S.; Andrieux, J.; Petit, F.; Halimi, E.; Bouquillon, S.; Manouvrier-Hanu, S.; Van De Kamp, J.; Boileau, C.; Hanna, N.; Jondeau, G.; Vaksmann, G.; Houfflin-Debarge, V.; Holder-Espinasse, M. 2015: ELN gene triplication responsible for familial supravalvular aortic aneurysm. Cardiology in the Young 25(4): 712-717
Drake, D.J. 2007: ELN implementation challenges. Drug Discovery Today 12(15-16): 647-649
Nelson, R. 2008: ELNEC: going strong after 10 years. Transforming end-of-life care. American Journal of Nursing 108(6): 86-87
Lu, J.; Gao, S.-P.; Yuan, J. 2012: ELNES for boron, carbon, and nitrogen K-edges with different chemical environments in layered materials studied by density functional theory. Ultramicroscopy 112(1): 61-68
Riedl, T.; Gemming, T.; Weissbach, T.; Seifert, G.; Gutmann, E.; Zschornak, M.; Meyer, D.C.; Gemming, S. 2009: ELNES study of chemical solution deposited SrO(SrTiO(3))(n) Ruddlesden-Popper films: experiment and simulation. Ultramicroscopy 110(1): 26-32
Skylar, A.; Matsuwaka, S.; Wu, X. 2013: ELONGATA3 is required for shoot meristem cell cycle progression in Arabidopsis thaliana seedlings. Developmental Biology 382(2): 436-445
Ohno, Y.; Suto, S.; Yamanaka, M.; Mizutani, Y.; Mitsutake, S.; Igarashi, Y.; Sassa, T.; Kihara, A. 2010: ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proceedings of the National Academy of Sciences of the United States of America 107(43): 18439-18444
Zadravec, D.; Tvrdik, P.; Guillou, H.é; Haslam, R.; Kobayashi, T.; Napier, J.A.; Capecchi, M.R.; Jacobsson, A. 2011: ELOVL2 controls the level of n-6 28:5 and 30:5 fatty acids in testis, a prerequisite for male fertility and sperm maturation in mice. Journal of Lipid Research 52(2): 245-255
Alsaleh, A.; Maniou, Z.; Lewis, F.J.; Hall, W.L.; Sanders, T.A.B.; O'Dell, S.D. 2014: ELOVL2 gene polymorphisms are associated with increases in plasma eicosapentaenoic and docosahexaenoic acid proportions after fish oil supplement. Genes and Nutrition 9(1): 362
Yu, M.; Benham, A.; Logan, S.; Brush, R.S.; Mandal, M.N.A.; Anderson, R.E.; Agbaga, M.-P. 2012: ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3. Journal of Lipid Research 53(3): 494-504
Di Gregorio, E.; Borroni, B.; Giorgio, E.; Lacerenza, D.; Ferrero, M.; Lo Buono, N.; Ragusa, N.; Mancini, C.; Gaussen, M.; Calcia, A.; Mitro, N.; Hoxha, E.; Mura, I.; Coviello, D.A.; Moon, Y.-A.; Tesson, C.; Vaula, G.; Couarch, P.; Orsi, L.; Duregon, E.; Papotti, M.G.; Deleuze, J.-F.ço.; Imbert, J.; Costanzi, C.; Padovani, A.; Giunti, P.; Maillet-Vioud, M.; Durr, A.; Brice, A.; Tempia, F.; Funaro, A.; Boccone, L.; Caruso, D.; Stevanin, G.; Brusco, A. 2014: ELOVL5 mutations cause spinocerebellar ataxia 38. American Journal of Human Genetics 95(2): 209-217
Morcillo, S.; Martín-Núñez, G.M.ía.; Rojo-Martínez, G.; Almaraz, M.ía.C.; García-Escobar, E.; Mansego, M.ía.L.; de Marco, G.; Chaves, F.J.; Soriguer, F. 2011: ELOVL6 genetic variation is related to insulin sensitivity: a new candidate gene in energy metabolism. Plos one 6(6): E21198
Lee, Y.; Min, K.; Son, H.; Park, A.R.; Kim, J.-C.; Choi, G.J.; Lee, Y.-W. 2014: ELP3 is involved in sexual and asexual development, virulence, and the oxidative stress response in Fusarium graminearum. Molecular Plant-Microbe Interactions: Mpmi 27(12): 1344-1355
Iizumi, T.; Semenov, M.A.; Nishimori, M.; Ishigooka, Y.; Kuwagata, T. 2012: ELPIS-JP: a dataset of local-scale daily climate change scenarios for Japan. Philosophical Transactions. Series A Mathematical Physical and Engineering Sciences 370(1962): 1121-1139
Conrad, U.; Plagmann, I.; Malchow, S.; Sack, M.; Floss, D.M.; Kruglov, A.A.; Nedospasov, S.A.; Rose-John, S.; Scheller, Jürgen. 2011: ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock. Plant Biotechnology Journal 9(1): 22-31
Hosking, M.P.; Lane, T.E. 2014: ELR(+) chemokine signaling in host defense and disease in a viral model of central nervous system disease. Frontiers in Cellular Neuroscience 8: 165
Rubie, C.; Frick, V.O.; Wagner, M.; Schuld, J.; Gräber, S.; Brittner, B.; Bohle, R.M.; Schilling, M.K. 2008: ELR+ CXC chemokine expression in benign and malignant colorectal conditions. Bmc Cancer 8: 178
O'Hayer, K.M.; Brady, D.C.; Counter, C.M. 2009: ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis. Carcinogenesis 30(11): 1841-1847
Wei, J.; Chen, X.; Li, Q.; Chen, J.; Khan, N.; Wang, B.; Cheng, J.-W.; Gordon, J.R.; Li, F. 2014: ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity. Oncology Reports 31(4): 1599-1604
Zhao, X.; Town, J.R.; Li, F.; Zhang, X.; Cockcroft, D.W.; Gordon, J.R. 2009: ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. Journal of Immunology 182(5): 3213-3222
Yates, C.C.; Whaley, D.; Y-Chen, A.; Kulesekaran, P.; Hebda, P.A.; Wells, A. 2008: ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. American Journal of Pathology 173(3): 643-652
Carew, J.S.; Esquivel, J.A.; Espitia, C.M.; Schultes, C.M.; Mülbaier, M.; Lewis, J.D.; Janssen, B.; Giles, F.J.; Nawrocki, S.T. 2012: ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinoma. Plos one 7(1): E31120
Risinger, A.L.; Westbrook, C.D.; Encinas, A.; Mülbaier, M.; Schultes, C.M.; Wawro, S.; Lewis, J.D.; Janssen, B.; Giles, F.J.; Mooberry, S.L. 2011: ELR510444, a novel microtubule disruptor with multiple mechanisms of action. Journal of Pharmacology and Experimental Therapeutics 336(3): 652-660
Galvão, A.éi.S.; Gondim, M.G.C.; Michereff, S.J. 2009: Diagrammatic scale of Aceria guerreronis Keifer (Acari: Eriophyidae) damage in coconut. Neotropical Entomology 37(6): 723-728
Barreto, S.M.; Ladeira, R.M.; Bastos, M.d.S.C.B.d.O.; Diniz, M.d.F.át.H.S.; Jesus, E.A.d.; Kelles, S.M.ár.B.; Luft, V.C.; Melo, E.C.P.; Oliveira, E.R.A.új.d. 2013: ELSA-Brasil strategies for outcome identification, investigation and ascertainment. Revista de Saude Publica 47(Suppl 2): 79-86
Yoshizawa, G.; Ho, C.W.-L.; Zhu, W.; Hu, C.; Syukriani, Y.; Lee, I.; Kim, H.; Tsai, D.F.C.; Minari, J.; Kato, K. 2014: ELSi practices in genomic research in East Asia: implications for research collaboration and public participation. Genome Medicine 6(5): 39
Mourão Carvalhal, M.Isabel.Martins.; Fonseca, S.; de Castro Coelho, E.Maria.Rocha.Teles. 2011: ELSa interventional Portuguese health program to promote physical activity. International Journal of Pediatric Obesity: Ijpo: An Official Journal of the International Association for the Study of Obesity 6 Suppl. 2: 39-41
Towner, R.A.; Jensen, R.L.; Colman, H.; Vaillant, B.; Smith, N.; Casteel, R.; Saunders, D.; Gillespie, D.L.; Silasi-Mansat, R.; Lupu, F.; Giles, C.B.; Wren, J.D. 2013: ELTD1, a potential new biomarker for gliomas. Neurosurgery 72(1): 77-90; Discussion 91
Sodtke, D.; Armbruster, M.M. 2007: ELTERN-AG--the low threshold school for parents for the early childhood. Praxis der Kinderpsychologie und Kinderpsychiatrie 56(8): 707-720
Hayashi, T.; Iwata, H. 2010: EM algorithm for Bayesian estimation of genomic breeding values. Bmc Genetics 11: 3
Fwu, J.K.; Djuric, P.M. 1997: EM algorithm for image segmentation initialized by a tree structure scheme. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 6(2): 349-352
Gao, F.; Liu, H. 2008: EM algorithm for the inverse problem of electrocardiography. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 25(4): 795-800
De Chastellier, C. 2008: EM analysis of phagosomes. Methods in Molecular Biology 445: 261-285
Ri, E.; Shimizuq, T.; Hirata, Y.; Inagaki, H.; Takizawa, H.; Azuma, A.; Kawada, T.; Sugawara, I.; Kudo, S.; Sunazuka, T.; Omura, S. 2009: EM and EM703 suppress inflammatory cytokines formation by human respiratory epithelial cells provoked by diesel exhaust particles. Japanese Journal of Antibiotics 62 Suppl A: 9-12
Green, R. 2008: EM dual training impacts the advancement of the specialty. Cjem 10(4): 322; Author Reply 322-4
Ibáñez-Marcelo, E.; Casanellas, M. 2014: EM for phylogenetic topology reconstruction on nonhomogeneous data. Bmc Evolutionary Biology 14: 132
Wang, Z.; Ma, S.; Wang, C.-Y.; Zappitelli, M.; Devarajan, P.; Parikh, C. 2014: EM for regularized zero-inflated regression models with applications to postoperative morbidity after cardiac surgery in children. Statistics in Medicine 33(29): 5192-5208
Ferlenghi, I.; Ilaria, F.; Giusti, F. 2011: EM reconstruction of adhesins: future prospects. Advances in Experimental Medicine and Biology 715: 271-284
Andreyev, A.; Sitek, A.; Celler, A. 2014: EM reconstruction of dual isotope PET using staggered injections and prompt gamma positron emitters. Medical Physics 41(2): 022501
Ramme, A.J.; Criswell, A.J.; Wolf, B.R.; Magnotta, V.A.; Grosland, N.M. 2011: EM segmentation of the distal femur and proximal tibia: a high-throughput approach to anatomic surface generation. Annals of Biomedical Engineering 39(5): 1555-1562
Adair, B.D.; Xiong, J.-P.; Alonso, J.é L.; Hyman, B.T.; Arnaout, M.A. 2013: EM structure of the ectodomain of integrin CD11b/CD18 and localization of its ligand-binding site relative to the plasma membrane. Plos one 8(2): E57951
Donaghy, S. 2008: EM training. Cjem 10(3): 196; Author Reply 196
Ovens, H.; Letovsky, E. 2008: EM training in Canada: two is better than one. Cjem 10(4): 319; Author Reply 322-4
Zhou, H.; Zhang, Y. 2012: EM vs MM: a Case Study. Computational Statistics and Data Analysis 56(12): 3909-3920
Migheli, A. 2011: EM-ISEL: a useful tool to visualize DNA damage at the ultrastructural level. Methods in Molecular Biology 682: 29-36
Mehrtash, A.; Damato, A.; Pernelle, G.; Barber, L.; Farhat, N.; Viswanathan, A.; Cormack, R.; Kapur, T. 2014: EM-Navigated Catheter Placement for Gynecologic Brachytherapy: An Accuracy Study. Proceedings of Spie--the International Society for Optical Engineering 9036: 90361f
Lindert, S.; Staritzbichler, R.é; Wötzel, N.; Karakaş, M.; Stewart, P.L.; Meiler, J. 2009: EM-fold: de novo folding of alpha-helical proteins guided by intermediate-resolution electron microscopy density maps. Structure 17(7): 990-1003
Lindert, S.; Alexander, N.; Wötzel, N.; Karakaş, M.; Stewart, P.L.; Meiler, J. 2012: EM-fold: de novo atomic-detail protein structure determination from medium-resolution density maps. Structure 20(3): 464-478
Karna, P.; Sharp, S.M.; Yates, C.; Prakash, S.; Aneja, R. 2009: EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells. Molecular Cancer 8: 93
El Yamani, F.-Z.; Yon, L.; Guérin, M.èn.; El Ouezzani, S.; Alaoui, A.; Chartrel, N.; Anouar, Y.; Magoul, R. 2010: EM66-containing neurones in the hypothalamic parvicellular paraventricular nucleus of the rat: no plasticity related to acute immune stress. Neuro Endocrinology Letters 31(5): 609-615
Matsune, S.; Oohori, J.; Yoshifuku, K.; Harada, M.; Kurono, Y.; Sunazuka, T. 2009: EM900 and eosinophilic paranasal sinusitis. Japanese Journal of Antibiotics 62 Suppl A: 5-8
Weiss, G.Garfinkel.; Gordon, B. 2011: EM@IL and your patients. Too risky & time-consuming, or an idea whose time has come?. Medical Economics 88(11): 22-4 29 31-3
Servant, N.; Gravier, E.; Gestraud, P.; Laurent, C.; Paccard, C.; Biton, A.; Brito, I.; Mandel, J.; Asselain, B.; Barillot, E.; Hupé, P. 2010: EMA - a R package for Easy Microarray data analysis. Bmc Research Notes 3: 277
Mayor, S. 2013: EMA confirms that hydroxyethyl starch solutions should not be used in critically ill, sepsis, or burns patients. Bmj 347: F6197
Barbui, C.; Baschirotto, C.; Cipriani, A. 2011: EMA must improve the quality of its clinical trial reports. Bmj 342: D2291
Doshi, P. 2014: EMA policy on transparency is "strikingly" similar to deal struck with drug company, say experts. Bmj 348: G3852
Doyle, L.A.; Fletcher, C.D.M. 2011: EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall. Journal of Cutaneous Pathology 38(9): 697-703
Peng, K.; Steele, S.C.; Becerra, L.; Borsook, D. 2018: Brodmann area 10: Collating, integrating and high level processing of nociception and pain. Progress in Neurobiology 161: 1-22
Uter, W.; Schnuch, A. 2011: EMA revokes marketing authorization for bufexamac. Contact Dermatitis 64(4): 235-236
Anonymous 2014: EMA to publish clinical trial reports. Cancer discovery 4(9): 981
Braillon, A. 2011: EMA urgently needs a cure. Bmj 342: D3832
Kmietowicz, Z. 2014: EMA's proposal to vet drug research that uses its data is "outdated," say critics. Bmj 349: G5076
Bertele', V.; Banzi, R.; Gluud, C.; Garattini, S. 2012: EMA's reflection on placebo does not reflect patients' interests. European Journal of Clinical Pharmacology 68(5): 877-879
Pott, A. 2011: EMA's response to articles. Bmj 342: D3838
Rosén, M.ån. 2013: EMA, transparency, and decision-making process. Lancet 382(9886): 26-27
Lu, W.-G.; Ye, F.; Shen, Y.-M.; Fu, Y.-F.; Chen, H.-Z.; Wan, X.-Y.; Xie, X. 2008: EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 18(2): 357-362
Svensén, C.; Hjelmqvist, H. 2014: EMA-decision on HES-restrictions. Lakartidningen 111(1-2): 20
Huang, R.-Y.; Fang, M.; Luo, Y.-S.; Liu, H.-C.; Lu, Q.-R.; Wang, G.-Q. 2014: EMA-pCR detection of enterohemorrhagic Eschrichia coli O157:H7. Sichuan da Xue Xue Bao. Yi Xue Ban 45(1): 152-155
Wang, L.; Mustapha, A. 2010: EMA-real-time PCR as a reliable method for detection of viable Salmonella in chicken and eggs. Journal of Food Science 75(3): M134-M139
Rice, A.S.C.; Dworkin, R.H.; McCarthy, T.D.; Anand, P.; Bountra, C.; McCloud, P.I.; Hill, J.; Cutter, G.; Kitson, G.; Desem, N.; Raff, M. 2014: EMA401, an orally administered highly selective angiotensin Ii type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 383(9929): 1637-1647
Barton, G.; Abbott, J.; Chiba, N.; Huang, D.W.; Huang, Y.; Krznaric, M.; Mack-Smith, J.; Saleem, A.; Sherman, B.T.; Tiwari, B.; Tomlinson, C.; Aitman, T.; Darlington, J.; Game, L.; Sternberg, M.J.E.; Butcher, S.A. 2008: EMAAS: an extensible grid-based rich internet application for microarray data analysis and management. Bmc Bioinformatics 9: 493
Urbain, R.ém.; Teillaud, J.-L.; Prost, J.-F.ço. 2009: EMABling antibodies: from feto-maternal allo-immunisation prophylaxis to chronic lymphocytic leukaemia therapy. Medecine Sciences: M/S 25(12): 1141-1144
Kalis, M.A. 2007: EMAC and environmental health in emergency response. Journal of Environmental Health 69(10): 61-62
Lopez, W.; Kershner, S.P.; Penn, M.S. 2013: EMAC volunteers: liability and workers' compensation. Biosecurity and Bioterrorism: Biodefense Strategy Practice and Science 11(3): 217-225
Richardson, L.; Venkataraman, S.; Stevenson, P.; Yang, Y.; Burton, N.; Rao, J.; Fisher, M.; Baldock, R.A.; Davidson, D.R.; Christiansen, J.H. 2010: EMAGE mouse embryo spatial gene expression database: 2010 update. Nucleic Acids Research 38(Database Issue): D703-D709
Richardson, L.; Venkataraman, S.; Stevenson, P.; Yang, Y.; Moss, J.; Graham, L.; Burton, N.; Hill, B.; Rao, J.; Baldock, R.A.; Armit, C. 2014: EMAGE mouse embryo spatial gene expression database: 2014 update. Nucleic Acids Research 42(Database Issue): D835-D844
Venkataraman, S.; Stevenson, P.; Yang, Y.; Richardson, L.; Burton, N.; Perry, T.P.; Smith, P.; Baldock, R.A.; Davidson, D.R.; Christiansen, J.H. 2008: EMAGE--Edinburgh Mouse Atlas of Gene Expression: 2008 update. Nucleic Acids Research 36(Database Issue): D860-D865
Richardson, L.; Stevenson, P.; Venkataraman, S.; Yang, Y.; Burton, N.; Rao, J.; Christiansen, J.H.; Baldock, R.A.; Davidson, D.R. 2014: EMAGE: Electronic Mouse Atlas of Gene Expression. Methods in Molecular Biology 1092: 61-79
Galmiche, J-Paul. 2008: EMANCIPATE study: drawing conclusions may be difficult in the absence of fundamental information. European Journal of Gastroenterology and Hepatology 20(2): 151-2; Author Reply 153-5
Labenz, J. 2008: EMANCIPATE versus EXPO: different results can be explained by differing study designs. European Journal of Gastroenterology and Hepatology 20(2): 152; Author Reply 153-5
Schwarz, R.E.; Awasthi, N.; Konduri, S.; Cafasso, D.; Schwarz, M.A. 2010: EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer. Annals of Surgical Oncology 17(5): 1442-1452
Hayamizu, T.F.; Wicks, M.N.; Davidson, D.R.; Burger, A.; Ringwald, M.; Baldock, R.A. 2013: EMAP/EMAPA ontology of mouse developmental anatomy: 2013 update. Journal of Biomedical Semantics 4(1): 15
Brincat, M.; Calleja-Agius, J.; Erel, C.Tamer.; Gambacciani, M.; Lambrinoudaki, I.; Moen, M.H.; Schenck-Gustafsson, K.; Tremollieres, F.; Vujovic, S.; Rees, M.; Rozenberg, S. 2011: EMAS position statement: Bone densitometry screening for osteoporosis. Maturitas 68(1): 98-101
Mintziori, G.; Lambrinoudaki, I.; Ceausu, I.; Depypere, H.; Erel, C.Tamer.; Pérez-López, F.R.; Schenck-Gustafsson, K.; van der Schouw, Y.T.; Simoncini, T.; Tremollieres, F.; Tarlatzis, B.C.; Rees, M.; Goulis, D.G. 2014: EMAS position statement: Fertility preservation. Maturitas 77(1): 85-89
Tremollieres, F.; Brincat, M.; Erel, C.Tamer.; Gambacciani, M.; Lambrinoudaki, I.; Moen, M.H.; Schenck-Gustafsson, K.; Vujovic, S.; Rozenberg, S.; Rees, M. 2011: EMAS position statement: Managing menopausal women with a personal or family history of VTE. Maturitas 69(2): 195-198
Schenck-Gustafsson, K.; Brincat, M.; Erel, C.Tamer.; Gambacciani, M.; Lambrinoudaki, I.; Moen, M.H.; Tremollieres, F.; Vujovic, S.; Rozenberg, S.; Rees, M. 2011: EMAS position statement: Managing the menopause in the context of coronary heart disease. Maturitas 68(1): 94-97
Moen, M.H.; Rees, M.; Brincat, M.; Erel, T.; Gambacciani, M.; Lambrinoudaki, I.; Schenck-Gustafsson, K.; Tremollieres, F.; Vujovic, S.; Rozenberg, S. 2010: EMAS position statement: Managing the menopause in women with a past history of endometriosis. Maturitas 67(1): 94-97
Vujovic, S.; Brincat, M.; Erel, T.; Gambacciani, M.; Lambrinoudaki, I.; Moen, M.H.; Schenck-Gustafsson, K.; Tremollieres, F.; Rozenberg, S.; Rees, M. 2010: EMAS position statement: Managing women with premature ovarian failure. Maturitas 67(1): 91-93
Brockie, J.; Lambrinoudaki, I.; Ceausu, I.; Depypere, H.; Erel, C.Tamer.; Pérez-López, F.R.; Schenck-Gustafsson, K.; van der Schouw, Y.T.; Simoncini, T.; Tremollieres, F.; Rees, M. 2014: EMAS position statement: Menopause for medical students. Maturitas 78(1): 67-69
Triantafyllopoulos, I.K.; Lambropoulou-Adamidou, K.; Nacopoulos, C.C.; Papaioannou, N.A.; Ceausu, I.; Depypere, H.; Erel, C.Tamer.; Pérez-López, F.R.; Schenck-Gustafsson, K.; van der Schouw, Y.T.; Simoncini, T.; Tremollieres, F.; Rees, M.; Lambrinoudaki, I. 2014: EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture. Maturitas 78(2): 131-137
Depypere, H.; Desreux, J.; Pérez-López, F.R.; Ceausu, I.; Erel, C.Tamer.; Lambrinoudaki, I.; Schenck-Gustafsson, K.; van der Schouw, Y.T.; Simoncini, T.; Tremollieres, F.; Rees, M.; Emas 2014: EMAS position statement: individualized breast cancer screening versus population-based mammography screening programmes. Maturitas 79(4): 481-486
Pérez-López, F.R.; Ornat, Lía.; Ceausu, I.; Depypere, H.; Erel, C.Tamer.; Lambrinoudaki, I.; Schenck-Gustafsson, K.; Simoncini, T.; Tremollieres, F.; Rees, M. 2014: EMAS position statement: management of uterine fibroids. Maturitas 79(1): 106-116
Lambrinoudaki, I.; Brincat, M.; Erel, C.Tamer.; Gambacciani, M.; Moen, M.H.; Schenck-Gustafsson, K.; Tremollieres, F.; Vujovic, S.; Rees, M.; Rozenberg, S. 2010: EMAS position statement: managing obese postmenopausal women. Maturitas 66(3): 323-326
Erel, C.Tamer.; Brincat, M.; Gambacciani, M.; Lambrinoudaki, I.; Moen, M.H.; Schenck-Gustafsson, K.; Tremollieres, F.; Vujovic, S.; Rozenberg, S.; Rees, M. 2010: EMAS position statement: managing the menopause in women with epilepsy. Maturitas 66(3): 327-328
Rees, M. 2014: EMAS position statements and clinical guides. Maturitas 77(4): 303-304
Skouloudis, A.; Jones, K.; Sfakianaki, E.; Lazoudi, E.; Evangelinos, K. 2013: EMAS statement: benign accountability or wishful thinking? Insights from the Greek EMAS registry. Journal of Environmental Management 128: 1043-1049
Kubinyi, M.; Kreibich, O.; Neuzil, J.; Smid, R. 2011: EMAT noise suppression using information fusion in stationary wavelet packets. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 58(5): 1027-1036
Walbert, H. 2010: EMB 2010. Cooperation always pays!. MMW Fortschritte der Medizin 152(19): 11
Leder, R.S. 2009: EMB history to increase health technology literacy in the general public for improved health worldwide. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2009: 1092-1093
Liang, Q.; Lu, X.; Jiang, L.; Wang, C.; Fan, Y.; Zhang, C. 2010: EMB1211 is required for normal embryo development and influences chloroplast biogenesis in Arabidopsis. Physiologia Plantarum 140(4): 380-394
Traube, T.; Vijayakumar, S.; Hirsch, M.; Uritsky, N.; Shokhen, M.; Albeck, A. 2010: EMBM - a new enzyme mechanism-based method for rational design of chemical sites of covalent inhibitors. Journal of Chemical Information and Modeling 50(12): 2256-2265
McElheny, V.K. 1966: EMBO Gets a Modest Green Light. Science 151(3709): 436-438
Bujard, H.; Grivell, L. 2009: EMBO Molecular Medicine--where molecular biology meets clinical research. Embo Molecular Medicine 1(1): 2-3
Hentze, M.W. 2009: EMBO Molecular Medicine: Conquering new frontiers. Embo Molecular Medicine 1(1): 5
Pulverer, B. 2014: EMBO Press - a new way to publish. EMBO Journal 33(1): 1-2
McKenna, N.J. 2012: EMBO Retinoids 2011: Mechanisms, biology and pathology of signaling by retinoic acid and retinoic acid receptors. Nuclear Receptor Signaling 10: E003
Nurse, P. 2014: EMBO at 50. Science 343(6167): 117
Dimmeler, S.; Carret, C.él.; Buccione, R. 2014: EMBO molecular medicine: fast forward. Embo Molecular Medicine 6(1): 1
Lin, N.U.; Burstein, H.J. 2011: EMBRACE, eribulin, and new realities of advanced breast cancer. Lancet 377(9769): 878-880
Blank, U.; Pucillo, C.E. 2015: EMBRN-COST International Mast cell and Basophil Meeting, satellite pof ICI2013. Molecular Immunology 63(1): 1-2
Webb-Johnson, A.E. 1925: EMBRYOMA OF THE TESTIS: Sudden Death from Thrombosis of Pulmonary Veins. British Medical Journal 2(3388): 1048-1049
Yu, D.; Jiang, L.; Gong, H.; Liu, C.-M. 2012: EMBRYONIC FACTOR 19 encodes a pentatricopeptide repeat protein that is essential for the initiation of zygotic embryogenesis in Arabidopsis. Journal of Integrative Plant Biology 54(1): 55-64
Pu, L.; Liu, M-Sen.; Kim, S.Yeol.; Chen, L-Fang.O.; Fletcher, J.C.; Sung, Z.Renee. 2013: EMBRYONIC FLOWER1 and ULTRAPETALA1 Act Antagonistically on Arabidopsis Development and Stress Response. Plant Physiology 162(2): 812-830
Wheeler, B. 2014: EMBS at half a century: IEEE's original life science and biomedical engineering initiative grows stronger every year. IEEE Pulse 5(1): 6; 13
Sharma, P.; Vasan, S.N.S.; Jain, A.; Panse, A.; Titus, A.H.; Cartwright, A.N.; Bednarek, D.R.; Rudin, S. 2011: EMCCD-based high resolution dynamic x-ray detector for neurovascular interventions. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2011: 7787-7790
Bestvater, F.; Seghiri, Z.; Kang, M.S.; Gröner, N.; Lee, J.Y.; Im, K.-B.; Wachsmuth, M. 2010: EMCCD-based spectrally resolved fluorescence correlation spectroscopy. Optics Express 18(23): 23818-23828
Stöger-Pollach, M.; Treiber, C.D.; Resch, G.P.; Keays, D.A.; Ennen, I. 2011: EMCD real space maps of Magnetospirillum magnetotacticum. Micron 42(5): 456-460
Cheng, H.-L.; Kuo, C.-Y.; Liao, Y.-W.; Lin, C.-C. 2012: EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-α-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner. European Journal of Pharmacology 689(1-3): 241-248
Ferri, M.; Bo, A. 2013: EMCDDA Best Practice Promotion in Europe: an internet based dissemination tool. Adicciones 25(1): 3-6
Wiessing, L.; Olszewski, D.; Klempová, D.; Vicente, J.; Griffiths, P. 2009: EMCDDA annual report 2009: cocaine and heroin maintain firm hold on Europe's drug scene. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 14(46)
Anonymous 2012: EMCDDA publishes 2012 report on the state of the drugs problem in Europe. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 17(46)
Wiessing, L.; Blystad, H. 2010: EMCDDA publishes guidelines on testing for HIV, viral hepatitis and other infections in injecting drug users. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 15(48)
Anonymous 2009: EMCDDA publishes updated version of the drug-related infectious diseases testing guidelines in July 2009. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 14(32)
Hirai, T.; Rosenberg, J.; Nathan, S.; Blair, J.E.A. 2018: Broken arrow: Successful retrieval of a dislodged coronary orbital atherectomy microtip. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 92(3): 511-514
Bladt, F.; Faden, B.; Friese-Hamim, M.; Knuehl, C.; Wilm, C.; Fittschen, C.; Grädler, U.; Meyring, M.; Dorsch, D.; Jaehrling, F.; Pehl, U.; Stieber, F.; Schadt, O.; Blaukat, A. 2013: EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 19(11): 2941-2951
Ochala, J.; Radell, P.J.; Eriksson, L.I.; Larsson, L. 2010: EMD 57033 partially reverses ventilator-induced diaphragm muscle fibre calcium desensitisation. Pflugers Archiv: European Journal of Physiology 459(3): 475-483
Alkan, E.A.; Parlar, A. 2011: EMD or subepithelial connective tissue graft for the treatment of single gingival recessions: a pilot study. Journal of Periodontal Research 46(6): 637-642
Nimunkar, A.J.; Tompkins, W.J. 2007: EMD-based 60-Hz noise filtering of the ECG. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2007: 1904-1907
Ackermann, T.F.; Boini, K.M.; Beier, N.; Scholz, W.; Fuchss, T.; Lang, F. 2011: EMD638683, a novel SGK inhibitor with antihypertensive potency. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 28(1): 137-146
Steele, R.; Kiss, A. 2008: EMDOC (Emergency Department overcrowding) Internet-based safety net research. Journal of Emergency Medicine 35(1): 101-107
Faretta, E. 2012: EMDR and Cognitive-Behavioural Therapy in the treatment of Panic Disorder: a comparison. Rivista di Psichiatria 47(2 Suppl): 19-25
Fernandez, I.; Giovannozzi, G. 2012: EMDR and adaptive information processing. Psychotherapy as a stimulation of the self-reparative psychological processes. Rivista di Psichiatria 47(2 Suppl): 4-7
van den Hout, M.A.; Engelhard, I.M.; Beetsma, D.; Slofstra, C.; Hornsveld, H.; Houtveen, J.; Leer, A. 2011: EMDR and mindfulness. Eye movements and attentional breathing tax working memory and reduce vividness and emotionality of aversive ideation. Journal of Behavior Therapy and Experimental Psychiatry 42(4): 423-431
Arnone, R.; Orrico, A.; D'aquino, G.; Di Munzio, W. 2012: EMDR and psychopharmacological therapy in the treatment of the post-traumatic stress disorder. Rivista di Psichiatria 47(2 Suppl): 8-11
Carpenter, J.T. 2004: EMDR as an integrative psychotherapy approach: Experts explore the paradigm prism. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 14(1): 135-136
Kapoula, Z.; Yang, Q.; Bonnet, A.; Bourtoire, P.; Sandretto, J. 2010: EMDR effects on pursuit eye movements. Plos one 5(5): E10762
Norgate, K. 2012: EMDR for post-traumatic stress and other psychological trauma. Nursing Times 108(44): 24-26
Onofri, A. 2012: EMDR in Psychiatry. Introduction to the Supplement. Rivista di psichiatria 47(2 Suppl): 1-3
Beer, R.ée.; Bronner, M.B. 2010: EMDR in paediatrics and rehabilitation: an effective tool for reduction of stress reactions?. Developmental Neurorehabilitation 13(5): 307-309
Schneider, J.; Hofmann, A.; Rost, C.; Shapiro, F. 2008: EMDR in the treatment of chronic phantom limb pain. Pain Medicine 9(1): 76-82
Landin-Romero, R.; Novo, P.; Vicens, V.; McKenna, P.J.; Santed, A.; Pomarol-Clotet, E.; Salgado-Pineda, P.; Shapiro, F.; Amann, B.L. 2013: EMDR therapy modulates the default mode network in a subsyndromal, traumatized bipolar patient. Neuropsychobiology 67(3): 181-184
Ahmad, A.; Larsson, B.; Sundelin-Wahlsten, V. 2007: EMDR treatment for children with PTSD: results of a randomized controlled trial. Nordic Journal of Psychiatry 61(5): 349-354
Bossini, L.; Tavanti, M.; Calossi, S.; Polizzotto, N.R.; Vatti, G.; Marino, D.; Castrogiovanni, P. 2011: EMDR treatment for posttraumatic stress disorder, with focus on hippocampal volumes: a pilot study. Journal of Neuropsychiatry and Clinical Neurosciences 23(2): E1-E2
Mevissen, L.; Lievegoed, R.; de Jongh, A. 2011: EMDR treatment in people with mild ID and PTSD: 4 cases. Psychiatric Quarterly 82(1): 43-57
Ter Heide, F.J.J.; Mooren, T.M.; Kleijn, W.; de Jongh, A.; Kleber, R.J. 2011: EMDR versus stabilisation in traumatised asylum seekers and refugees: results of a pilot study. European Journal of Psychotraumatology 2
van den Hout, M.A.; Engelhard, I.M.; Rijkeboer, M.M.; Koekebakker, J.; Hornsveld, H.; Leer, A.; Toffolo, M.B.J.; Akse, N. 2011: EMDR: eye movements superior to beeps in taxing working memory and reducing vividness of recollections. Behaviour Research and Therapy 49(2): 92-98
Nuske, H.J.; McGhee Hassrick, E.; Bronstein, B.; Hauptman, L.; Aponte, C.; Levato, L.; Stahmer, A.; Mandell, D.S.; Mundy, P.; Kasari, C.; Smith, T. 2019: Broken bridges-new school transitions for students with autism spectrum disorder: a systematic review on difficulties and strategies for success. Autism: the International Journal of Research and Practice 23(2): 306-325
Lawson, C.L.; Baker, M.L.; Best, C.; Bi, C.; Dougherty, M.; Feng, P.; van Ginkel, G.; Devkota, B.; Lagerstedt, I.; Ludtke, S.J.; Newman, R.H.; Oldfield, T.J.; Rees, I.; Sahni, G.; Sala, R.; Velankar, S.; Warren, J.; Westbrook, J.D.; Henrick, K.; Kleywegt, G.J.; Berman, H.M.; Chiu, W. 2011: EMDataBank.org: unified data resource for CryoEM. Nucleic Acids Research 39(Database Issue): D456-D464
Hinrichs, U.; Schmidt, H.; Carpendale, S. 2008: EMDialog: bringing information visualization into the museum. IEEE Transactions on Visualization and Computer Graphics 14(6): 1181-1188
Fairclough, J.A.; Wilson, S.E. 2008: EMEA symposium on new non-pharmaceutical ways to reduce surgical site infections. Introduction. Journal of Hospital Infection 70 Suppl. 2: 1-2
Rees, I.; Langley, E.; Chiu, W.; Ludtke, S.J. 2013: EMEN2: an object oriented database and electronic lab notebook. Microscopy and Microanalysis: the Official Journal of Microscopy Society of America Microbeam Analysis Society Microscopical Society of Canada 19(1): 1-10
Hudson, D.L.; Estrin, T. 1984: EMERGE-A Data-Driven Medical Decision Making Aid. IEEE Transactions on Pattern Analysis and Machine Intelligence 6(1): 87-91
Hemp, A.; Hemp, C. 2018: Broken bridges: the isolation of Kilimanjaro's ecosystem. Global Change Biology 24(8): 3499-3507
West, J.C. 2005: EMERGENCY MEDICINE: EMTALA requires medical screening of newborns. Preston V. Meriter Hospital, Inc. Journal of Healthcare Risk Management: the Journal of the American Society for Healthcare Risk Management 25(3): 35-36
West, J.C. 2005: EMERGENCY MEDICINE: requiring a patient to sign payment guarantee does not violate EMTALA. Burton V. William Beaumont Hospital. Journal of Healthcare Risk Management: the Journal of the American Society for Healthcare Risk Management 25(3): 37-38
Duffy, J.C. 1978: Emergency Mental Health Services and a Major Aircraft Accident. Disasters 2(2-3): 159-162
Henry, J.; Henry, R.J. 1948: The effect of streptomycin on the metabolism of resting bacteria and on certain purified enzymes. Journal of Bacteriology 56(5): 527-539